rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTTACTAGCGGGAGTGAGGGTGAGCAGTTCTTCGGGCCA	CASSVTSGSEGEQFF	In	VDJ	1	22	3.898980948161276E-4	4.574565416285453E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	3	2	9	1	6	23	37	49	38	55			01,02										Vb 1	CASSVTSGSEGEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGGCTAGAGGTGAGGGGGGCCTACGAGCAGTACTTCGGGCCG	CASRLEVRGAYEQYF	In	VDJ	1	22	3.898980948161276E-4	4.574565416285453E-4	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	5	5	1	2	10	1	23	34	50	44	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASRLEVRGAYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCGGAGGGGCCGACACTGAAACTTTCTTTGGACAA	CASGGADTETFF	In	VDJ	1	22	3.898980948161276E-4	4.574565416285453E-4	36	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	10	0	12	0	13	23	-1	38	32	51			01,02										Vb 1	CASGGADTETFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01*02	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATTTAGGGTCTGGCTACACCTTCGGTTCG	CASSVDLGSGYTF	In	VDJ	1	23	4.0762073548958794E-4	4.782500207934792E-4	39	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-02	01	0	5	3	7	4	2	23	39	47	43	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVDLGSGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01		TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTATTTCGGGGCATCGGCCTATCACAGACACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	28	4.962339388568897E-4		58	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	1	7	0	3	4	18	23	38	47	42	65			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	X+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCTATGTGGGGGAACACTAAAGCTTTCTTTGGACAA	CASSPMWGNTKAFF	In	VDJ	1	29	5.1395657953035E-4	6.030108957830824E-4	42	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	4	6	1	9	7	7	23	35	47	42	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSPMWGNTKAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATAGCGGCCAGGAGACCCAGTACTTCGGGCCA	CASSVDSGQETQYF	In	VDJ	1	34	6.025697828976517E-4	7.069782916077518E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	5	5	5	1	4	23	39	46	40	50			01,02			01,02							Vb 1	CASSVDSGQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTACGGTGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSVRWGTGELFF	In	VDJ	1	35	6.202924235711121E-4	7.277717707726857E-4	42	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-02	01	1	6	2	4	4	0	23	38	-1	42	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVRWGTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01		TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCCAGACTGGGGGGGTGGTCGAGCAGTACTTCGGGCCG	CASSAQTGGVVEQYF	In	VDJ	1	40	7.089056269384139E-4	8.317391665973551E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	9	0	6	8	4	23	36	51	44	55			01,02										Vb 1	CASSAQTGGVVEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAAGGTGGACTCTCAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVEGGLSNTGELFF	In	VDJ	1	46	8.152414709791759E-4	9.565000415869584E-4	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	1	10	2	5	4	23	39	49	44	53			01,02			01,02							Vb 1	CASSVEGGLSNTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCTATGGCGGGAGGCTTGATGAGCAGTTCTTCGGGCCA	CASSVYGGRLDEQFF	In	VDJ	1	50	8.861320336730173E-4	0.0010396739582466939	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	7	1	8	5	4	23	37	50	42	54			01,02										Vb 1	CASSVYGGRLDEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCTTTCACTGAGCAGTTCTTCGGGCCA	CASSVAFTEQFF	In	VDJ	1	51	9.038546743464776E-4	0.0010604674374116278	36	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	0	3	7	9	5	0	23	39	-1	44	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVAFTEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGCGCGGGCGGAGAAGATACGCAGTATTTTGGCCCA	CASSVGAGGEDTQYF	In	VDJ	1	53	9.392999556933983E-4	0.0011020543957414954	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	7	4	5	2	6	23	39	46	41	52			01,02			01,02							Vb 1	CASSVGAGGEDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCCTACAAGGACAGGGATTCGAGCAGTTCTTCGGGCCA	CASSVLQGQGFEQFF	In	VDJ	1	73	0.0012937527691626051	0.001517923979040173	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	3	10	7	4	23	37	52	44	56			01,02										Vb 1	CASSVLQGQGFEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAGCCAGGGTCTTCCTACGAGCAGTACTTCGGGCCG	CASSVEPGSSYEQYF	In	VDJ	2	111	0.0019672131147540984	0.0023080761873076603	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	1	3	3	23	39	47	42	50			01,02										Vb 1	CASSVEPGSSYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTATCCGACAGTGGCTACGAGCAGTACTTCGGGCCG	CASSVSDSGYEQYF	In	VDJ	5	344	0.0060965883916703585	0.0071529568327372535	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	5	3	3	3	23	38	46	41	49			01,02										Vb 1	CASSVSDSGYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCGGCCATGTATCTCTGTGCTAGCAGCATCGGGACTAGCGGGAGTGCTGAGCAGTTCTTCGGGCCA	CASSIGTSGSAEQFF	In	VDJ	1	20	3.544528134692069E-4	4.1586958329867756E-4	45	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	2	9	3	3	19	31	48	34	51														CASSIGTSGSAEQFF+TCRBV11-01+TCRBJ02-01	TCRBV11-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTATAGTGGGGGAATCTCCTACGAGCAGTACTTCGGGCCG	CASSYSGGISYEQYF	In	VDJ	1	30	5.316792202038103E-4	6.238043749480163E-4	45	TCRBV11	TCRBV11-01	01				TCRBJ02	TCRBJ02-07	01	4	6	1	0	5	3	19	32	42	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGGISYEQYF+TCRBV11-01+TCRBJ02-07	TCRBV11-01*01		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCCCACGTTGGGAGTCCTACGAGCAGTACTTCGGGCCG	CASSPRWESYEQYF	In	VDJ	1	40	7.089056269384139E-4	8.317391665973551E-4	42	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	9	2	1	7	0	19	31	-1	38	43														CASSPRWESYEQYF+TCRBV11-01+TCRBJ02-07	TCRBV11-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGTACACAGACAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQGTQTTNEKLFF	In	VDJ	1	31	5.494018608772708E-4	6.445978541129502E-4	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	3	5	0	4	1	29	45	53	49	54													Vb 16	CASSQGTQTTNEKLFF+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAAACGAAGTCTAACACAGATACGCAGTATTTTGGCCCA	CASSQETKSNTDTQYF	In	VDJ	1	47	8.329641116526362E-4	9.772935207518923E-4	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	9	2	8	1	29	46	57	54	58						01,02							Vb 16	CASSQETKSNTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAACTGAACACTGAAGCTTTCTTTGGACAA	CASSQELNTEAFF	In	VDJ	1	74	0.0013114754098360656	0.0015387174582051069	39	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-01	01	0	3	7	0	0	0	29	-1	-1	46	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQELNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGCCAGCGTCGGTGAGGCGGCCCAGTACTTCGGGCCA	CASSQASVGEAAQYF	In	VDJ	2	140	0.0024811696942844486	0.0029110870830907428	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	6	6	9	2	12	29	45	51	47	63						01,02							Vb 16	CASSQASVGEAAQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAAGGACACGAACTTTAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	150	0.002658396101019052		47	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	6	5	1	9	29	44	50	45	59													Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCACAGGGGGCGCAACACTGAAGCTTTCTTTGGACAA	CASSHRGRNTEAFF	In	VDJ	3	228	0.004040762073548958	0.004740913249604924	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	0	2	0	2	29	-1	51	43	53													Vb 16	CASSHRGRNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGATGTTCTATGCAGGGCGTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	3.544528134692069E-4		56	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	3	4	10	14	24	35	50	45	64														X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGGAAGGAAATACGCAGTATTTTGGCCCA	CASSVGEGNTQYF	In	VDJ	1	22	3.898980948161276E-4	4.574565416285453E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	5	2	7	2	6	24	36	43	38	49														CASSVGEGNTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAGGGGACTAGCGGGAGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	26	4.60788657509969E-4		49	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	0	1	1	1	0	24	37	-1	38	53														X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCAGACAGGGCGTTCTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	27	4.785112981834293E-4		43	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	3	7	3	5	24	36	46	39	51														X+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSVVYTGELFF	In	VDJ	1	34	6.025697828976517E-4	7.069782916077518E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	5	8	3	1	3	24	36	40	37	43						01,02								CASSVVYTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGAGCCGGAAAGGATGTATGGCTACACCTTCGGTTCG	CASSEPERMYGYTF	In	VDJ	1	45	7.975188303057156E-4	9.357065624220244E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	1	8	5	6	7	24	35	44	41	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEPERMYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGACAGGGGTACTGAAGCTTTCTTTGGACAA	CASSLDRGTEAFF	In	VDJ	1	48	8.506867523260966E-4	9.98086999916826E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	2	5	3	1	24	36	47	39	48														CASSLDRGTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCACCACAGGGGAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	77	0.0013646433318564466		41	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	10	3	2	0	5	0	24	31	-1	36	43														X+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTTGGACTAGGCCCCAATACGCAGTATTTTGGCCCA	CASSVVGLGPNTQYF	In	VDJ	2	117	0.0020735489587948605	0.0024328370622972635	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	8	7	6	6	24	36	49	42	55						01,02								CASSVVGLGPNTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGTCGGGTAGCGGGACCTACGAGCAGTACTTCGGGCCG	CASSLSGSGTYEQYF	In	VDJ	1	21	3.7217545414266725E-4	4.3666306246361144E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	5	3	2	6	0	18	32	-1	38	46														CASSLSGSGTYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGTCCGGGACAGCCGGGGGCGAGCAGTACTTCGGGCCG	CASSLSGTAGGEQYF	In	VDJ	1	22	3.898980948161276E-4	4.574565416285453E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	5	6	4	7	18	32	43	36	50														CASSLSGTAGGEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGGGGGAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGGTNTGELFF	In	VDJ	1	47	8.329641116526362E-4	9.772935207518923E-4	45	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-02	01	1	0	8	0	1	1	18	34	39	35	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGTNTGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01		TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTTGGACAGATAGAAAATGAAAAACTGTTTTTTGGCAGT	CASSFGQIENEKLFF	In	VDJ	1	48	8.506867523260966E-4	9.98086999916826E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	1	5	5	1	6	18	32	39	33	45														CASSFGQIENEKLFF+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCAAGTCGAGGGAGAAGCCTACGAGCAGTACTTCGGGCCG	CASSQVEGEAYEQYF	In	VDJ	2	134	0.0023748338502436865	0.0027863262081011396	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	9	2	2	8	3	18	30	43	38	46														CASSQVEGEAYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGGAAAGCAGTATGAACACTGAAGCTTTCTTTGGACAA	CASSLESSMNTEAFF	In	VDJ	1	34	6.025697828976517E-4	7.069782916077518E-4	45	TCRBV07	TCRBV07-05	01				TCRBJ01	TCRBJ01-01	01	2	1	8	0	0	8	19	-1	36	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLESSMNTEAFF+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCATGACCCCTGCGGGGAGGGTTGAGACCCAGTACTTCGGGCCA	CASSMTPAGRVETQYF	In	VDJ	1	37	6.557377049180328E-4	7.693587291025534E-4	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	9	0	5	12	2	19	31	50	43	52														CASSMTPAGRVETQYF+TCRBV07-05+TCRBJ02-05	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCGTCGGACTAGCGGGAGCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	3.898980948161276E-4		50	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	1	2	2	5	2	19	32	50	37	52													Vb 5.1	X+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTTCCCTAAGCGGGAGTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSLSGSSYNEQFF	In	VDJ	1	26	4.60788657509969E-4	5.406304582882808E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	2	1	7	1	19	30	45	37	46													Vb 5.1	CASSSLSGSSYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTACTATCGACAGGGCCAAAAACATTCAGTACTTCGGCGCC	CASSTIDRAKNIQYF	In	VDJ	1	28	4.962339388568897E-4	5.822174166181485E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	2	4	1	7	0	19	30	-1	37	43													Vb 5.1	CASSTIDRAKNIQYF+TCRBV05-01+TCRBJ02-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCGCAGGGATTCGAGACAATGAGCAGTTCTTCGGGCCA	CASSPAGIRDNEQFF	In	VDJ	1	30	5.316792202038103E-4	6.238043749480163E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	3	5	4	7	19	31	40	35	47													Vb 5.1	CASSPAGIRDNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACTGGAGCGGGAGGCTACAATGAGCAGTTCTTCGGGCCA	CASTGAGGYNEQFF	In	VDJ	1	20	3.544528134692069E-4	4.1586958329867756E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	6	1	3	4	0	25	35	-1	39	48													Vb 3	CASTGAGGYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCGACAGGGGAGGTTCCGAGTTCTTCGGGCCA	CASSSDRGGSEFF	In	VDJ	1	21	3.7217545414266725E-4	4.3666306246361144E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	2	14	2	8	25	38	48	40	56													Vb 3	CASSSDRGGSEFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCTCGATGACTAGCGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASMTSGGYNEQFF	In	VDJ	1	22	3.898980948161276E-4	4.574565416285453E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	11	2	2	3	5	0	25	31	-1	36	48													Vb 3	CASMTSGGYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGCAGAAGAGGGCAGGGGAAACACCATATATTTTGGAGAG	CASRAEEGRGNTIYF	In	VDJ	1	23	4.0762073548958794E-4	4.782500207934792E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	11	0	4	7	4	25	36	48	43	52													Vb 3	CASRAEEGRGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGGGCAGGGGGTCACTGAAGCTTTCTTTGGACAA	CASSGQGVTEAFF	In	VDJ	1	25	4.4306601683650863E-4	5.198369791233469E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	1	4	4	1	25	36	47	40	48													Vb 3	CASSGQGVTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGTGGTTAACTATGGCTACACCTTCGGTTCG	CASSLVVNYGYTF	In	VDJ	1	25	4.4306601683650863E-4	5.198369791233469E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	2	0	10	1	2	1	25	40	44	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLVVNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGAGGGACGGGGCGGCAGGGGAACCTACGAGCAGTACTTCGGGCCG	CASEGRGGRGTYEQYF	In	VDJ	1	25	4.4306601683650863E-4	5.198369791233469E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	4	2	2	14	2	25	34	54	48	56													Vb 3	CASEGRGGRGTYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATAGCGGGAGCCCACAAGCAGTACTTCGGGCCG	CASSLIAGAHKQYF	In	VDJ	1	26	4.60788657509969E-4	5.406304582882808E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	5	2	8	1	6	25	40	50	41	56													Vb 3	CASSLIAGAHKQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCATCCTTGACCGGGACAGGGCCGGAAACACCATATATTTTGGAGAG	CAILDRDRAGNTIYF	In	VDJ	1	27	4.785112981834293E-4	5.614239374532147E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	10	0	3	4	9	2	25	32	50	41	52													Vb 3	CAILDRDRAGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCGGAGGGAATCCTGGGGCGCTTTCTTTGGACAA	CASSSRRESWGAFF	In	VDJ	1	29	5.1395657953035E-4	6.030108957830824E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	0	11	3	11	25	38	47	41	58													Vb 3	CASSSRRESWGAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACCTAACGGGGGGTACAATGAGCAGTTCTTCGGGCCA	CASRPNGGYNEQFF	In	VDJ	1	30	5.316792202038103E-4	6.238043749480163E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	1	4	6	0	25	36	-1	42	49													Vb 3	CASRPNGGYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACGGGGGGGACTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	30	5.316792202038103E-4		44	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	8	0	0	0	1	25	-1	48	40	49													Vb 3	X+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGCCCGGACAGGGCCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASARTGPSGANVLTF	In	VDJ	1	31	5.494018608772708E-4	6.445978541129502E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	8	1	3	0	4	2	25	34	46	38	48													Vb 3	CASARTGPSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTGCAAAGTGAGCAGTTCTTCGGGCCA	CASSLLQSEQFF	In	VDJ	1	32	5.671245015507311E-4	6.65391333277884E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	1	4	6	9	2	3	25	41	45	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLLQSEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCATGGGACACACCCCGAATCAGCCCCAGCATTTTGGTGAT	CASSPMGHTPNQPQHF	In	VDJ	1	33	5.848471422241914E-4	6.861848124428179E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	6	4	5	7	25	37	48	42	55													Vb 3	CASSPMGHTPNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAACCGGGACAGAATTCAGCCCCAGCATTTTGGTGAT	CASNRDRIQPQHF	In	VDJ	1	35	6.202924235711121E-4	7.277717707726857E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	0	5	6	3	3	25	35	45	38	48													Vb 3	CASNRDRIQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTAAGGACTAGCGGGGGCCCAGATACGCAGTATTTTGGCCCA	CASSLRTSGGPDTQYF	In	VDJ	1	35	6.202924235711121E-4	7.277717707726857E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	1	2	4	5	2	25	36	54	41	56													Vb 3	CASSLRTSGGPDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGTCCCCGTCGGGTGAGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	39	6.911829862649534E-4		35	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	13	8	4	7	7	4	25	29	40	36	44						01,02							Vb 3	X+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCGACAAAGGGAGCGGGAGCCCCTAATGAGCAGTTCTTCGGGCCA	CATKGAGAPNEQFF	In	VDJ	1	40	7.089056269384139E-4	8.317391665973551E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	12	6	2	7	9	5	25	30	47	39	52													Vb 3	CATKGAGAPNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCATTAGCAGGAGCTGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	43	7.620735489587948E-4		44	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	3	4	4	4	6	5	25	39	49	45	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCACTCGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	46	8.152414709791759E-4		34	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	3	10	4	2	3	25	36	41	38	44						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGACCTTTATGGCTACACCTTCGGTTCG	CASSLDLYGYTF	In	VDJ	1	46	8.152414709791759E-4	9.565000415869584E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	3	1	7	5	0	3	25	-1	43	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLDLYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTCCCGTTGGCCAGATACGCAGTATTTTGGCCCA	CASSRWPDTQYF	In	VDJ	1	49	8.684093929995569E-4	0.00101888047908176	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	9	0	4	7	0	25	34	-1	41	44													Vb 3	CASSRWPDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCAAGGTCTTCCGGAGGGTAGATGGCTACACCTTCGGTTCG	CATKVFRRVDGYTF	In	VDJ	1	50	8.861320336730173E-4	0.0010396739582466939	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	10	10	0	6	12	3	25	32	50	44	53													Vb 3	CATKVFRRVDGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGACGTCAGATACGCAGTATTTTGGCCCA	CASSLGTSDTQYF	In	VDJ	1	53	9.392999556933983E-4	0.0011020543957414954	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	2	0	7	4	0	2	25	-1	45	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGTSDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTTCGACCTACCGCAGTGGCTACACCTTCGGTTCG	CASSFSTYRSGYTF	In	VDJ	1	55	9.74745237040319E-4	0.0011436413540713633	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	3	2	7	7	3	9	25	39	45	42	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFSTYRSGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCGACAGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSSDRANTEAFF	In	VDJ	1	56	9.924678777137794E-4	0.001164434833236297	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	1	2	1	25	38	47	40	48													Vb 3	CASSSDRANTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAACAGGGGCCCTCAATCAGCCCCAGCATTTTGGTGAT	CASSLTGALNQPQHF	In	VDJ	1	57	0.0010101905183872396	0.001185228312401231	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	2	3	0	4	25	-1	47	40	51													Vb 3	CASSLTGALNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGTTAGGGGGCGAGGGAACACTGAAGCTTTCTTTGGACAA	CASSFVRGRGNTEAFF	In	VDJ	1	57	0.0010101905183872396	0.001185228312401231	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	5	0	1	4	4	25	39	50	43	54													Vb 3	CASSFVRGRGNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCAAAGGACAGTGCGGGGAGCTTTCTTTGGACAA	CASSFQRTVRGAFF	In	VDJ	1	59	0.0010456357997341605	0.0012268152707310988	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	3	1	5	10	5	7	25	39	50	44	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFQRTVRGAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATACGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSLIRANTEAFF	In	VDJ	1	61	0.001081081081081081	0.0012684022290609664	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	2	8	0	1	4	0	25	40	-1	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLIRANTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCTAAATCTAGCGGGATAGCCAAAAACATTCAGTACTTCGGCGCC	CASSSKSSGIAKNIQYF	In	VDJ	1	63	0.0011165263624280017	0.0013099891873908343	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	6	4	3	0	8	1	25	36	53	44	54													Vb 3	CASSSKSSGIAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGAATACCAGGGGTCGCCCAATCAGCCCCAGCATTTTGGTGAT	CASSEYQGSPNQPQHF	In	VDJ	1	64	0.0011342490031014622	0.001330782666555768	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	2	3	6	5	25	37	49	43	54													Vb 3	CASSEYQGSPNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGTAGGGGGCTGACCCAGTACTTCGGGCCA	CASSLGRGLTQYF	In	VDJ	1	74	0.0013114754098360656	0.0015387174582051069	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	5	0	7	3	1	25	40	50	43	51													Vb 3	CASSLGRGLTQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGAGTCCCGGGGAGCTGTTTTTTGGAGAA	CASSLSPGELFF	In	VDJ	1	79	0.0014000886132033673	0.0016426848540297763	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	11	2	6	0	2	25	-1	42	39	44													Vb 3	CASSLSPGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGCAGGCCTCTTGACACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	84	0.001488701816570669		55	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	12	7	25	37	53	49	60													Vb 3	X+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAACAGTGGGTTGACAGGGGGTAAGGACAAAAACATTCAGTACTTCGGCGCC	CANSGLTGGKDKNIQYF	In	VDJ	1	87	0.00154186973859105	0.0018090326873492473	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	2	1	3	5	6	25	37	51	42	57													Vb 3	CANSGLTGGKDKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCCGTAGGACAACCGTGATGAACGCAGTATTTTGGCCCA	CASSSVGQP**TQYF	Stop	VDJ	1	94	0.0016659282233052724		45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	6	9	7	10	25	36	48	43	58													Vb 3	CASSSVGQP**TQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCTTACTAGCGGACGCCTACGAGCAGTACTTCGGGCCG	CASTLLADAYEQYF	In	VDJ	1	96	0.0017013735046521932	0.001996173999833652	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	3	5	2	4	3	25	35	47	39	50						01,02							Vb 3	CASTLLADAYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGCGGGGTAGAAACACCATATATTTTGGAGAG	CASSSRGRNTIYF	In	VDJ	1	97	0.0017190961453256535	0.002016967478998586	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	4	7	3	5	1	2	25	38	45	39	47													Vb 3	CASSSRGRNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGCTGGTGGGGCCGGTGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSSLVGPVDTGELFF	In	VDJ	1	97	0.0017190961453256535	0.002016967478998586	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	7	0	3	7	6	25	38	50	45	56													Vb 3	CASSSLVGPVDTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACAGACAGGCTCTGGAAACACCATATATTTTGGAGAG	CASRQTGSGNTIYF	In	VDJ	2	107	0.001896322552060257	0.0022249022706479246	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	4	0	3	0	25	36	-1	39	45													Vb 3	CASRQTGSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCATCTTTGGAAACACCATATATTTTGGAGAG	CASSIFGNTIYF	In	VDJ	2	144	0.00255206025697829	0.002994260999750478	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-03	01	6	4	6	3	0	4	25	-1	38	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSIFGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01		TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCARCAGTCTAAGCGGGAGTCACACCGGGGAGCTGTTTTTTGGAGAA	CAXSLSGSHTGELFF	In	VDJ	2	144	0.00255206025697829	0.002994260999750478	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	6	2	3	3	2	25	37	48	40	50													Vb 3	CAXSLSGSHTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGGTTGACAGGGGGTAGGGACAAAAACATTCAGTACTTCGGCGCC	CASSGLTGGRDKNIQYF	In	VDJ	2	146	0.0025875055383252103	0.003035847958080346	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	2	1	3	5	6	25	37	51	42	57													Vb 3	CASSGLTGGRDKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGACTAGCGGGAGGAGTGGCCAAAAACATTCAGTACTTCGGCGCC	CASSGLAGGVAKNIQYF	In	VDJ	3	194	0.003438192290651307	0.004033934957997172	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	1	1	1	0	4	25	-1	51	37	55													Vb 3	CASSGLAGGVAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCACCGAGTCGAGGGGAGGCTCCTACGAGCAGTACTTCGGGCCG	CATESRGGSYEQYF	In	VDJ	1	22	3.898980948161276E-4	4.574565416285453E-4	42	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	12	9	1	0	12	0	18	23	-1	35	41														CATESRGGSYEQYF+TCRBV12-02+TCRBJ02-07	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTCTCGTAGGAACAGGCGTCCGGCACAGATACGCAGTATTTTGGCCCA	CASRFS*EQASGTDTQYF	Stop	VDJ	1	26	4.60788657509969E-4		54	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	4	1	9	6	18	32	46	41	52														CASRFS*EQASGTDTQYF+TCRBV12-02+TCRBJ02-03	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGTCAGAACCCGGATAGGACTAATGAAAAACTGTTTTTTGGCAGT	CASQNPDRTNEKLFF	In	VDJ	1	21	3.7217545414266725E-4	4.3666306246361144E-4	45	TCRBV27	TCRBV27-01	01				TCRBJ01	TCRBJ01-04	01	9	1	8	2	9	4	23	31	43	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	CASQNPDRTNEKLFF+TCRBV27-01+TCRBJ01-04	TCRBV27-01*01		TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TTCTGTGCCAGCAGTTTACATTGGATGGACTAGCCTGGTTCCCATGAATATTACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	54	9.570225963668586E-4		68	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	1	7	2	8	19	3	18	34	26	53						01,02							Vb 14	X+TCRBV27-01+TCRBJ02-05	TCRBV27-01*01	TCRBD02-01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGGACTAGCGGGGTGGGAGATACGCAGTATTTTGGCCCA	CSVGTSGVGDTQYF	In	VDJ	1	22	3.898980948161276E-4	4.574565416285453E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	0	3	5	1	4	25	33	47	34	51													Vb 4	CSVGTSGVGDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGACAGGGGGTTGGAAACACCATATATTTTGGAGAG	CSVEGQGVGNTIYF	In	VDJ	1	22	3.898980948161276E-4	4.574565416285453E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	1	3	0	1	25	-1	47	36	48													Vb 4	CSVEGQGVGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGCGGGAGGTACTACGAGCAGTACTTCGGGCCG	CSVEGGRYYEQYF	In	VDJ	1	24	4.253433761630483E-4	4.99043499958413E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	7	1	3	0	2	25	-1	46	38	48													Vb 4	CSVEGGRYYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCCGACTAGCGGGAGGTTTCCAAGAGACCCAGTACTTCGGGCCA	CSVARLAGGFQETQYF	In	VDJ	1	26	4.60788657509969E-4	5.406304582882808E-4	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	2	1	1	3	3	25	35	51	38	54													Vb 4	CSVARLAGGFQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGAGGGGGAGGGTCCTACAATAAGCAGTTCTTCGGGCCA	CSVGGGGSYNKQFF	In	VDJ	1	27	4.785112981834293E-4	5.614239374532147E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	9	0	11	4	10	25	35	46	39	56													Vb 4	CSVGGGGSYNKQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGCAGGGCTACAATGAGCAGTTCTTCGGGCCA	CSVGQGYNEQFF	In	VDJ	1	31	5.494018608772708E-4	6.445978541129502E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	3	3	2	0	25	35	-1	37	42													Vb 4	CSVGQGYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAGTTCAGGGGAATATTCATGGCTACACCTTCGGTTCG	CSVVQGNIHGYTF	In	VDJ	1	32	5.671245015507311E-4	6.65391333277884E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	2	6	4	7	25	33	43	37	50													Vb 4	CSVVQGNIHGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCTAACCCTGAGACAGCCTTCGGAGGCTACACCTTCGGTTCG		Out	VDJ	1	34	6.025697828976517E-4		44	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	5	8	11	8	25	33	49	44	57													Vb 4	X+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAAAGGGCACAGATACGCAGTATTTTGGCCCA	CSVEKGTDTQYF	In	VDJ	1	40	7.089056269384139E-4	8.317391665973551E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	2	5	4	1	1	0	25	37	-1	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEKGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGTGACTAGCGGGAGAACCCAGGCGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	41	7.266282676118742E-4		49	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	4	2	4	0	10	25	-1	46	36	56													Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGAGGGGACAGGGGGTCGGGGAGCTGTTTTTTGGAGAA	CSVRGQGVGELFF	In	VDJ	1	47	8.329641116526362E-4	9.772935207518923E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	1	7	3	1	25	33	47	36	48													Vb 4	CSVRGQGVGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGCGTCCTAGGGACAATGAGCAGTTCTTCGGGCCA	CSVRPRDNEQFF	In	VDJ	1	47	8.329641116526362E-4	9.772935207518923E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	6	5	3	5	7	0	25	33	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVRPRDNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGGACTAGCCACCTACGAGCAGTACTTCGGGCCG	CSVGGLATYEQYF	In	VDJ	1	47	8.329641116526362E-4	9.772935207518923E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	7	2	1	2	25	35	45	36	47						01,02							Vb 4	CSVGGLATYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGCCGGGATTCCTCCCATGGCTACACCTTCGGTTCG	CSGRDSSHGYTF	In	VDJ	1	48	8.506867523260966E-4	9.98086999916826E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	8	3	6	2	8	25	32	39	34	47													Vb 4	CSGRDSSHGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCCCCGGGACAGGGAAGGGCTACACCTTCGGTTCG	CSVVPGTGKGYTF	In	VDJ	1	54	9.570225963668586E-4	0.0011228478749064294	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	8	5	3	25	35	49	40	52													Vb 4	CSVVPGTGKGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCAACTTATTCCGAATTGGCCTAGCGGGAGTAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	55	9.74745237040319E-4		58	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	4	2	3	20	1	23	33	63	53	64													Vb 4	X+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTGACAGGGTTTGAGTACGAGCAGTACTTCGGGCCG	CSVLTGFEYEQYF	In	VDJ	1	61	0.001081081081081081	0.0012684022290609664	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	4	2	6	25	34	43	36	49													Vb 4	CSVLTGFEYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCCCAACTTCGCGGGAGGATACAATAAGCAGTTCTTCGGGCCA	CSVPNFAGGYNKQFF	In	VDJ	1	63	0.0011165263624280017	0.0013099891873908343	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	7	1	11	10	8	25	33	51	43	59													Vb 4	CSVPNFAGGYNKQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATTGGCGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSVEDWRSSYNEQFF	In	VDJ	1	63	0.0011165263624280017	0.0013099891873908343	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	7	5	0	3	2	25	39	46	42	48						01,02							Vb 4	CSVEDWRSSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGTGCAAACTCGACAGGGTGGGGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	74	0.0013114754098360656		40	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	2	3	5	9	5	25	30	46	39	51													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCTTCCGGGGGGGGACGGATTCTCCTACGAGCAGTACTTCGGGCCG	CSALPGGDGFSYEQYF	In	VDJ	1	78	0.0013823659725299068	0.0016218913748648424	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	8	0	0	6	8	25	32	46	38	54													Vb 4	CSALPGGDGFSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACAGGGAAGACTACGAGCAGTACTTCGGGCCG	CSVDREDYEQYF	In	VDJ	2	108	0.0019140451927337173	0.0022456957498128587	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	3	0	4	25	-1	41	36	45													Vb 4	CSVDREDYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCAAGGCAGAGGAGCGGCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	3	170	0.003012848914488259		44	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	6	6	5	3	11	0	25	33	-1	44	49						01,02							Vb 4	X+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD02-01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCCTTAGCGGCAAGGTGGCGGCAGGGCAGTTCTTCGGGCCA	CSLSGKVAAGQFF	In	VDJ	6	401	0.007106778910057599	0.008338185145138484	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	5	5	12	2	15	25	31	39	33	54						01,02							Vb 4	CSLSGKVAAGQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGACATCTTCTCCTACGAGCAGTACTTCGGGCCG	CSVEDIFSYEQYF	In	VDJ	10	688	0.012193176783340717	0.014305913665474507	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	6	0	0	4	25	-1	41	36	45													Vb 4	CSVEDIFSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCGAACAGGGCCACAATGAGCAGTTCTTCGGGCCA	CASSEQGHNEQFF	In	VDJ	1	28	4.962339388568897E-4	5.822174166181485E-4	39	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	3	5	0	2	24	-1	44	39	46														CASSEQGHNEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGAAGCGGGAGGGCCAGATACGCAGTATTTTGGCCCA	CASSEEAGGPDTQYF	In	VDJ	1	29	5.1395657953035E-4	6.030108957830824E-4	45	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	6	0	4	1	1	23	39	50	40	51														CASSEEAGGPDTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGACAGGCTCAGCCCCAGCATTTTGGTGAT	CASSEGQAQPQHF	In	VDJ	1	34	6.025697828976517E-4	7.069782916077518E-4	39	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	2	4	6	0	1	23	-1	45	39	46														CASSEGQAQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGAGGAGCACAATGAGCAGTTCTTCGGGCCA	CASSEEEHNEQFF	In	VDJ	1	38	6.734603455914931E-4	7.901522082674874E-4	39	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	10	2	5	1	1	23	39	44	40	45														CASSEEEHNEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGTCAGGGGGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	41	7.266282676118742E-4		43	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	1	4	2	1	23	40	49	42	50														X+TCRBV06-01+TCRBJ02-05	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGAGCCAGGGGGACAGATACGCAGTATTTTGGCCCA	CASSEGARGTDTQYF	In	VDJ	1	45	7.975188303057156E-4	9.357065624220244E-4	45	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	4	1	3	4	0	23	39	-1	43	50														CASSEGARGTDTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGAGGAGGGGGAATCCCACGAGCAGTACTTCGGGCCG	CASSEEEGESHEQYF	In	VDJ	1	49	8.684093929995569E-4	0.00101888047908176	45	TCRBV06	TCRBV06-01	01				TCRBJ02	TCRBJ02-07	01	1	5	1	5	3	6	23	39	48	42	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEEEGESHEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGTGGAAACACCATATATTTTGGAGAG	CASSEGGNTIYF	In	VJ	1	58	0.0010279131590607	0.0012060217915661649	36	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-03	01	1	0	0	3	0	1	23	-1	39	-1	40														CASSEGGNTIYF+TCRBV06-01+TCRBJ01-03	TCRBV06-01*01		TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGYCAGCAGTGAAGGTAGCGGGAGCTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CXSSEGSGSSNTGELFF	In	VDJ	2	136	0.002410279131590607	0.002827913166431007	51	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	5	2	0	1	2	23	39	49	40	51														CXSSEGSGSSNTGELFF+TCRBV06-01+TCRBJ02-02	TCRBV06-01*01	TCRBD02-01*02	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTACTGTAACCCCCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	34	6.025697828976517E-4		43	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	3	10	4	0	8	22	-1	38	35	46						01,02								X+TCRBV07-04+TCRBJ02-02	TCRBV07-04*01	TCRBD02-01	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGGGCAGGGAGAACACTGAAGCTTTCTTTGGACAA	CAWKGRENTEAFF	In	VDJ	1	19	3.3673017279574655E-4	3.950761041337437E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	1	4	1	26	36	45	40	46													Vb 20	CAWKGRENTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGGGTCACTAGGACAGACGAACGTGAAGCTTTCTTTGGACAA		Out	VDJ	1	19	3.3673017279574655E-4		46	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	5	7	10	7	26	36	52	46	59													Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGAACAGGGGACACTGAAGCTTTCTTTGGACAA	CAWGTGDTEAFF	In	VDJ	1	19	3.3673017279574655E-4	3.950761041337437E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	2	3	3	0	26	35	-1	38	45													Vb 20	CAWGTGDTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGACCAGGGGGGGAATCAGCCCCAGCATTTTGGTGAT	CAWRDQGGNQPQHF	In	VDJ	1	20	3.544528134692069E-4	4.1586958329867756E-4	42	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-05	01	3	4	1	4	4	2	26	37	48	41	50			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWRDQGGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02		TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCGAGCGGGGGTTACAATGAGCAGTTCTTCGGGCCA	CAWSASGGYNEQFF	In	VDJ	1	22	3.898980948161276E-4	4.574565416285453E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	6	2	4	2	1	26	39	49	41	50													Vb 20	CAWSASGGYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTTGCGGAGCAGTACTTCGGGCCG	CAWSVLAEQYF	In	VDJ	1	27	4.785112981834293E-4	5.614239374532147E-4	33	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	3	10	7	0	4	26	-1	43	40	47						01,02							Vb 20	CAWSVLAEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCACCCGGAGGGGCCAGGGGACCTACGAGCAGTACTTCGGGCCG	CATRRGQGTYEQYF	In	VDJ	1	28	4.962339388568897E-4	5.822174166181485E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	8	4	2	2	12	1	26	32	50	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CATRRGQGTYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACTCGAGGGGGGGATACGCAGTATTTTGGCCCA	CAWTRGGDTQYF	In	VDJ	1	29	5.1395657953035E-4	6.030108957830824E-4	36	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-03	01	4	5	1	6	4	1	26	36	46	40	47			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWTRGGDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02		TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACAGAGCAATCAGCCCCAGCATTTTGGTGAT	CAWSVQSNQPQHF	In	VDJ	1	30	5.316792202038103E-4	6.238043749480163E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	5	1	0	0	26	-1	-1	40	44													Vb 20	CAWSVQSNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCTTGCGAGACAGAAATCGCCTACGAGCAGTACTTCGGGCCG	CACETEIAYEQYF	In	VDJ	1	40	7.089056269384139E-4	8.317391665973551E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	2	5	2	6	6	26	31	42	37	48			unresolved										Vb 20	CACETEIAYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTGAGTTTTAGCGCGAAGGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAWS*VLARRAGANVLTF	Stop	VDJ	1	43	7.620735489587948E-4		54	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	2	5	6	2	7	7	26	38	50	45	57						01,02							Vb 20	CAWS*VLARRAGANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*02	TCRBD02-01	TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTCGAGGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CAWSLEGGNQPQHF	In	VDJ	1	49	8.684093929995569E-4	0.00101888047908176	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	5	1	2	4	0	26	38	-1	42	48													Vb 20	CAWSLEGGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTACCCGGGACAGGGCCAAACACCATATATTTTGGAGAG	CAWSVLPGTGPNTIYF	In	VDJ	1	49	8.684093929995569E-4	0.00101888047908176	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	0	3	6	7	2	26	40	56	47	58													Vb 20	CAWSVLPGTGPNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCACTCTGGGGGTCGGTCGGGGACAATGAGCAGTTCTTCGGGCCA	CAWSPLWGSVGDNEQFF	In	VDJ	1	51	9.038546743464776E-4	0.0010604674374116278	51	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-01	01	2	6	1	5	7	10	26	38	50	45	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSPLWGSVGDNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGACAGGGGGCCGTAGTAATCAGCCCCAGCATTTTGGTGAT	CAWRTGGRSNQPQHF	In	VDJ	1	53	9.392999556933983E-4	0.0011020543957414954	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	0	4	0	6	26	-1	47	37	53													Vb 20	CAWRTGGRSNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCAGACAGGGGGCGTACGAGCAGTACTTCGGGCCG	CAWSRQGAYEQYF	In	VDJ	1	54	9.570225963668586E-4	0.0011228478749064294	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	0	4	2	1	26	37	49	39	50													Vb 20	CAWSRQGAYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAAAGGGGGACGGGATCAGCCCCAGCATTTTGGTGAT	CAWSKGGRDQPQHF	In	VDJ	1	83	0.0014709791758972088	0.0017258587706895118	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	5	1	5	2	5	26	38	46	40	51			unresolved										Vb 20	CAWSKGGRDQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAATCCAGGCGAATAACAGATACGCAGTATTTTGGCCCA	CAWKSRRITDTQYF	In	VDJ	1	84	0.001488701816570669	0.0017466522498544457	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	4	3	4	6	26	36	44	40	50			unresolved										Vb 20	CAWKSRRITDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCGGGATCGCCCGAGTCTACACTGAAGCTTTCTTTGGACAA	CAGIARVYTEAFF	In	VDJ	1	85	0.0015064244572441294	0.0017674457290193795	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	11	2	3	6	3	26	36	45	42	48			unresolved										Vb 20	CAGIARVYTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACTAAAACCCCCGACAGTGAAGCTTTCTTTGGACAA	CAWTKTPDSEAFF	In	VDJ	1	87	0.00154186973859105	0.0018090326873492473	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	5	7	11	0	26	36	-1	47	52			unresolved										Vb 20	CAWTKTPDSEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTATCGTCCTCCGGGCTTGGGGCCAACGTCCTGACTTTCGGGGCC	CAWSVSSSGLGANVLTF	In	VDJ	1	90	0.0015950376606114311	0.0018714131248440489	51	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-06	01	0	8	0	3	10	1	26	40	54	50	55			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVSSSGLGANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*01		TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCGACCGGGACAGGGGAGGGAAGCTTTCTTTGGACAA	CAWRPGQGREAFF	In	VDJ	1	93	0.0016482055826318122	0.0019337935623388505	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	2	8	5	3	26	35	50	40	53			unresolved										Vb 20	CAWRPGQGREAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCGGTTCGTGGAAACACCATATATTTTGGAGAG	CAWSAVRGNTIYF	In	VDJ	1	95	0.0016836508639787328	0.0019753805206687183	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	1	8	5	3	0	4	26	-1	42	39	46			unresolved			01,02							Vb 20	CAWSAVRGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD02-01	TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGGCATGCTGACAGGGGGTGGCTACACCTTCGGTTCG	CAWSVGMLTGGGYTF	In	VDJ	2	110	0.001949490474080638	0.0022872827081427266	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	1	7	9	0	26	40	-1	49	58			unresolved										Vb 20	CAWSVGMLTGGGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGTCTGGAGTTTCCAATACGAGCAGTACTTCGGGCCG	CVWSFQYEQYF	In	VDJ	2	110	0.001949490474080638	0.0022872827081427266	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	6	4	3	1	26	38	43	41	44													Vb 20	CVWSFQYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGGACTACAGAAACACCGGGGAGCTGTTTTTTGGAGAA	CAWSGDYRNTGELFF	In	VDJ	2	118	0.002091271599468321	0.0024536305414621976	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	0	9	2	0	4	26	-1	46	39	50						01,02							Vb 20	CAWSGDYRNTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02	TCRBD02-01	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGTCTGGAGTGTAAGGGGAAGTACTGAAGCTTTCTTTGGACAA	CVWSVRGSTEAFF	In	VDJ	2	130	0.0023039432875498447	0.002703152291441404	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	2	5	1	4	26	40	46	41	50			unresolved										Vb 20	CVWSVRGSTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGACCGTGCCCTGGGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	133	0.002357111209570226		37	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	6	6	2	5	10	0	26	34	-1	44	48			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGGCCAGCCGAACCCTATTCTACGAGCAGTACTTCGGGCCG	CAWKASRTLFYEQYF	In	VDJ	2	150	0.002658396101019052	0.0031190218747400816	45	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-07	01	4	4	5	3	4	12	26	36	43	40	55			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKASRTLFYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACAGAGTCTGGAAACACCATATATTTTGGAGAG	CAWTESGNTIYF	In	VDJ	2	168	0.002977403633141338	0.0034933044997088915	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	4	4	5	1	0	2	26	-1	39	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWTESGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAACTTAGGGCTTGGGGGAGGAAACACCATATATTTTGGAGAG	CAWSVNLGLGGGNTIYF	In	VDJ	3	173	0.0030660168365086397	0.0035972718955335605	51	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	0	6	1	4	13	1	26	40	58	53	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVNLGLGGGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACACAGGGTTACACCGGGGAGCTGTTTTTTGGAGAA	CAWTQGYTGELFF	In	VDJ	3	194	0.003438192290651307	0.004033934957997172	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	3	3	1	2	26	36	43	37	45													Vb 20	CAWTQGYTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGGCCAGGGGATATTTATGGCTACACCTTCGGTTCG		Out	VDJ	4	270	0.004785112981834293		41	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	2	5	4	5	26	37	47	41	52													Vb 20	X+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATGCGGCGGATACGCAGTATTTTGGCCCA	CAWNAADTQYF	In	VDJ	4	294	0.0052104563579973414	0.00611328287449056	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	7	5	6	2	2	26	36	42	38	44						01,02							Vb 20	CAWNAADTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAAGGATCCCGCTTACGAGCAGTACTTCGGGCCG	CASKDPAYEQYF	In	VDJ	1	21	3.7217545414266725E-4	4.3666306246361144E-4	36	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-07	01	7	1	8	4	1	7	23	33	37	34	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASKDPAYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCCGGGGGTTCCAGGGGGCTAGTTATGGCTACACCTTCGGTTCG	CASRGFQGASYGYTF	In	VDJ	1	25	4.4306601683650863E-4	5.198369791233469E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	4	0	5	9	4	23	32	49	41	53													Vb 22	CASRGFQGASYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAAGGAGGGTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASKEGSGANVLTF	In	VDJ	1	26	4.60788657509969E-4	5.406304582882808E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	7	10	0	1	1	1	23	33	40	34	41													Vb 22	CASKEGSGANVLTF+TCRBV02-01+TCRBJ02-06	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAAAGGGATTGATGAAAAACTGTTTTTTGGCAGT	CASKGIDEKLFF	In	VDJ	1	32	5.671245015507311E-4	6.65391333277884E-4	36	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-04	01	7	0	8	6	2	3	23	33	39	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASKGIDEKLFF+TCRBV02-01+TCRBJ01-04	TCRBV02-01*01		TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAATGCGGCCCGACAAGAAACCCAGTACTTCGGGCCA	CASNAARQETQYF	In	VDJ	1	39	6.911829862649534E-4	8.109456874324212E-4	39	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-05	01	7	2	6	8	9	4	23	33	46	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASNAARQETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01		TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTTTTTTATGTCATTCCATGAGCAGTTCTTCGGGCCA	CASSFFMSFHEQFF	In	VDJ	1	46	8.152414709791759E-4	9.565000415869584E-4	42	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-01	01	5	4	6	8	10	4	23	35	47	45	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSFFMSFHEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGGGGGACTACCGGAACCTACGAGCAGTACTTCGGGCCG	CARGTTGTYEQYF	In	VDJ	1	50	8.861320336730173E-4	0.0010396739582466939	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	9	0	9	2	1	6	23	31	39	32	45						01,02							Vb 22	CARGTTGTYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAAGTGGCGAGAAGAGACCCAGTACTTCGGGCCA	CASKWREETQYF	In	VDJ	1	63	0.0011165263624280017	0.0013099891873908343	36	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-05	01	7	9	0	3	3	3	23	33	39	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASKWREETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01		TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCCCAGGAGGGGTTCTATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	45	7.975188303057156E-4		34	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	11	10	0	8	3	5	28	34	43	37	48			01,02											X+TCRBV06-04+TCRBJ02-01	TCRBV06-04	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGAGATTTAGCGGCACACCACAAATACGCAGTATTTTGGCCCA		Out	VDJ	1	60	0.0010633584404076207		46	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	5	5	7	5	10	28	39	50	44	60			01,02			01,02								X+TCRBV06-04+TCRBJ02-03	TCRBV06-04	TCRBD02-01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACGGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	20	3.544528134692069E-4		34	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-01	01	2	0	9	6	0	0	26	-1	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCACCCAGCAACACGAGCAGTACTTCGGGCCG	CASTQQHEQYF	In	VDJ	1	22	3.898980948161276E-4	4.574565416285453E-4	33	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-07	01	7	4	5	5	2	4	26	36	41	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTQQHEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTAGCCTGCTTTACAATGAGCAGTTCTTCGGGCCA	CASSSLLYNEQFF	In	VDJ	1	23	4.0762073548958794E-4	4.782500207934792E-4	39	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	6	7	4	0	6	26	-1	41	38	47						01,02								CASSSLLYNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCTTACAGGTTGGATTTATCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLQVGFISYNEQFF	In	VDJ	1	29	5.1395657953035E-4	6.030108957830824E-4	51	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	4	0	3	10	26	37	45	40	55														CASSLQVGFISYNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAGGCGAATGAGCAGTTCTTCGGGCCA	CASSEANEQFF	In	VDJ	1	31	5.494018608772708E-4	6.445978541129502E-4	33	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	11	1	7	0	2	26	-1	42	38	44														CASSEANEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAGGACTACTTAGAGCAGTTCTTCGGGCCA	CASSEDYLEQFF	In	VDJ	1	39	6.911829862649534E-4	8.109456874324212E-4	36	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	9	10	2	4	26	38	46	40	50						01,02								CASSEDYLEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAAACGCAGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSENAGSGANVLTF	In	VDJ	1	71	0.0012583074878156845	0.0014763370207103053	48	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	4	3	1	7	0	26	38	-1	45	50														CASSENAGSGANVLTF+TCRBV06-07+TCRBJ02-06	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCAGCCATGTATCGCTGTGCTAGCAGCCGATTTGACTAGCGGACACGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSRFD*RTRSYNEQFF	Stop	VDJ	1	37	6.557377049180328E-4		54	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	5	0	6	5	19	31	46	37	51						01,02								CASSRFD*RTRSYNEQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCCCCCTACTAATCCGATTAATGGCTACACCTTCGGTTCG	CASSPPTNPINGYTF	In	VDJ	3	228	0.004040762073548958	0.004740913249604924	45	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	3	9	6	5	9	29	42	51	47	60			01,02			01,02								CASSPPTNPINGYTF+TCRBV16-01+TCRBJ01-02	TCRBV16-01	TCRBD02-01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTAGTTCAGGGTACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	20	3.544528134692069E-4		44	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	3	3	2	2	18	34	41	36	43		TCRBV11-01,TCRBV11-03												X+TCRBV11-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGGGGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTAGGTTCCCCCACAGATACGCAGTATTTTGGCCCA	CASSLGSPTDTQYF	In	VJ	1	24	4.253433761630483E-4	4.99043499958413E-4	42	TCRBV07	unresolved					TCRBJ02	TCRBJ02-03	01	1	0	0	2	0	7	18	-1	34	-1	41		TCRBV07-04,TCRBV07-06												CASSLGSPTDTQYF+TCRBV07-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTCTGACCGTTGGACAGGGCGCTGAAGCTTTCTTTGGACAA	CASSLTVGQGAEAFF	In	VDJ	1	27	4.785112981834293E-4	5.614239374532147E-4	45	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	3	6	9	2	26	38	55	47	57		TCRBV10-01,TCRBV10-02												CASSLTVGQGAEAFF+TCRBV10-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCTCCGGGGGGGCTTTCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGGAFNTGELFF	In	VDJ	1	27	4.785112981834293E-4	5.614239374532147E-4	48	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	8	0	2	1	5	19	32	41	33	46		TCRBV07-05,TCRBV07-06												CASSSGGAFNTGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACAAGCGGGATCAGCCCCAGCATTTTGGTGAT	CASSYKRDQPQHF	In	VDJ	1	29	5.1395657953035E-4	6.030108957830824E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	6	4	5	1	0	23	38	-1	39	45		TCRBV06-07,TCRBV06-08				01,02								CASSYKRDQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATTCATAGGGGGCTACAGATACGCAGTATTTTGGCCCA	CASSDS*GATDTQYF	Stop	VDJ	1	32	5.671245015507311E-4		45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	5	0	3	7	1	23	35	49	42	50		TCRBV06-07,TCRBV06-08												CASSDS*GATDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGATTCACAGGGGGCTACAGATACGCAGTATTTTGGCCCA	CASSDSQGATDTQYF	In	VDJ	1	32	5.671245015507311E-4	6.65391333277884E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	5	0	3	7	1	26	38	52	45	53		TCRBV06-07,TCRBV06-08												CASSDSQGATDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTAATCCCGGGGGGAAACACCATATATTTTGGAGAG	CASSLIPGGNTIYF	In	VDJ	1	34	6.025697828976517E-4	7.069782916077518E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	2	8	3	4	4	0	22	37	-1	41	46		TCRBV07-01,TCRBV07-04												CASSLIPGGNTIYF+TCRBV07-X+TCRBJ01-03	unresolved	TCRBD02-01*01	TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCCCACTCGCTAACAATGAGCAGTTCTTCGGGCCA	CASSPLANNEQFF	In	VDJ	1	37	6.557377049180328E-4	7.693587291025534E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	10	5	2	5	22	34	39	36	44		TCRBV07-01,TCRBV07-04				01,02								CASSPLANNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AMSCTCYCAGACATCTGTGTACTTCTGTGCCAGCAGTGAAGGACAGGATCTTGCTAAAGGGTCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	38	6.734603455914931E-4		56	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	2	4	3	0	15	24	-1	46	40	61		TCRBV06-01,TCRBV06-04												X+TCRBV06-X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSYSDTGELFF	In	VDJ	1	43	7.620735489587948E-4	8.941196040921567E-4	39	TCRBV06	unresolved					TCRBJ02	TCRBJ02-02	01	0	0	10	3	0	0	23	-1	-1	40	42		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSDTGELFF+TCRBV06-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCCCGGACCCCACATCAGGGAAAAACTGTTTTTTGGCAGT	CASSPGPHIREKLFF	In	VDJ	1	43	7.620735489587948E-4	8.941196040921567E-4	45	TCRBV06	unresolved					TCRBJ01	TCRBJ01-04	01	5	1	7	8	3	11	26	38	45	41	56		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPHIREKLFF+TCRBV06-X+TCRBJ01-04	unresolved		TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTTACTAGCGGGGGGATACAATGAGCAGTTCTTCGGGCCA	CASSLLAGGYNEQFF	In	VDJ	1	56	9.924678777137794E-4	0.001164434833236297	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	3	1	4	1	1	23	36	49	37	50		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSLLAGGYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAACGTACTAGCGGTAACAATGAGCAGTTCTTCGGGCCA	CASSERTSGNNEQFF	In	VDJ	1	58	0.0010279131590607	0.0012060217915661649	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	3	5	5	3	2	23	38	49	41	51		TCRBV06-01,TCRBV06-08				01,02								CASSERTSGNNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCTTAATTTTCCGGGACAGGAACACTGAAGCTTTCTTTGGACAA	CASSLIFRDRNTEAFF	In	VDJ	1	75	0.001329198050509526	0.0015595109373700408	48	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	5	1	7	0	19	34	-1	41	48		TCRBV07-05,TCRBV07-06												CASSLIFRDRNTEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCGTCCGGGACTGACACAATGAGCAGTTCTTCGGGCCA	CASSVRD*HNEQFF	Stop	VDJ	1	75	0.001329198050509526		42	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	5	4	3	22	34	44	38	47		TCRBV07-01,TCRBV07-04				01,02								CASSVRD*HNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCTCAGAAGGCTAGCGGGAGGGCCGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	81	0.001435533894550288		43	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	11	4	0	5	8	3	23	29	49	37	52		TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGTATCGGAGGCAGATACGCAGTATTTTGGCCCA	CASSVSEADTQYF	In	VDJ	2	106	0.0018785999113867967	0.002204108791482991	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	10	1	4	4	0	28	41	-1	45	50		TCRBV06-04,TCRBV06-08												CASSVSEADTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCACCAACCAGACATCTGTGTATCTCTATGCCAGCAGTCCCCAGGGTGAGCAGTTCTTCGGGCCA	YASSPQGEQFF	In	VDJ	1	23	4.0762073548958794E-4	4.782500207934792E-4	33	TCRBV26	TCRBV26-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	9	3	0	27	39	-1	42	47														YASSPQGEQFF+TCRBV26-01+TCRBJ02-01	TCRBV26-01*01	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCACCAACCAGACATCTGTGTATCTCTATGCCAGCAGTCCGCATGTCAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	143	0.0025343376163048294		47	TCRBV26	TCRBV26-01	01				TCRBJ02	TCRBJ02-06	01	5	4	6	5	3	10	27	39	44	42	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV26-01+TCRBJ02-06	TCRBV26-01*01		TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGGGACGCCCAGTGAGGCAATCAGCCCCAGCATTTTGGTGAT	CASSRDAQ*GNQPQHF	Stop	VDJ	1	20	3.544528134692069E-4		48	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-05	01	4	0	7	2	0	10	23	-1	41	36	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDAQ*GNQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01		TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGCGTACGCCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQAYASNQPQHF	In	VDJ	1	24	4.253433761630483E-4	4.99043499958413E-4	45	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-05	01	1	3	7	1	3	3	23	39	44	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAYASNQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01		TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGCCCTAAATGAGCAGTTCTTCGGGCCA	CASSQALNEQFF	In	VDJ	1	30	5.316792202038103E-4	6.238043749480163E-4	36	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-01	01	3	9	0	7	0	4	23	-1	40	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQALNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCATGACAGGGTTAGCGACGAGCAGTACTTCGGGCCG	CASSHDRVSDEQYF	In	VDJ	1	43	7.620735489587948E-4	8.941196040921567E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	3	5	1	6	23	37	45	38	51														CASSHDRVSDEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTTGCAGGGGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLAGGSNQPQHF	In	VDJ	1	47	8.329641116526362E-4	9.772935207518923E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	1	0	3	0	23	36	-1	39	46														CASSLAGGSNQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTTCCAGGGGTTTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	53	9.392999556933983E-4		43	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	2	5	3	3	23	39	48	42	51														X+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTTCCCGGGACTAATGAAAAACTGTTTTTTGGCAGT	CASSQVPGTNEKLFF	In	VDJ	1	87	0.00154186973859105	0.0018090326873492473	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	8	4	2	4	0	23	39	-1	43	47						01,02								CASSQVPGTNEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD02-01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCACACGACATCCCAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	94	0.0016659282233052724		40	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	6	7	4	5	23	35	43	39	48														X+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCAAATTAATCCGTGGGGCAGTTTAGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	19	3.3673017279574655E-4		52	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	7	0	5	12	8	22	34	51	46	59														X+TCRBV07-01+TCRBJ02-05	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGTCAACCACGTCGGGCTAGACAAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	57	0.0010101905183872396		50	TCRBV07	TCRBV07-01	01				TCRBJ02	TCRBJ02-01	01	6	2	6	5	17	1	22	33	54	50	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-01+TCRBJ02-01	TCRBV07-01*01		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCAATGCCCCTACGGGATCACCTATAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	69	0.0012228622064687639		50	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	8	3	7	10	8	22	34	49	44	57														X+TCRBV07-01+TCRBJ02-01	TCRBV07-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTACAATATCCACTTAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSTIST*QSRANVLTF	Stop	VDJ	1	22	3.898980948161276E-4		54	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-06	01	5	3	6	5	0	19	23	-1	38	35	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSTIST*QSRANVLTF+TCRBV10-02+TCRBJ02-06	TCRBV10-02*01		TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGCTTGGCTCTGGGAATACGCAGTATTTTGGCCCA	CASSELGSGNTQYF	In	VDJ	1	39	6.911829862649534E-4	8.109456874324212E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-03	01	2	0	8	7	9	0	23	38	-1	47	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSELGSGNTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01		TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTAGACAGGGCGTCTACGAGCAGTACTTCGGGCCG	CASSRQGVYEQYF	In	VDJ	1	41	7.266282676118742E-4	8.525326457622889E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	3	1	3	23	35	43	36	46													Vb 12	CASSRQGVYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGCAGGAGTACTACAATGAGCAGTTCTTCGGGCCA	CASRQEYYNEQFF	In	VDJ	1	45	7.975188303057156E-4	9.357065624220244E-4	39	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-01	01	6	4	4	3	1	4	23	34	39	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASRQEYYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCGCCACAGGGGGAGAGACCCAGTACTTCGGGCCA	CASATGGETQYF	In	VDJ	1	49	8.684093929995569E-4	0.00101888047908176	36	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	3	1	4	3	0	23	32	-1	35	43													Vb 12	CASATGGETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGAGCGGTAGTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	56	9.924678777137794E-4		40	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	5	8	3	3	1	23	38	44	41	45						01,02							Vb 12	X+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGGACTAGCGGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSEGLAASYNEQFF	In	VDJ	1	73	0.0012937527691626051	0.001517923979040173	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	1	5	0	0	1	23	-1	48	38	49						01,02							Vb 12	CASSEGLAASYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAATACCGGAGCCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASNTGAPNTGELFF	In	VDJ	2	122	0.002162162162162162	0.002536804458121933	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	10	2	0	5	3	23	33	42	38	45													Vb 12	CASNTGAPNTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTTCGGACTAGCGGGAGTGTATGAGCAGTTCTTCGGGCCA	CASSFGLAGVYEQFF	In	VDJ	3	180	0.0031900753212228622	0.0037428262496880978	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	1	2	8	3	3	23	35	51	38	54													Vb 12	CASSFGLAGVYEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCAGGCAATCAGCCCCAGCATTTTGGTGAT	CAISESGNQPQHF	In	VDJ	1	21	3.7217545414266725E-4	4.3666306246361144E-4	39	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-05	01	0	5	5	2	0	0	23	-1	-1	40	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESGNQPQHF+TCRBV10-03+TCRBJ01-05	TCRBV10-03*01		TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGACTATAGCCCGCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CAISETIARPNTGELFF	In	VDJ	1	32	5.671245015507311E-4	6.65391333277884E-4	51	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	3	9	0	0	9	23	-1	42	38	51						01,02							Vb 12	CAISETIARPNTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01	TCRBD02-01	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCGAGATAGCGGGAGGTCGCACAGATACGCAGTATTTTGGCCCA	CASSEIAGGRTDTQYF	In	VDJ	1	38	6.734603455914931E-4	7.901522082674874E-4	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	5	1	1	1	2	24	39	50	40	52													Vb 12	CASSEIAGGRTDTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGGAGTGTTCGGCTACACCTTCGGTTCG	CAISEGVFGYTF	In	VDJ	1	43	7.620735489587948E-4	8.941196040921567E-4	36	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	10	2	8	0	5	23	-1	42	38	47													Vb 12	CAISEGVFGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD02-01*02	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCTGGGTTTCCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	47	8.329641116526362E-4		35	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-03	01	10	0	9	4	3	5	24	31	37	34	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01		TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCCCCCGGACAGCTTAATGAAAAACTGTTTTTTGGCAGT	CAISESPGQLNEKLFF	In	VDJ	1	53	9.392999556933983E-4	0.0011020543957414954	48	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	1	5	4	4	2	23	40	50	44	52													Vb 12	CAISESPGQLNEKLFF+TCRBV10-03+TCRBJ01-04	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCGCGGATCCCGCAATGAGCAGTTCTTCGGGCCA	CASSPRGSRNEQFF	In	VDJ	1	19	3.3673017279574655E-4	3.950761041337437E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	7	5	6	4	6	27	39	47	43	53			01,02			01,02							Vb 17	CASSPRGSRNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTAGGCGGGCTTGAAGCTTTCTTTGGACAA	CASSVGGLEAFF	In	VDJ	1	19	3.3673017279574655E-4	3.950761041337437E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	7	4	7	0	2	27	-1	48	43	50			01,02			01,02							Vb 17	CASSVGGLEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTGGAGACAGAATCAGCCCCAGCATTTTGGTGAT	CASSIWRQNQPQHF	In	VDJ	1	20	3.544528134692069E-4	4.1586958329867756E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	5	4	5	0	27	41	-1	46	51			01,02										Vb 17	CASSIWRQNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCTACCGGGGGGGACAGTAAACCAATCAGCCCCAGCATTTTGGTGAT	CATYRGGQ*TNQPQHF	Stop	VDJ	1	23	4.0762073548958794E-4		48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	10	8	0	3	5	9	27	34	47	39	56			01,02										Vb 17	CATYRGGQ*TNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACACCTGGACAGAACTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	23	4.0762073548958794E-4		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	1	5	0	5	2	27	37	48	42	50			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGACTGGGACAGGGGAATCAGCCCCAGCATTTTGGTGAT	CASSGLGQGNQPQHF	In	VDJ	1	23	4.0762073548958794E-4	4.782500207934792E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	2	4	5	0	27	39	-1	44	54			01,02										Vb 17	CASSGLGQGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGTGGGGAACGAACACTGAAGCTTTCTTTGGACAA	CASRWGTNTEAFF	In	VDJ	1	26	4.60788657509969E-4	5.406304582882808E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	6	0	8	1	3	2	27	38	45	41	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRWGTNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCAGGCGTGGGACAGCCGAACACTGAAGCTTTCTTTGGACAA	CASTPGVGQPNTEAFF	In	VDJ	1	31	5.494018608772708E-4	6.445978541129502E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	5	1	10	2	27	37	54	47	56			01,02										Vb 17	CASTPGVGQPNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGGGCGGAACCTACGAGCAGTACTTCGGGCCG	CASKGGTYEQYF	In	VDJ	1	36	6.380150642445725E-4	7.485652499376195E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	7	5	3	2	0	5	27	-1	41	37	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASKGGTYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCCCGGTCAGGACTCAGCCCCAGCATTTTGGTGAT	CASSPPVRTQPQHF	In	VDJ	1	37	6.557377049180328E-4	7.693587291025534E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	6	1	7	6	11	0	27	38	-1	49	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPPVRTQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGAGAGGGGCGAGCTTTCTTTGGACAA	CASSIGEGRAFF	In	VDJ	1	38	6.734603455914931E-4	7.901522082674874E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	1	5	2	10	3	2	27	43	51	46	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGEGRAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGCCGGGCGGTTCCCGGGAGACCCAGTACTTCGGGCCA	CASSPPGGSRETQYF	In	VDJ	1	39	6.911829862649534E-4	8.109456874324212E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	5	8	0	5	5	9	27	39	48	44	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPPGGSRETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATTTTACAGGAAAATAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	41	7.266282676118742E-4		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	4	1	5	4	27	37	47	42	51			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCGACATACTAGTACCTACGAGCAGTACTTCGGGCCG	CASRHTSTYEQYF	In	VDJ	1	44	7.797961896322552E-4	9.149130832570906E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	3	8	2	6	2	27	36	47	42	49			01,02			01,02							Vb 17	CASRHTSTYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGAGGGGGGATACGCAGTATTTTGGCCCA	CASRRGDTQYF	In	VDJ	1	46	8.152414709791759E-4	9.565000415869584E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	5	1	6	1	0	27	38	-1	39	45			01,02										Vb 17	CASRRGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGGACAGGGCCTACGAGCAGTACTTCGGGCCG	CASSPDRAYEQYF	In	VDJ	1	47	8.329641116526362E-4	9.772935207518923E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	3	2	2	0	27	39	-1	41	49			01,02										Vb 17	CASSPDRAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTCACAGGGGACGAAACACTGAAGCTTTCTTTGGACAA	CASTHRGRNTEAFF	In	VDJ	1	48	8.506867523260966E-4	9.98086999916826E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	2	2	3	4	27	37	47	40	51			01,02										Vb 17	CASTHRGRNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACACTATGGGGGGACACTGAAGCTTTCTTTGGACAA	CASTLWGDTEAFF	In	VDJ	1	49	8.684093929995569E-4	0.00101888047908176	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	9	1	3	6	0	27	37	-1	43	49			01,02										Vb 17	CASTLWGDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTACGAACACTGAAGCTTTCTTTGGACAA	CASSITNTEAFF	In	VDJ	1	54	9.570225963668586E-4	0.0011228478749064294	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	3	7	1	1	0	27	41	-1	42	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSITNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACGCAGGGGATGTCTATGGCTACACCTTCGGTTCG	CASSNAGDVYGYTF	In	VDJ	1	57	0.0010101905183872396	0.001185228312401231	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	4	3	4	27	40	49	43	53			01,02										Vb 17	CASSNAGDVYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGTCGTCTGGAGACCCAGTACTTCGGGCCA	CASSIGRLETQYF	In	VDJ	1	61	0.001081081081081081	0.0012684022290609664	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	4	10	5	5	1	27	43	50	48	51			01,02			01,02							Vb 17	CASSIGRLETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGCCAACTCCTACGAGCAGTACTTCGGGCCG	CASSIANSYEQYF	In	VDJ	1	62	0.0010988037217545415	0.0012891957082259004	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	4	6	0	3	1	27	41	46	44	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIANSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCCGCCGGGCGCTTACTACGAGCAGTACTTCGGGCCG	CASSPPPGAYYEQYF	In	VDJ	1	62	0.0010988037217545415	0.0012891957082259004	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	5	8	0	3	8	5	27	39	51	47	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPPPGAYYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGTCTTTGTTCCGGGGAGGGTACGAAAAACTGTTTTTTGGCAGT	CASRSLFRGGYEKLFF	In	VDJ	1	65	0.0011519716437749224	0.001351576145720702	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	6	9	0	8	12	3	27	38	57	50	60			01,02										Vb 17	CASRSLFRGGYEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*02	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCGACTAGCGGGCAAGAGACCCAGTACTTCGGGCCA	CASSATSGQETQYF	In	VDJ	1	66	0.0011696942844483828	0.0013723696248856359	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	2	4	2	2	0	27	39	-1	41	51			01,02			01,02							Vb 17	CASSATSGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGGGACTAGCGGGAGGCGAGCAGTTCTTCGGGCCA	CASTGLAGGEQFF	In	VDJ	1	68	0.0012051395657953034	0.0014139565832155035	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	0	1	10	1	1	27	37	53	38	54			01,02										Vb 17	CASTGLAGGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCCGGACTACCAGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	69	0.0012228622064687639		46	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	1	9	0	3	6	27	36	45	39	51			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCCCGCGGGTGATATCGGGCAGTACTTCGGGCCG	CASRPAGDIGQYF	In	VDJ	1	75	0.001329198050509526	0.0015595109373700408	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	7	4	9	4	9	27	38	47	42	56			01,02			01,02							Vb 17	CASRPAGDIGQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCATAGGGGGTTTGGGACAGCCCCAGCATTTTGGTGAT	CASTIGGLGQPQHF	In	VDJ	1	79	0.0014000886132033673	0.0016426848540297763	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	5	1	7	4	7	27	37	47	41	54			01,02										Vb 17	CASTIGGLGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGACGGGACGGGAACACGGGACCCAGTACTTCGGGCCA	CASRTGREHGTQYF	In	VDJ	1	85	0.0015064244572441294	0.0017674457290193795	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	6	0	7	7	3	10	27	38	46	41	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRTGREHGTQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGCAGGGAGATCCTACGAGCAGTACTTCGGGCCG	CASAGRSYEQYF	In	VDJ	1	91	0.0016127603012848915	0.0018922066040089828	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	9	4	3	1	2	3	27	35	42	37	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASAGRSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGCCARGAACTAGCACAGATACGCAGTATTTTGGCCCA	CASKPXTSTDTQYF	In	VDJ	1	91	0.0016127603012848915	0.0018922066040089828	42	TCRBV19	TCRBV19-01		unresolved			TCRBJ02	TCRBJ02-03	01	7	4	4	0	3	4	27	37	44	40	48			01,02	TCRBD01,TCRBD02									Vb 17	CASKPXTSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	unresolved	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGACCTTAGCGGGAGGGAACAATGAGCAGTTCTTCGGGCCA	CASSRTLAGGNNEQFF	In	VDJ	1	94	0.0016659282233052724	0.0019545870415037846	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	0	5	6	1	27	40	57	46	58			01,02										Vb 17	CASSRTLAGGNNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGTTTCGCAATCAGCCCCAGCATTTTGGTGAT	CASTFRNQPQHF	In	VDJ	1	95	0.0016836508639787328	0.0019753805206687183	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	8	6	2	0	4	27	-1	39	37	43			01,02			01,02							Vb 17	CASTFRNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTGTTCTCGGGACAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	95	0.0016836508639787328		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	0	8	0	27	39	-1	47	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTACAGGGACTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSTTGTSYNEQFF	In	VDJ	1	97	0.0017190961453256535	0.002016967478998586	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	4	3	3	1	2	3	27	40	48	42	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTTGTSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGAGTATCCATGATACGCAGTATTTTGGCCCA	CASSIGSIHDTQYF	In	VDJ	2	110	0.001949490474080638	0.0022872827081427266	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	10	2	6	0	7	27	-1	47	43	54			01,02										Vb 17	CASSIGSIHDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCCGGCCCTACAATGAGCAGTTCTTCGGGCCA	CASSLRPYNEQFF	In	VDJ	2	110	0.001949490474080638	0.0022872827081427266	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	5	9	0	2	4	0	27	39	-1	43	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSLRPYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCGTTAGCGGGAGGGTTCTCGTTCTACAATGAGCAGTTCTTCGGGCCA	CASSSLAGGFSFYNEQFF	In	VDJ	2	110	0.001949490474080638	0.0022872827081427266	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	0	3	4	8	27	39	54	43	62			01,02										Vb 17	CASSSLAGGFSFYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGTGACACCGACGGGGGGAAAACTGTTTTTTGGCAGT	CASSMVTPTGGKLFF	In	VDJ	2	113	0.002002658396101019	0.002349663145637528	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	1	10	11	0	27	41	-1	52	59			01,02										Vb 17	CASSMVTPTGGKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCTTAGCGGGAGGGCGAACCGGGGAGCTGTTTTTTGGAGAA	CASSLLAGGRTGELFF	In	VDJ	2	122	0.002162162162162162	0.002536804458121933	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	5	0	5	4	3	27	39	54	43	57			01,02										Vb 17	CASSLLAGGRTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGAGGGTAGGGCGGGCTACAATGAGCAGTTCTTCGGGCCA	CASEGRAGYNEQFF	In	VDJ	2	132	0.0023393885688967656	0.0027447392497712718	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	7	4	3	9	0	27	36	-1	45	50			01,02			01,02							Vb 17	CASEGRAGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCGCCAAGACGGGTACGCAGTATTTTGGCCCA	CATAKTGTQYF	In	VDJ	2	144	0.00255206025697829	0.002994260999750478	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	10	8	4	8	9	0	27	34	-1	43	47			01,02			01,02							Vb 17	CATAKTGTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGTACAGGGAGGGGAATGAGCAGTTCTTCGGGCCA	CASSRYREGNEQFF	In	VDJ	2	153	0.002711564023039433	0.003181402312234883	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	9	0	7	6	1	27	40	53	46	54			01,02										Vb 17	CASSRYREGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACTATGGCGGGGTCGGGTAGAGATACGCAGTATTTTGGCCCA	CATMAGSGRDTQYF	In	VDJ	2	154	0.0027292866637128933	0.003202195791399817	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	10	7	3	5	5	8	27	34	45	39	53			01,02										Vb 17	CATMAGSGRDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTTGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSILGTGELFF	In	VDJ	2	162	0.002871067789100576	0.003368543624719288	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	3	6	2	5	3	0	27	41	-1	44	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSILGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGCGGGACAGGGTGGTAACTGAAGCTTTCTTTGGACAA	CASTRDRVVTEAFF	In	VDJ	2	164	0.0029065130704474967	0.0034101305830491558	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	3	5	3	5	27	37	49	40	54			01,02										Vb 17	CASTRDRVVTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGCGACGCAGCGACGAGCAGTACTTCGGGCCG	CASSPRRSDEQYF	In	VDJ	2	165	0.002924235711120957	0.0034309240622140895	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	6	6	5	9	0	27	39	-1	48	52			01,02			01,02							Vb 17	CASSPRRSDEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGACTCTGGTGAATGAGCAGTTCTTCGGGCCA	CASSTTLVNEQFF	In	VDJ	3	175	0.0031014621178555605	0.0036388588538634283	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	10	7	1	6	27	40	45	41	51			01,02			01,02							Vb 17	CASSTTLVNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGAGACTTTAATCGGGAAGCTTTCTTTGGACAA	CASGDFNREAFF	In	VDJ	3	199	0.0035268054940186086	0.004137902353821841	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	8	2	10	8	3	8	27	36	43	39	51			01,02			01,02							Vb 17	CASGDFNREAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAGGGTTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRVATNEKLFF	In	VDJ	3	209	0.003704031900753212	0.00434583714547118	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	9	4	3	0	0	3	27	-1	40	35	43			01,02										Vb 17	CASRVATNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCACGGTAGCAAGTGAAAAACTGTTTTTTGGCAGT	CASSITVASEKLFF	In	VDJ	4	257	0.004554718653079309	0.005343924145388006	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	5	7	7	5	3	27	41	50	46	53			01,02			01,02							Vb 17	CASSITVASEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGTCCCAGGGAAACACCATATATTTTGGAGAG	CASSGSQGNTIYF	In	VDJ	4	260	0.0046078865750996895	0.005406304582882808	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	5	0	9	4	0	6	27	-1	42	39	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSGSQGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCGGGTAGCACTGAAGCTTTCTTTGGACAA	CASSISGSTEAFF	In	VDJ	4	261	0.00462560921577315	0.005427098062047742	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	8	4	4	1	3	27	42	47	43	50			01,02			01,02							Vb 17	CASSISGSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCTTATCCCTAGGGGCTGGCTATGGCTACACCTTCGGTTCG	CASSLSLGAGYGYTF	In	VDJ	1	25	4.4306601683650863E-4	5.198369791233469E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	5	2	4	9	4	23	34	48	43	52													Vb 11	CASSLSLGAGYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGACCTAGGCGCGGGAGAAGTCGGGATACGCAGTATTTTGGCCCA	CASSGPRRGRSRDTQYF	In	VDJ	1	25	4.4306601683650863E-4	5.198369791233469E-4	51	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	7	2	6	9	7	23	36	52	45	59													Vb 11	CASSGPRRGRSRDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGGAGTGAGGGGGCTGATGGCTACACCTTCGGTTCG	CASRSEGADGYTF	In	VDJ	1	26	4.60788657509969E-4	5.406304582882808E-4	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	5	0	6	5	2	23	34	46	39	48													Vb 11	CASRSEGADGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAAGGGGACATCAAGAGACCCAGTACTTCGGGCCA	CASSERGHQETQYF	In	VDJ	1	33	5.848471422241914E-4	6.861848124428179E-4	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	6	2	2	1	23	38	46	40	47													Vb 11	CASSERGHQETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGCGACGATTAACTATGGCTACACCTTCGGTTCG	CASSATINYGYTF	In	VDJ	1	56	9.924678777137794E-4	0.001164434833236297	39	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-02	01	4	2	7	1	1	3	23	36	40	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSATINYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01		TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCACATACCTCTCAGTACCTCTGTGCCACCTCTGGACAGGGCTATGGCTACACCTTCGGTTCG	CATSGQGYGYTF	In	VDJ	1	61	0.001081081081081081	0.0012684022290609664	36	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	1	3	4	5	0	23	30	-1	35	43													Vb 11	CATSGQGYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGCGACAGGCTTGGGGGAAAAACTGTTTTTTGGCAGT	CASSEATGLGEKLFF	In	VDJ	1	75	0.001329198050509526	0.0015595109373700408	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	2	4	8	2	7	23	38	46	40	53													Vb 11	CASSEATGLGEKLFF+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCACCAGTGAGCCCGGGACTTCAGTTCTTCGGGCCA		Out	VDJ	1	34	6.025697828976517E-4		34	TCRBV22	TCRBV22-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	13	0	10	13	15	1	25	28	49	43	50						01,02								X+TCRBV22-01+TCRBJ02-01	TCRBV22-01*01	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTTCGGGGCCGGCCTCACCGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	3.7217545414266725E-4		56	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-07	01	1	7	0	0	3	13	23	39	47	42	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	X+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCTCAGGGAAGGCTTTTCCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLREGFSSNQPQHF	In	VDJ	1	28	4.962339388568897E-4	5.822174166181485E-4	51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	3	1	1	11	23	36	42	37	53													Vb 7.1	CASSLREGFSSNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCTCCTCGGTAGGGAATCAGCCCCAGCATTTTGGTGAT	CASSSVGNQPQHF	In	VDJ	1	21	3.7217545414266725E-4	4.3666306246361144E-4	39	TCRBV10	TCRBV10-01					TCRBJ01	TCRBJ01-05	01	8	5	3	4	8	0	26	35	-1	43	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSSVGNQPQHF+TCRBV10-01+TCRBJ01-05	TCRBV10-01		TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGCGCCTTAAGGGGAGGTAACACTGAAGCTTTCTTTGGACAA	CASSALRGGNTEAFF	In	VDJ	1	29	5.1395657953035E-4	6.030108957830824E-4	45	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	1	2	9	1	26	37	52	46	53			01,02										Vb 12	CASSALRGGNTEAFF+TCRBV10-01+TCRBJ01-01	TCRBV10-01	TCRBD02-01*02	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCCGTGGGGGAGCTGTTTTTTGGAGAA	CASSESVGELFF	In	VDJ	1	42	7.443509082853345E-4	8.733261249272229E-4	36	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	8	6	8	0	2	26	-1	45	43	47			01,02			01,02							Vb 12	CASSESVGELFF+TCRBV10-01+TCRBJ02-02	TCRBV10-01	TCRBD02-01	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGTATCCAATTTCGGGAGAGGGCAGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVSNFGRGQSYNEQFF	In	VDJ	1	76	0.0013469206911829862	0.0015803044165349747	57	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	2	1	10	7	24	37	53	47	60			01,02										Vb 12	CASSVSNFGRGQSYNEQFF+TCRBV10-01+TCRBJ02-01	TCRBV10-01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCCTGGACCGGGACTTCCCTTTTAGAGGCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	44	7.797961896322552E-4		56	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	10	4	7	14	22	34	47	41	61						01,02								X+TCRBV12-01+TCRBJ02-03	TCRBV12-01*01	TCRBD02-01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCCCGTGTTGTGCCCTTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	62	0.0010988037217545415		46	TCRBV12	TCRBV12-01	01				TCRBJ02	TCRBJ02-01	01	5	10	0	3	9	4	22	34	45	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-01+TCRBJ02-01	TCRBV12-01*01		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCCGACCGGGGACAGGGTACCTACGAGCAGTACTTCGGGCCG	CASSSDRGQGTYEQYF	In	VDJ	1	19	3.3673017279574655E-4	3.950761041337437E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	2	8	2	26	38	55	46	57		TCRBV03-01,TCRBV03-02												CASSSDRGQGTYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGAGGTACGGACTACGAGCAGTACTTCGGGCCG	CSARDGGTDYEQYF	In	VDJ	1	19	3.3673017279574655E-4	3.950761041337437E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	10	1	3	1	6	26	40	46	41	52		TCRBV20-01,TCRBV20-or09_02												CSARDGGTDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATGGGTACAGGGGAAACCTGAAGCTTTCTTTGGACAA	CSARWVQGKPEAFF	In	VDJ	1	19	3.3673017279574655E-4	3.950761041337437E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	2	6	5	4	26	38	50	43	54		TCRBV20-01,TCRBV20-or09_02												CSARWVQGKPEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTAGGAGAGACCCAGTACTTCGGGCCA	CSARLGETQYF	In	VDJ	1	19	3.3673017279574655E-4	3.950761041337437E-4	33	TCRBV20						TCRBJ02	TCRBJ02-05	01	2	5	4	4	2	0	26	38	-1	40	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARLGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAATCACAGCGGCCGACCTACAATGAGCAGTTCTTCGGGCCA	CSAQSQRPTYNEQFF	In	VDJ	1	19	3.3673017279574655E-4	3.950761041337437E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	6	5	2	7	4	26	35	47	42	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSAQSQRPTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCTCCGGATTGTCACAGATATGCAGTATTTTGGCCCA	CASSLRIVTDMQYF	In	VDJ	1	19	3.3673017279574655E-4	3.950761041337437E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	5	11	12	4	22	34	50	46	54		TCRBV12-03,TCRBV12-04												CASSLRIVTDMQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTCCTTGTAACCGGGACAGGGGTACGTGGCTACACCTTCGGTTCG	CASSFLVTGTGVRGYTF	In	VDJ	1	19	3.3673017279574655E-4	3.950761041337437E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	2	7	12	4	24	36	58	48	62	TCRBV24,TCRBV27													CASSFLVTGTGVRGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGGGCTCCCTCTGGGCTTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	19	3.3673017279574655E-4		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	8	0	3	10	1	18	34	48	44	49	TCRBV07,TCRBV11													X+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTCGGCGGGGCCGCTCCGGATGAGCAGTTCTTCGGGCCA	CASSVGGAAPDEQFF	In	VDJ	1	20	3.544528134692069E-4	4.1586958329867756E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	3	8	5	9	26	37	48	42	57		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVGGAAPDEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGTGGTGATCAGCCCCAGCATTTTGGTGAT	CSASRGDQPQHF	In	VDJ	1	20	3.544528134692069E-4	4.1586958329867756E-4	36	TCRBV20						TCRBJ01	TCRBJ01-05	01	3	0	10	5	4	2	26	37	43	41	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRGDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGGACTAGCGGGAGGGGTACGCAGTATTTTGGCCCA	CASRTSGRGTQYF	In	VDJ	1	20	3.544528134692069E-4	4.1586958329867756E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	2	0	8	0	1	22	-1	47	33	48		TCRBV12-03,TCRBV12-04												CASRTSGRGTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTCCGACCTAGCAGTCGTTAATGAGCAGTTCTTCGGGCCA	CASSSDLAVVNEQFF	In	VDJ	1	20	3.544528134692069E-4	4.1586958329867756E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	7	7	5	7	18	31	41	36	48	TCRBV07,TCRBV11					01,02								CASSSDLAVVNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCGAGACTAGATACTCTGGCTACACCTTCGGTTCG		Out	VDJ	1	20	3.544528134692069E-4		41	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	2	8	7	3	6	18	31	40	34	46	TCRBV07,TCRBV11					01,02								X+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCAGCGTAGACGTCCTAGCGGAGCAGTTCTTCGGGCCA	CASSVDVLAEQFF	In	VDJ	1	20	3.544528134692069E-4	4.1586958329867756E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	6	10	5	0	23	39	-1	44	50	TCRBV03,TCRBV09					01,02								CASSVDVLAEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTAAGGCGGACAGGGGGCTGATACGCAGTATTTTGGCCCA	CASS*GGQGADTQYF	Stop	VDJ	1	21	3.7217545414266725E-4		45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	0	6	2	1	26	42	55	44	56		TCRBV03-01,TCRBV03-02												CASS*GGQGADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTAGCAGCGAACTACAATGAGCAGTTCTTCGGGCCA	CSARVAANYNEQFF	In	VDJ	1	21	3.7217545414266725E-4	4.3666306246361144E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	5	7	3	0	6	26	-1	43	39	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVAANYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCGTCGCAGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSRRRSSYNEQFF	In	VDJ	1	21	3.7217545414266725E-4	4.3666306246361144E-4	45	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	4	4	0	5	2	24	36	45	41	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRRRSSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCTTACCTCCGCCAGCGGGAGGGGGACCCAGTACTTCGGGCCA	CASSLTSASGRGTQYF	In	VDJ	1	21	3.7217545414266725E-4	4.3666306246361144E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	6	0	7	12	1	19	31	53	43	54	TCRBV07,TCRBV11													CASSLTSASGRGTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGARGACTCRGCCCTKTATCTYTGCGCCAGCAGCCAAGTCGCCAGCGGGAGGGCTATCTCCTACGAGCAGTACTTCGGGCCG	CASSQVASGRAISYEQYF	In	VDJ	1	21	3.7217545414266725E-4	4.3666306246361144E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	6	0	0	9	4	19	31	50	40	54	TCRBV04,TCRBV05													CASSQVASGRAISYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGTAMSCTCYCAGACATCTGTGTACTTCTGTGCCAGCAGTGACTCGTGTTACACCTTTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	21	3.7217545414266725E-4		53	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	6	0	5	6	28	45	53	50	59	TCRBV06,TCRBV10													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGTATCTCTGYGCCAGCAGCTTGGAGTACAGCAAGATCGTACAACTCATCATCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	21	3.7217545414266725E-4		67	unresolved			unresolved			TCRBJ01	TCRBJ01-03	01	0	3	5	0	3	22	8	24	31	27	53	TCRBV05,TCRBV23			TCRBD01,TCRBD02										X+X+TCRBJ01-03	unresolved	unresolved	TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGGACCCCGGGGGCAGGGAGCAGTACTTCGGGCCG	CASSQDPGGREQYF	In	VDJ	1	22	3.898980948161276E-4	4.574565416285453E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	3	6	0	7	7	3	23	37	50	44	53	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDPGGREQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCTTAAAGATGATGCGGGTCATAATATGGCTACACCTTCGGTTCG		Out	VDJ	1	22	3.898980948161276E-4		49	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	7	4	5	11	6	26	38	54	49	60	TCRBV03,TCRBV12					01,02								X+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAACGCCCCAGGGGGGCTATACGAGCAGTACTTCGGGCCG	CSANAPGGLYEQYF	In	VDJ	1	22	3.898980948161276E-4	4.574565416285453E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	1	4	8	4	26	34	49	42	53		TCRBV20-01,TCRBV20-or09_02												CSANAPGGLYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGCCCGGACTAGCGGGAGAAACTACGAGCAGTACTTCGGGCCG	CASSARTSGRNYEQYF	In	VDJ	1	22	3.898980948161276E-4	4.574565416285453E-4	48	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	1	2	3	5	3	22	33	51	38	54		TCRBV12-03,TCRBV12-04												CASSARTSGRNYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTTAGGTGGCAAGGTAGTCTCTCTCTCTCTGGAAACACCATATATTTTGGAGAG	CASSFRWQGSLSLSGNTIYF	In	VDJ	1	22	3.898980948161276E-4	4.574565416285453E-4	60							TCRBJ01	TCRBJ01-03	01	3	5	4	0	1	20	18	32	36	33	56	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRWQGSLSLSGNTIYF+X+TCRBJ01-03			TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGGGACACCTCTGGGCACTGAAGCTTTCTTTGGACAA	CASSLGTPLGTEAFF	In	VDJ	1	22	3.898980948161276E-4	4.574565416285453E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	6	4	0	8	18	-1	39	34	47	TCRBV07,TCRBV11													CASSLGTPLGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGGACCTAGCACAGATACGCAGTATTTTGGCCCA	CASSGPSTDTQYF	In	VDJ	1	23	4.0762073548958794E-4	4.782500207934792E-4	39	TCRBV12						TCRBJ02	TCRBJ02-03	01	6	1	7	0	1	2	26	37	42	38	44		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGPSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGCACCTAATGAGCAGTTCTTCGGGCCA	CASSAPNEQFF	In	VDJ	1	23	4.0762073548958794E-4	4.782500207934792E-4	33	TCRBV12						TCRBJ02	TCRBJ02-01	01	5	3	7	7	2	2	26	38	42	40	44		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAPNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTAGTCGTCCATTTTTGGCATCATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	23	4.0762073548958794E-4		52	TCRBV03						TCRBJ01	TCRBJ01-05	01	4	9	0	5	16	3	26	39	58	55	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTACGCACCTAAGGGAAAACATTCAGTACTTCGGCGCC	CASSTHLRENIQYF	In	VDJ	1	23	4.0762073548958794E-4	4.782500207934792E-4	42	TCRBV03						TCRBJ02	TCRBJ02-04	01	6	5	3	5	10	0	26	37	-1	47	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTHLRENIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03		TCRBJ02-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGCGGTAGCGCTTCAGATACGCAGTATTTTGGCCCA	CSAGGSASDTQYF	In	VDJ	1	23	4.0762073548958794E-4	4.782500207934792E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	6	4	5	3	26	35	45	40	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGGSASDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTTCCCGAGGGGGAAGAAACACCATATATTTTGGAGAG	CASSSRGGRNTIYF	In	VDJ	1	23	4.0762073548958794E-4	4.782500207934792E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	5	1	5	4	2	22	35	45	39	47	TCRBV12,TCRBV21													CASSSRGGRNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACACCTCCGGGACAGGGACTACGAGCAGTACTTCGGGCCG	CASSLHLRDRDYEQYF	In	VDJ	1	23	4.0762073548958794E-4	4.782500207934792E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	3	10	1	24	36	55	46	56		TCRBV24-01,TCRBV24-or09_02												CASSLHLRDRDYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCRTGTATSKCTGTGCCAGCGAGTCTCTCGACCAGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	23	4.0762073548958794E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	4	4	4	12	6	18	27	43	39	49	TCRBV07,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGACAGGGGGTGATTTTGAGTAATCAGCCCCAGCATTTTGGTGAT	CASSLGQGVILSNQPQHF	In	VDJ	1	24	4.253433761630483E-4	4.99043499958413E-4	54	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	2	1	4	0	11	26	-1	51	42	62		TCRBV12-03,TCRBV12-04												CASSLGQGVILSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAACAGCCCCTTCGGGACAGCTACAAACACTGAAGCTTTCTTTGGACAA	CANSPFGTATNTEAFF	In	VDJ	1	24	4.253433761630483E-4	4.99043499958413E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	2	5	5	26	39	51	44	56		TCRBV03-01,TCRBV03-02												CANSPFGTATNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAGGACAGGATGGCTACACCTTCGGTTCG	CASSLGQDGYTF	In	VDJ	1	24	4.253433761630483E-4	4.99043499958413E-4	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	4	6	2	0	26	39	-1	41	48		TCRBV03-01,TCRBV03-02												CASSLGQDGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGAAACTAGCGGGAGGTGAAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	24	4.253433761630483E-4		46	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	3	1	3	4	4	26	35	51	39	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTACTTCAAAGGGGGCGGATTTTACGTTGAATAGCAATCAGCCCCAGCATTTTGGTGAT	CSTSKGADFTLNSNQPQHF	In	VDJ	1	24	4.253433761630483E-4	4.99043499958413E-4	57	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	5	0	0	7	15	24	30	44	37	59		TCRBV20-01,TCRBV20-or09_02												CSTSKGADFTLNSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTATCCGGGGCGATGGGAGAGCAGTACTTCGGGCCG	CASSLSGAMGEQYF	In	VDJ	1	24	4.253433761630483E-4	4.99043499958413E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	2	7	0	7	3	7	18	33	41	36	48	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSGAMGEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCATTGGGGGGGCTGCCGCCCGCACAGATACACAGTATTTTGGCCCA	CASIGGAAARTDTQYF	In	VDJ	1	24	4.253433761630483E-4	4.99043499958413E-4	48	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	9	0	12	2	20	19	29	38	31	58		TCRBV05-06,TCRBV05-07												CASIGGAAARTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCAGAGAGCCCCAGAACACTGAAGCTTTCTTTGGACAA	CASSREPQNTEAFF	In	VDJ	1	24	4.253433761630483E-4	4.99043499958413E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	6	7	1	3	4	24	37	43	40	47	TCRBV09,TCRBV21					01,02								CASSREPQNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGACGGGGTCCCATTTCCTCCGACAATGAGCAGTTCTTCGGGCCA	CASSGRGPISSDNEQFF	In	VDJ	1	25	4.4306601683650863E-4	5.198369791233469E-4	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	3	5	3	14	26	38	46	41	60		TCRBV03-01,TCRBV03-02												CASSGRGPISSDNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCCCGAGTAGGAATAACTATGGCTACACCTTCGGTTCG	CSPSRNNYGYTF	In	VDJ	1	25	4.4306601683650863E-4	5.198369791233469E-4	36	TCRBV20						TCRBJ01	TCRBJ01-02	01	9	1	8	1	8	1	26	31	42	39	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSPSRNNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCGCCGGCTTAGGGAATGAGCAGTTCTTCGGGCCA	CSARVAGLGNEQFF	In	VDJ	1	25	4.4306601683650863E-4	5.198369791233469E-4	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	1	5	3	7	10	0	26	39	-1	49	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVAGLGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGACGGTTATACGAGCAGTACTTCGGGCCG	CASSQGRLYEQYF	In	VDJ	1	25	4.4306601683650863E-4	5.198369791233469E-4	39	unresolved						TCRBJ02	TCRBJ02-07	01	1	2	7	4	0	5	23	-1	42	39	47	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGRLYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCCCTCCAAACTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	25	4.4306601683650863E-4		40	TCRBV05						TCRBJ02	TCRBJ02-06	01	7	4	6	2	4	2	19	28	34	32	36		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV05-X+TCRBJ02-06	TCRBV05		TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCCGGGACTAGCGGGAGGTTTGCATGAGCAGTTCTTCGGGCCA	CASSPGLAGGLHEQFF	In	VDJ	1	26	4.60788657509969E-4	5.406304582882808E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	1	8	3	5	26	37	55	40	60	TCRBV09,TCRBV12													CASSPGLAGGLHEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTTTAATTGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	26	4.60788657509969E-4		35	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	5	9	8	4	4	26	37	43	41	47		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								X+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTCTAGCGGGAGTCAGTGAGACCCAGTACTTCGGGCCA	CSAILAGVSETQYF	In	VDJ	1	26	4.60788657509969E-4	5.406304582882808E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	4	2	5	2	5	26	36	48	38	53		TCRBV20-01,TCRBV20-or09_02												CSAILAGVSETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CMCCAACCAGACAKCTMTKTACYTCTGTGCCAGCAGCCCTCCCAGCATCCCGATACGCAGTATTTTGGCCCA		Out	VDJ	1	26	4.60788657509969E-4		41	unresolved						TCRBJ02	TCRBJ02-03	01	7	4	5	6	6	6	24	35	44	41	50	TCRBV24,TCRBV28			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACCTCCAGGTCCACTAATGAAAAACTGTTTTTTGGCAGT	CATSRSTNEKLFF	In	VDJ	1	26	4.60788657509969E-4	5.406304582882808E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	4	4	2	4	3	23	30	38	34	41	TCRBV06,TCRBV10													CATSRSTNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTGAAAGCGGGAGATTCGCTTCCGGGGAGCTGTTTTTTGGAGAA	CASSESGRFASGELFF	In	VDJ	1	26	4.60788657509969E-4	5.406304582882808E-4	48	TCRBV06			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	6	2	6	0	8	26	-1	49	41	57		TCRBV06-01,TCRBV06-09												CASSESGRFASGELFF+TCRBV06-X+TCRBJ02-02	TCRBV06	TCRBD02-01*02	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCAGAGACAGACCCAGCGTAGCACTGAARCTTTCTTTGGACAA	CASSQRQTQRSTEXFF	In	VDJ	1	26	4.60788657509969E-4	5.406304582882808E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	5	12	4	19	19	31	40	35	59	TCRBV05,TCRBV11													CASSQRQTQRSTEXFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGGRGACWYGGCWSTGTATCTCTGYGCCAGCAGCTCGTACGGAGGGTACGAGCAGTACTTCGGGCCG	CASSSYGGYEQYF	In	VDJ	1	26	4.60788657509969E-4	5.406304582882808E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	0	4	4	0	22	36	-1	40	46	TCRBV07,TCRBV23													CASSSYGGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGCCGGGAGAGATACGCAGTATTTTGGCCCA	CSAAGRDTQYF	In	VDJ	1	27	4.785112981834293E-4	5.614239374532147E-4	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	8	2	5	3	0	26	34	-1	37	43		TCRBV20-01,TCRBV20-or09_02												CSAAGRDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCGACAGACAGGGTTACATGGCTACACCTTCGGTTCG	CSATRQTGLHGYTF	In	VDJ	1	27	4.785112981834293E-4	5.614239374532147E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	6	7	4	26	36	50	43	54		TCRBV20-01,TCRBV20-or09_02												CSATRQTGLHGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCGAAAGGGGAAAAACTGTTTTTTGGCAGT	CASSPKGEKLFF	In	VDJ	1	27	4.785112981834293E-4	5.614239374532147E-4	36	TCRBV24						TCRBJ01	TCRBJ01-04	01	6	5	3	8	5	0	24	36	-1	41	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPKGEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTGGGGAGTTCTTTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLGSSLAKNIQYF	In	VDJ	1	27	4.785112981834293E-4	5.614239374532147E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	9	2	0	1	6	18	32	38	33	44	TCRBV05,TCRBV07,TCRBV11													CASSLGSSLAKNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGTAAACTAACTAGAACCACCGGGGAGCTGTTTTTTGGAGAA	CASKLTRTTGELFF	In	VDJ	1	27	4.785112981834293E-4	5.614239374532147E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	3	8	4	7	3	23	31	43	38	46	TCRBV02,TCRBV09					01,02								CASKLTRTTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAGATACGCAGTATTTTGGCCCA	CASSQGDTQYF	In	VJ	1	28	4.962339388568897E-4	5.822174166181485E-4	33	TCRBV03						TCRBJ02	TCRBJ02-03	01	1	0	0	5	0	1	26	-1	42	-1	43		TCRBV03-01,TCRBV03-02												CASSQGDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAATCCTCTAGGGCAGGCCGAAGCTTTCTTTGGACAA	CASNPLGQAEAFF	In	VDJ	1	28	4.962339388568897E-4	5.822174166181485E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	7	4	4	8	11	2	22	32	47	43	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNPLGQAEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACGGGCACGGACGACTACAATGAGCAGTTCTTCGGGCCA	CATGTDDYNEQFF	In	VDJ	1	28	4.962339388568897E-4	5.822174166181485E-4	39	unresolved						TCRBJ02	TCRBJ02-01	01	10	1	7	3	7	2	23	30	41	37	43	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATGTDDYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGATTTTCTGTCGTCAGAAAACTATGGCTACACCTTCGGTTCG	CASSLDFLSSENYGYTF	In	VDJ	1	28	4.962339388568897E-4	5.822174166181485E-4	51	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	5	2	14	2	19	33	50	47	52		TCRBV05-06,TCRBV05-07												CASSLDFLSSENYGYTF+TCRBV05-X+TCRBJ01-02	TCRBV05	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGGACTCSGCCSTSTATCTCTGTGCCAGCAGTCCGGGACGGCAGACCTACGAGCAGTACTTCGGGCCG	CASSPGRQTYEQYF	In	VDJ	1	28	4.962339388568897E-4	5.822174166181485E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	5	0	7	2	3	6	19	30	38	33	44	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGRQTYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCTAGACAGTATTGGAAACACCATATATTTTGGAGAG	CSARDLDSIGNTIYF	In	VDJ	1	29	5.1395657953035E-4	6.030108957830824E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	2	5	3	4	3	26	40	49	44	52		TCRBV20-01,TCRBV20-or09_02												CSARDLDSIGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGGAAATCCCGGACTTGAAAAACTGTTTTTTGGCAGT	CASSGNPGLEKLFF	In	VDJ	1	29	5.1395657953035E-4	6.030108957830824E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	1	10	7	9	0	22	34	-1	43	48		TCRBV12-03,TCRBV12-04				01,02								CASSGNPGLEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGATTCGTGCGGGACTAGCCACCGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	29	5.1395657953035E-4		46	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	7	6	8	5	24	35	52	43	57		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAAATCGGTCGCCAGGGGGTTCTCCTACGAGCAGTACTTCGGGCCG	CASKSVARGFSYEQYF	In	VDJ	1	30	5.316792202038103E-4	6.238043749480163E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	4	1	0	10	2	24	34	51	44	53	TCRBV06,TCRBV10													CASKSVARGFSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCAACCGGACAGACCAACACTGAAGCTTTCTTTGGACAA	CASSSTGQTNTEAFF	In	VDJ	1	30	5.316792202038103E-4	6.238043749480163E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	5	2	5	3	18	31	42	36	45	TCRBV07,TCRBV11													CASSSTGQTNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGGCCGGACTCGTCGAGCAATGAGCAGTTCTTCGGGCCA	CASRPDSSSNEQFF	In	VDJ	1	31	5.494018608772708E-4	6.445978541129502E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	10	6	3	7	26	37	45	40	52		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASRPDSSSNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCTTCGTTCGGGAGCCAAATCTACGAGCAGTACTTCGGGCCG	CASSPSFGSQIYEQYF	In	VDJ	1	31	5.494018608772708E-4	6.445978541129502E-4	48	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	2	3	8	6	26	38	52	46	58		TCRBV12-03,TCRBV12-04												CASSPSFGSQIYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACGGGACTAGCGGGAGTACTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSHGTSGSTSYNEQFF	In	VDJ	1	31	5.494018608772708E-4	6.445978541129502E-4	54	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	0	2	1	1	4	26	40	55	41	59		TCRBV03-01,TCRBV03-02												CASSHGTSGSTSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGTAGACCCTACACGGACTATGGCTACACCTTCGGTTCG	CSASRPYTDYGYTF	In	VDJ	1	31	5.494018608772708E-4	6.445978541129502E-4	42	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	2	7	3	5	9	26	34	42	39	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRPYTDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCAGCTTAGGACAGGCCAAGAGACCCAGTACTTCGGGCCA	CASSQLRTGQETQYF	In	VDJ	1	31	5.494018608772708E-4	6.445978541129502E-4	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	4	1	7	0	19	31	-1	38	45		TCRBV05-06,TCRBV05-07												CASSQLRTGQETQYF+TCRBV05-X+TCRBJ02-05	TCRBV05	TCRBD01-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCGAGGCGACAGGGTAGCCGCTGAAGCTTTCTTTGGACAA	CASSRGDRVAAEAFF	In	VDJ	1	32	5.671245015507311E-4	6.65391333277884E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	3	6	7	6	26	37	51	44	57		TCRBV03-01,TCRBV03-02												CASSRGDRVAAEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTGACGGTAATCAGCCCCAGCATTTTGGTGAT	CSATDGNQPQHF	In	VDJ	1	32	5.671245015507311E-4	6.65391333277884E-4	36	TCRBV20						TCRBJ01	TCRBJ01-05	01	4	2	7	4	2	3	26	36	41	38	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATDGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTCAGGGCCATTTCGGGCAATCAGCCCCAGCATTTTGGTGAT	CSARDLRAISGNQPQHF	In	VDJ	1	32	5.671245015507311E-4	6.65391333277884E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	3	2	3	9	26	40	48	43	57		TCRBV20-01,TCRBV20-or09_02												CSARDLRAISGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCTGGACCTCAGTACCCCTGAAGCTTTCTTTGGACAA	CSASLDLSTPEAFF	In	VDJ	1	32	5.671245015507311E-4	6.65391333277884E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	1	7	6	3	10	26	37	44	40	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASLDLSTPEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAAGGTGAAAAACTGTTTTTTGGCAGT	CASSQEGEKLFF	In	VDJ	1	32	5.671245015507311E-4	6.65391333277884E-4	36	unresolved						TCRBJ01	TCRBJ01-04	01	0	5	4	7	0	0	23	-1	-1	40	43	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCTCGAGAACTAGCGGGTATTGGTGTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	32	5.671245015507311E-4		49	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	3	4	6	6	9	23	32	47	38	56	TCRBV24,TCRBV27					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGTCGGACAGGGCTAACTACAATGAGCAGTTCTTCGGGCCA	CATSESDRANYNEQFF	In	VDJ	1	32	5.671245015507311E-4	6.65391333277884E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	3	3	3	4	24	38	49	41	53		TCRBV24-01,TCRBV24-or09_02												CATSESDRANYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGTACGACTAGTCAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	32	5.671245015507311E-4		43	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	11	2	8	0	4	4	24	31	41	35	45		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGTAGCCGCTCTGGGGCCAACACTGAAGCTTTCTTTGGACAA	CASSRSGANTEAFF	In	VDJ	1	33	5.848471422241914E-4	6.861848124428179E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	7	0	2	5	1	26	39	49	44	50		TCRBV03-01,TCRBV03-02												CASSRSGANTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCTCCGGGGAGCGGGATCCTTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	33	5.848471422241914E-4		49	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	3	2	10	5	26	34	51	44	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTACTAGGGGCATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	33	5.848471422241914E-4		43	TCRBV20						TCRBJ02	TCRBJ02-01	01	1	5	2	4	5	2	26	39	49	44	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CACCAGCCARACMKMTYTGTACYWCTGTGCCAGCAGTTTAGTACGGGGGTTCCTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	33	5.848471422241914E-4		47	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	8	2	3	8	5	22	32	46	40	51	TCRBV08,TCRBV22													X+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCGACGACAGGGTAGCTATGGTTACACCTTCGGTTCG	CASSQDRRQGSYGYTF	In	VDJ	1	33	5.848471422241914E-4	6.861848124428179E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	3	11	5	10	18	35	47	40	57	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDRRQGSYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGGGACTAGCGGGAGGGCCAAGGTTTCAATATTTTGGCCCA	CSATGLAGGPRFQYF	In	VDJ	1	34	6.025697828976517E-4	7.069782916077518E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	0	0	15	1	12	26	36	53	37	65		TCRBV20-01,TCRBV20-or09_02												CSATGLAGGPRFQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACTAGCGGAGGACGGGGAAACAATGAGCAGTTCTTCGGGCCA	CSARGTSGGRGNNEQFF	In	VDJ	1	34	6.025697828976517E-4	7.069782916077518E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	1	5	5	0	11	26	-1	49	39	60		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGTSGGRGNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGAGCTGGACCGAGGAAAAACATTCAGTACTTCGGCGCC	CSARAGPRKNIQYF	In	VDJ	1	34	6.025697828976517E-4	7.069782916077518E-4	42	TCRBV20						TCRBJ02	TCRBJ02-04	01	1	1	7	4	2	5	26	39	45	41	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARAGPRKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20		TCRBJ02-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGTTACAGGGACTATGGCTACACCTTCGGTTCG	CSGYRDYGYTF	In	VDJ	1	34	6.025697828976517E-4	7.069782916077518E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	3	3	3	0	26	33	-1	36	42		TCRBV20-01,TCRBV20-or09_02												CSGYRDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGACTAAGGGAGATACGCAGTATTTTGGCCCA	CASSLTKGDTQYF	In	VDJ	1	34	6.025697828976517E-4	7.069782916077518E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	9	5	2	4	24	36	43	38	47		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLTKGDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCTGACTAGCGGGAATGGGCATGAGCAGTTCTTCGGGCCA	CASSLTSGNGHEQFF	In	VDJ	1	34	6.025697828976517E-4	7.069782916077518E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	2	3	8	2	6	18	30	43	32	49	TCRBV07,TCRBV11													CASSLTSGNGHEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGCTAGATACCTACGAGCAGTACTTCGGGCCG	CASSVGLDTYEQYF	In	VDJ	1	34	6.025697828976517E-4	7.069782916077518E-4	42	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	5	5	3	2	2	7	24	36	42	38	49	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSVGLDTYEQYF+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCGCACCTGGGACAGGGGGACTGAAAAACTGTTTTTTGGCAGT	CASSRTWDRGTEKLFF	In	VDJ	1	35	6.202924235711121E-4	7.277717707726857E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	1	7	7	2	26	38	56	45	58		TCRBV12-03,TCRBV12-04												CASSRTWDRGTEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCATCGCCGGGATCCCTACCTACGAGCAGTACTTCGGGCCG	CSARSIAGIPTYEQYF	In	VDJ	1	35	6.202924235711121E-4	7.277717707726857E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	8	3	2	8	6	26	38	51	46	57		TCRBV20-01,TCRBV20-or09_02												CSARSIAGIPTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCCGGGGGGACCAGGTCTATGGCTACACCTTCGGTTCG	CASSFRGDQVYGYTF	In	VDJ	1	35	6.202924235711121E-4	7.277717707726857E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	1	4	3	7	24	36	46	39	53		TCRBV24-01,TCRBV24-or09_02												CASSFRGDQVYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACCTCGCGACCGGATAACAAGAACACTGAAGCTTTCTTTGGACAA	CATSRPDNKNTEAFF	In	VDJ	1	35	6.202924235711121E-4	7.277717707726857E-4	45	unresolved						TCRBJ01	TCRBJ01-01	01	10	1	8	1	10	6	23	30	43	40	49	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRPDNKNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGGCCATATCTGGAAGACAGGGGAAACACCATATATTTTGGAGAG	CASRPYLEDRGNTIYF	In	VDJ	1	35	6.202924235711121E-4	7.277717707726857E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	4	4	13	0	23	34	-1	47	53	TCRBV06,TCRBV10													CASRPYLEDRGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGTAGCGGGAGGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSVAGGTYNEQFF	In	VDJ	1	36	6.380150642445725E-4	7.485652499376195E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	5	0	2	2	1	26	37	50	39	51	TCRBV12,TCRBV21													CASSVAGGTYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGAGGCGGGACTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	36	6.380150642445725E-4		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	0	10	0	6	0	26	40	-1	46	52		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGCCAGTCTGAAAGGCGAGCAGTACTTCGGGCCG	CASSASLKGEQYF	In	VDJ	1	36	6.380150642445725E-4	7.485652499376195E-4	39	unresolved						TCRBJ02	TCRBJ02-07	01	4	4	5	6	1	9	23	36	40	37	49	TCRBV02,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSASLKGEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAGCCCAGGGGGCGGGCTACACCTTCGGTTCG	CASSLAQGAGYTF	In	VDJ	1	37	6.557377049180328E-4	7.693587291025534E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	0	8	6	1	26	38	52	44	53		TCRBV03-01,TCRBV03-02												CASSLAQGAGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATATCTGGGGACTGGCCCTTCAAATGAGCAGTTCTTCGGGCCA	CASSLYLGTGPSNEQFF	In	VDJ	1	37	6.557377049180328E-4	7.693587291025534E-4	51	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	10	7	9	9	24	36	51	45	60		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLYLGTGPSNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTGAGGAATATGACTAGCGGGTAGGTAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	37	6.557377049180328E-4		55	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	2	4	3	9	5	23	37	56	46	61	TCRBV09,TCRBV21					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGGACACAAATATCGGATTCACTGAAGCTTTCTTTGGACAA	CASRDTNIGFTEAFF	In	VDJ	1	38	6.734603455914931E-4	7.901522082674874E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	6	4	0	13	26	-1	42	37	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRDTNIGFTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTACATCTACAATCAGCCCCAGCATTTTGGTGAT	CSAYIYNQPQHF	In	VDJ	1	38	6.734603455914931E-4	7.901522082674874E-4	36	TCRBV20						TCRBJ01	TCRBJ01-05	01	5	3	6	3	1	4	26	35	39	36	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAYIYNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGCCGCAGGGTACGGGGGGATAGAAAAACTGTTTTTTGGCAGT	CASSAAGYGGIEKLFF	In	VDJ	1	38	6.734603455914931E-4	7.901522082674874E-4	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	1	8	10	3	24	37	54	47	57		TCRBV24-01,TCRBV24-or09_02												CASSAAGYGGIEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD02-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAAGCGGGAACCTCTATGGCTACACCTTCGGTTCG	CASSLSGNLYGYTF	In	VDJ	1	38	6.734603455914931E-4	7.901522082674874E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	6	3	4	3	4	24	36	46	39	50	TCRBV24,TCRBV27													CASSLSGNLYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCCGACAGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPTVSGANVLTF	In	VDJ	1	38	6.734603455914931E-4	7.901522082674874E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	2	5	0	2	1	19	31	38	33	39	TCRBV05,TCRBV11													CASSPTVSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGCAGGGGAACACTGAAGCTTTCTTTGGACAA	CSAKQGNTEAFF	In	VDJ	1	39	6.911829862649534E-4	8.109456874324212E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	1	2	0	26	36	-1	38	43		TCRBV20-01,TCRBV20-or09_02												CSAKQGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCCGGACAGACCTATGGCTACACCTTCGGTTCG	CASSPGQTYGYTF	In	VDJ	1	39	6.911829862649534E-4	8.109456874324212E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	5	4	2	2	23	36	44	38	46	TCRBV01,TCRBV04													CASSPGQTYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGGAGGGACTCGAACAGGGGATGAACACTGAAGCTTTCTTTGGACAA	CATSEEGLEQGMNTEAFF	In	VDJ	1	39	6.911829862649534E-4	8.109456874324212E-4	54	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	2	0	12	1	24	38	57	50	58		TCRBV24-01,TCRBV24-or09_02												CATSEEGLEQGMNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTGGGTCAGTAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	39	6.911829862649534E-4		43	TCRBV24						TCRBJ02	TCRBJ02-05	01	1	0	9	3	1	5	24	41	45	42	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCACAGCTGGACAAGAGACCCAGTACTTCGGGCCA	CASSFTAGQETQYF	In	VDJ	1	39	6.911829862649534E-4	8.109456874324212E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	3	5	2	3	5	24	36	43	39	48		TCRBV24-01,TCRBV24-or09_02												CASSFTAGQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCGCACTAATGGGGGACACCCTAAAGAGACCCAGTACTTCGGGCCA	CASSRTNGGHPKETQYF	In	VDJ	1	39	6.911829862649534E-4	8.109456874324212E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	6	3	11	5	18	30	47	41	52	TCRBV07,TCRBV11													CASSRTNGGHPKETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCAGGGACAGTATGGCACTGAAGCTTTCTTTGGACAA	CASSQGQYGTEAFF	In	VDJ	1	40	7.089056269384139E-4	8.317391665973551E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	4	2	5	24	36	45	38	50	TCRBV06,TCRBV10													CASSQGQYGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGCGGGAGACAACAATGAGCAGTTCTTCGGGCCA	CASSAGDNNEQFF	In	VDJ	1	40	7.089056269384139E-4	8.317391665973551E-4	39				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	2	5	0	3	24	-1	43	37	46	TCRBV06,TCRBV10	TCRBV06-01,TCRBV10-03												CASSAGDNNEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTAGTGACACTAACTATGGCTACACCTTCGGTTCG	CSVSDTNYGYTF	In	VDJ	1	40	7.089056269384139E-4	8.317391665973551E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	6	0	1	0	26	37	-1	38	42		TCRBV20-01,TCRBV20-or09_02												CSVSDTNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCACCGGGGGCTAGCGGGGTTCAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	40	7.089056269384139E-4		46	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	4	3	5	7	5	22	32	48	39	53		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCTCCCGGGGAAGGGGGGGTATAGGGCTACACCTTCGGTTCG		Out	VDJ	1	40	7.089056269384139E-4		47	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	7	9	0	8	12	5	24	35	54	47	59		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCCTGGACAGGGGTGAAGCTTTCTTTGGACAA	CASSFLDRGEAFF	In	VDJ	1	41	7.266282676118742E-4	8.525326457622889E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	2	7	3	0	26	40	-1	43	52		TCRBV12-03,TCRBV12-04												CASSFLDRGEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTAAACGGGAGGGCCTCTTACGAGCAGTACTTCGGGCCG	CSARDLNGRASYEQYF	In	VDJ	1	41	7.266282676118742E-4	8.525326457622889E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	8	0	4	6	5	26	40	54	46	59		TCRBV20-01,TCRBV20-or09_02												CSARDLNGRASYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCCGCAATTGCCGCCCCACGAGCAGTACTTCGGGCCG	CASSPQLPPHEQYF	In	VDJ	1	41	7.266282676118742E-4	8.525326457622889E-4	42	TCRBV12						TCRBJ02	TCRBJ02-07	01	5	4	6	5	3	11	22	34	39	37	50		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPQLPPHEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCACCTTCGGGGGAGATTATCAGCCCCAGCATTTTGGTGAT	CASTFGGDYQPQHF	In	VDJ	1	41	7.266282676118742E-4	8.525326457622889E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	7	8	2	5	4	5	26	36	46	40	51	TCRBV06,TCRBV10													CASTFGGDYQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGTCAGCAGTTTAAACGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CVSSLNGNTGELFF	In	VDJ	1	42	7.443509082853345E-4	8.733261249272229E-4	42	TCRBV12						TCRBJ02	TCRBJ02-02	01	2	1	8	2	3	0	26	41	-1	44	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CVSSLNGNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACAGTTGGGGTTCCTATGGCTACACCTTCGGTTCG	CASSQDSWGSYGYTF	In	VDJ	1	42	7.443509082853345E-4	8.733261249272229E-4	45	unresolved						TCRBJ01	TCRBJ01-02	01	0	6	2	4	5	3	23	40	49	45	52	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDSWGSYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCGTCCACTAGCGGGCTTATCCACGAGCAGTACTTCGGGCCG	CSARPSTSGLIHEQYF	In	VDJ	1	42	7.443509082853345E-4	8.733261249272229E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	3	4	5	6	7	26	38	53	44	60		TCRBV20-01,TCRBV20-or09_02				01,02								CSARPSTSGLIHEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTGGGGGCTGGCTACACCTTCGGTTCG	CSARDLGAGYTF	In	VDJ	1	42	7.443509082853345E-4	8.733261249272229E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	6	0	7	3	0	26	40	-1	43	49		TCRBV20-01,TCRBV20-or09_02												CSARDLGAGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCCCTTAGCGGCGTGGCGCGCGAGCAGTACTTCGGGCCG	CSASSLSGVAREQYF	In	VDJ	1	42	7.443509082853345E-4	8.733261249272229E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	5	5	6	6	9	26	37	49	43	58		TCRBV20-01,TCRBV20-or09_02				01,02								CSASSLSGVAREQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCCCTACACTAGCGGCTTGAGCACAGATACGCAGTATTTTGGCCCA	CASSPYTSGLSTDTQYF	In	VDJ	1	42	7.443509082853345E-4	8.733261249272229E-4	51	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	5	0	6	4	22	34	48	40	52		TCRBV12-03,TCRBV12-04				01,02								CASSPYTSGLSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGGCAGGGGACGCCGTTGAGGAAGGCCAGTACTTCGGGCCA	CASRAGDAVEEGQYF	In	VDJ	1	43	7.620735489587948E-4	8.941196040921567E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	2	10	2	16	26	37	45	39	61		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRAGDAVEEGQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACAGACTCCACCCTGGATTACAATGAGCAGTTCTTCGGGCCA	CSATDSTLDYNEQFF	In	VDJ	1	43	7.620735489587948E-4	8.941196040921567E-4	45	TCRBV20						TCRBJ02	TCRBJ02-01	01	6	3	5	4	1	14	26	34	39	35	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATDSTLDYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTGGACAAGACACTGAAGCTTTCTTTGGACAA	CSATGQDTEAFF	In	VDJ	1	43	7.620735489587948E-4	8.941196040921567E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	6	3	2	2	26	36	43	38	45		TCRBV20-01,TCRBV20-or09_02												CSATGQDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTCCCTGGGACTAGCGGGAGAAGGTTGTTCTTCGGGCCA	CSAFPGTSGRRLFF	In	VDJ	1	43	7.620735489587948E-4	8.941196040921567E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	2	15	6	6	26	35	55	41	61		TCRBV20-01,TCRBV20-or09_02												CSAFPGTSGRRLFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGGAGGGGGGCCCCTACGAGCAGTACTTCGGGCCG	CASSQEEGGPYEQYF	In	VDJ	1	43	7.620735489587948E-4	8.941196040921567E-4	45							TCRBJ02	TCRBJ02-07	01	0	5	1	2	2	3	18	35	43	37	46	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEEGGPYEQYF+X+TCRBJ02-07			TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCACCTATTATAAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	43	7.620735489587948E-4		47	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	9	0	1	7	22	36	40	37	47	TCRBV01,TCRBV04,TCRBV07,TCRBV17					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGACACTTGGGGAACACTGAAGCTTTCTTTGGACAA	CSARHLGNTEAFF	In	VDJ	1	44	7.797961896322552E-4	9.149130832570906E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	6	1	2	6	26	34	40	36	46		TCRBV20-01,TCRBV20-or09_02												CSARHLGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGACAGGCATACGAGCAGTACTTCGGGCCG	CASSQGQAYEQYF	In	VDJ	1	44	7.797961896322552E-4	9.149130832570906E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	4	4	0	2	23	-1	45	39	47	TCRBV01,TCRBV04													CASSQGQAYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGAGGACCCGGTCAGCCAGCCCCAGCATTTTGGTGAT	CASSEDPVSQPQHF	In	VDJ	1	44	7.797961896322552E-4	9.149130832570906E-4	42	TCRBV12						TCRBJ01	TCRBJ01-05	01	6	1	7	7	3	9	22	33	40	36	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEDPVSQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCTGGGACCATTAAACAGGGGCATAGAGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	44	7.797961896322552E-4		49	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	11	3	2	8	14	6	24	31	52	45	58		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGCGCCACCTTGAACACTGAAGCTTTCTTTGGACAA	CSARDGATLNTEAFF	In	VDJ	1	45	7.975188303057156E-4	9.357065624220244E-4	45	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	9	0	0	1	7	26	40	44	41	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDGATLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCAGGGGAACTACTACGAGCAGTACTTCGGGCCG	CSASQGNYYEQYF	In	VDJ	1	45	7.975188303057156E-4	9.357065624220244E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	3	1	5	26	37	44	38	49		TCRBV20-01,TCRBV20-or09_02												CSASQGNYYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTATGGGAAGGGCCTGAACACTGAAGCTTTCTTTGGACAA	CSAYGKGLNTEAFF	In	VDJ	1	45	7.975188303057156E-4	9.357065624220244E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	0	8	0	3	6	26	35	42	38	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAYGKGLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACATCCGGGACACATTACGAGCAGTACTTCGGGCCG	CASTSGTHYEQYF	In	VDJ	1	45	7.975188303057156E-4	9.357065624220244E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	0	6	4	8	3	24	31	45	39	48		TCRBV24-01,TCRBV24-or09_02												CASTSGTHYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACCCCACGTTCCCCGACAGGGTATGCGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	45	7.975188303057156E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	2	3	8	13	6	23	30	50	43	56	TCRBV06,TCRBV10													X+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGCGGGACAGGGAATACACTTCGGGCCG		Out	VDJ	1	46	8.152414709791759E-4		38	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	3	14	3	5	26	42	54	45	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAAACAAGGGGGATCTAACTATGGCTACACCTTCGGTTCG	CSAKQGGSNYGYTF	In	VDJ	1	46	8.152414709791759E-4	9.565000415869584E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	5	1	0	6	2	26	34	46	40	48		TCRBV20-01,TCRBV20-or09_02												CSAKQGGSNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGGACAGGGGTAGCTATGGCTACACCTTCGGTTCG	CSATDRGSYGYTF	In	VDJ	1	47	8.329641116526362E-4	9.772935207518923E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	2	4	1	3	26	36	46	37	49		TCRBV20-01,TCRBV20-or09_02												CSATDRGSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCAAAGACTAGCGGGAGTACGGATGAGCAGTTCTTCGGGCCA	CSAPKTSGSTDEQFF	In	VDJ	1	47	8.329641116526362E-4	9.772935207518923E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	2	2	8	5	5	26	35	52	40	57		TCRBV20-01,TCRBV20-or09_02												CSAPKTSGSTDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAATATCGGAGGCGGGGAGGGCCTCTAGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	47	8.329641116526362E-4		58	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	9	0	3	11	7	23	38	56	49	63	TCRBV01,TCRBV04													X+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGTATTGGGCAGAACCACAGATACGCAGTATTTTGGCCCA	CASSLVLGRTTDTQYF	In	VDJ	1	47	8.329641116526362E-4	9.772935207518923E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	8	0	2	8	5	24	36	48	44	53		TCRBV24-01,TCRBV24-or09_02												CASSLVLGRTTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCGACAGGGGGCAACACTACGAGCAGTACTTCGGGCCG	CASSDRGQHYEQYF	In	VDJ	1	47	8.329641116526362E-4	9.772935207518923E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	0	3	0	4	19	-1	41	31	45		TCRBV05-06,TCRBV05-07												CASSDRGQHYEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGTAGGGGAACTGAAGCTTTCTTTGGACAA	CSASRGTEAFF	In	VDJ	1	49	8.684093929995569E-4	0.00101888047908176	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	2	5	4	1	26	34	43	38	44		TCRBV20-01,TCRBV20-or09_02												CSASRGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGTCGGGACTAGCGGGAGTTTCGGGGACCCAGTACTTCGGGCCA	CSASGLAGVSGTQYF	In	VDJ	1	49	8.684093929995569E-4	0.00101888047908176	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	0	2	7	3	7	26	34	51	37	58		TCRBV20-01,TCRBV20-or09_02												CSASGLAGVSGTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCGGGGAGGGGAAGGACAATGAGCAGTTCTTCGGGCCA	CSASGEGKDNEQFF	In	VDJ	1	49	8.684093929995569E-4	0.00101888047908176	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	0	5	4	5	26	35	46	39	51		TCRBV20-01,TCRBV20-or09_02												CSASGEGKDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCTGACTGCTGAGCAGTTCTTCGGGCCA	CASSQDLTAEQFF	In	VDJ	1	49	8.684093929995569E-4	0.00101888047908176	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	2	10	9	3	2	23	40	47	43	49	TCRBV01,TCRBV04					01,02								CASSQDLTAEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCACCGGTGAAAGCGGGAGGGTTGCCCACAATGAGCAGTTCTTCGGGCCA	CATGESGRVAHNEQFF	In	VDJ	1	50	8.861320336730173E-4	0.0010396739582466939	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	10	6	0	5	8	6	26	33	51	41	57		TCRBV03-01,TCRBV03-02												CATGESGRVAHNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGTCGGGCACAAGGGTCGGCCAGTACTTCGGGCCG	CATSESGTRVGQYF	In	VDJ	1	50	8.861320336730173E-4	0.0010396739582466939	42	TCRBV24						TCRBJ02	TCRBJ02-07	01	4	5	3	10	10	5	24	38	52	48	57		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSESGTRVGQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACCCAGACTATACCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	50	8.861320336730173E-4		41	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	11	2	9	0	7	3	24	31	43	38	46		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGACAGGGGCTTCGGCAGCCCCAGCATTTTGGTGAT	CSASRQGLRQPQHF	In	VDJ	1	51	9.038546743464776E-4	0.0010604674374116278	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	2	7	2	6	26	37	47	39	53		TCRBV20-01,TCRBV20-or09_02												CSASRQGLRQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGTGGACAGACTGGAAACACCATATATTTTGGAGAG	CSAGGQTGNTIYF	In	VDJ	1	51	9.038546743464776E-4	0.0010604674374116278	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	1	5	2	3	1	26	35	44	38	45		TCRBV20-01,TCRBV20-or09_02												CSAGGQTGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTACAGACAGGGCCCTACGAGCAGTACTTCGGGCCG	CASSVQTGPYEQYF	In	VDJ	1	51	9.038546743464776E-4	0.0010604674374116278	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	3	2	2	1	23	38	47	40	48	TCRBV09,TCRBV21													CASSVQTGPYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATTTATTAAGGGGGCCCTTCCAAGAGACCCAGTACTTCGGGCCA	CSANLLRGPFQETQYF	In	VDJ	1	52	9.21577315019938E-4	0.0010812609165765615	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	5	0	1	8	4	26	36	51	44	55		TCRBV20-01,TCRBV20-or09_02												CSANLLRGPFQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCTATTGACAGTGAGACTGAAGCTTTCTTTGGACAA	CSASSIDSETEAFF	In	VDJ	1	52	9.21577315019938E-4	0.0010812609165765615	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	5	5	7	4	26	37	49	44	53		TCRBV20-01,TCRBV20-or09_02												CSASSIDSETEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCCTTAAAGCGGGAGTCGCTGAGCAGTTCTTCGGGCCA	CASLKAGVAEQFF	In	VDJ	1	52	9.21577315019938E-4	0.0010812609165765615	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	6	2	9	5	4	22	31	44	36	48	TCRBV09,TCRBV12													CASLKAGVAEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTCTCACAGGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSFSQGSNQPQHF	In	VDJ	1	53	9.392999556933983E-4	0.0011020543957414954	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	3	3	0	3	0	22	36	-1	39	45		TCRBV12-03,TCRBV12-04												CASSFSQGSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATTGGGGGCGGAGCAGTTCTTCGGGCCA	CASSLLGAEQFF	In	VDJ	1	53	9.392999556933983E-4	0.0011020543957414954	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	6	0	10	1	1	23	39	46	40	47	TCRBV24,TCRBV27													CASSLLGAEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TTTCTGTGCCAGCAGCGGACTAGCCGTAGTCGGTGGGGTCGATGGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	53	9.392999556933983E-4		67	TCRBV21			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	1	7	0	0	24	4	-1	24	16	48		TCRBV21-or09_02,TCRBV21-01				01,02								X+TCRBV21-X+TCRBJ02-02	TCRBV21	TCRBD02-01	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGTAMSCTCYCAGACATCTGTGTACTTCTGTGCCAGCAGTGACGAGACTAGCGGAGACAATGAGCAGTTCTTCGGGCCA	CASSDETSGDNEQFF	In	VDJ	1	55	9.74745237040319E-4	0.0011436413540713633	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	2	5	5	3	2	24	38	50	41	52	TCRBV06,TCRBV10					01,02								CASSDETSGDNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATTCACGGACTATGAGGAATGAGCAGTTCTTCGGGCCA	CASSHSRTMRNEQFF	In	VDJ	1	55	9.74745237040319E-4	0.0011436413540713633	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	9	7	5	5	26	40	51	45	56		TCRBV03-01,TCRBV03-02				01,02								CASSHSRTMRNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGTCCGGGAGGGGACTATGGCTACACCTTCGGTTCG	CSASSPGGDYGYTF	In	VDJ	1	55	9.74745237040319E-4	0.0011436413540713633	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	8	0	3	5	1	26	37	50	42	51		TCRBV20-01,TCRBV20-or09_02												CSASSPGGDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCGGCAGGGCCTTCGAAGCTTTCTTTGGACAA	CSAIGRAFEAFF	In	VDJ	1	55	9.74745237040319E-4	0.0011436413540713633	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	8	4	5	26	36	45	40	50		TCRBV20-01,TCRBV20-or09_02												CSAIGRAFEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGCGCGGGACAGGGGGCTTTGTTGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	56	9.924678777137794E-4		47	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	9	0	0	1	4	7	26	31	47	35	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCCCTAGCGGGAGACGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	56	9.924678777137794E-4		50	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	4	2	0	3	1	26	39	52	42	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAGACAGGGTATCAGCCCCAGCATTTTGGTGAT	CSAQTGYQPQHF	In	VDJ	1	57	0.0010101905183872396	0.001185228312401231	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	3	5	3	1	26	34	44	37	45		TCRBV20-01,TCRBV20-or09_02												CSAQTGYQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTACTACAATGAGCAGTTCTTCGGGCCA	CSASYYNEQFF	In	VDJ	1	57	0.0010101905183872396	0.001185228312401231	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	9	3	1	0	26	37	-1	38	40		TCRBV20-01,TCRBV20-or09_02				01,02								CSASYYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACAGGGGTCCTACGAGCAGTACTTCGGGCCG	CSARQGSYEQYF	In	VDJ	1	58	0.0010279131590607	0.0012060217915661649	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	1	0	0	26	-1	-1	38	44		TCRBV20-01,TCRBV20-or09_02												CSARQGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCACGAAGGGAAGGGGTTGGTTGGCTACACCTTCGGTTCG		Out	VDJ	1	58	0.0010279131590607		38	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	5	2	7	7	5	24	32	44	39	49	TCRBV24,TCRBV27													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCAAGTCCCCCTACGAGCAGTACTTTGGGCCG	CSVKSPYEQYF	In	VDJ	1	59	0.0010456357997341605	0.0012268152707310988	33	TCRBV20						TCRBJ02	TCRBJ02-07	01	7	4	5	19	17	6	26	33	53	50	59		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSVKSPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTGGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSLAGVNTEAFF	In	VDJ	1	59	0.0010456357997341605	0.0012268152707310988	42							TCRBJ01	TCRBJ01-01	01	0	6	2	0	1	0	18	35	-1	36	40	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGVNTEAFF+X+TCRBJ01-01			TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGGCGCCATTTACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSWRHLQSRANVLTF	In	VDJ	1	60	0.0010633584404076207	0.0012476087498960325	51	TCRBV03						TCRBJ02	TCRBJ02-06	01	5	3	6	5	11	5	26	38	52	49	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWRHLQSRANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03		TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGCCGGGACAGGGTTATCAGCCCCAGCATTTTGGTGAT	CSARAPGQGYQPQHF	In	VDJ	1	60	0.0010633584404076207	0.0012476087498960325	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	0	3	5	4	2	26	39	52	43	54		TCRBV20-01,TCRBV20-or09_02												CSARAPGQGYQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACATGGGACCGCGGGGTGGGTGGCTACACCTTCGGTTCG	CSTWDRGVGGYTF	In	VDJ	1	61	0.001081081081081081	0.0012684022290609664	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	8	7	3	7	10	4	26	32	48	42	52		TCRBV20-01,TCRBV20-or09_02												CSTWDRGVGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGAGCGGGAGGGGGGACAGATACGCAGTATTTTGGCCCA	CSARRAGGGTDTQYF	In	VDJ	1	61	0.001081081081081081	0.0012684022290609664	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	6	0	3	2	3	26	38	50	40	53		TCRBV20-01,TCRBV20-or09_02												CSARRAGGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGACGGTTATCGGGAGGAAACCCCTACGAGCAGTACTTCGGGCCG	CSAGRLSGGNPYEQYF	In	VDJ	1	61	0.001081081081081081	0.0012684022290609664	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	1	2	10	5	26	35	52	45	57		TCRBV20-01,TCRBV20-or09_02												CSAGRLSGGNPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGTCAAAGTGCAGGACGGACTCAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	62	0.0010988037217545415		46	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	9	1	10	2	14	1	26	34	53	48	54		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTCAGAGACAGAACTATGGCTACACCTTCGGTTCG	CSAIQRQNYGYTF	In	VDJ	1	62	0.0010988037217545415	0.0012891957082259004	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	5	2	6	0	26	36	-1	42	47		TCRBV20-01,TCRBV20-or09_02												CSAIQRQNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGAAGGGGGGAGGGCGTCCCGGGGAGCTGTTTTTTGGAGAA	CSAREKGGGRPGELFF	In	VDJ	1	63	0.0011165263624280017	0.0013099891873908343	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	9	0	6	6	4	26	40	53	46	57		TCRBV20-01,TCRBV20-or09_02												CSAREKGGGRPGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCGGACAGGGGAAGCGGGTGGCTACACCTTCGGTTCG		Out	VDJ	1	63	0.0011165263624280017		40	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	2	7	2	7	26	35	46	37	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAACGGACTAGATTCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	64	0.0011342490031014622		41	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	1	8	2	4	5	26	34	45	38	50		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCCAGGGACAGGGGGCGATCGGATCAGCCCCAGCATTTTGGTGAT	CATSDPRDRGRSDQPQHF	In	VDJ	1	64	0.0011342490031014622	0.001330782666555768	54	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	0	5	5	6	24	38	55	43	61		TCRBV24-01,TCRBV24-or09_02												CATSDPRDRGRSDQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGCCTTCTCGGGACAGGGGGCTCGTGGCAATCAGCCCCAGCATTTTGGTGAT	CASSAFSGQGARGNQPQHF	In	VDJ	1	64	0.0011342490031014622	0.001330782666555768	57	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	0	2	8	5	24	36	56	44	61		TCRBV12-03,TCRBV12-04												CASSAFSGQGARGNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGAGGGACAGCGTATGGCTACACCTTCGGTTCG	CSARRGTAYGYTF	In	VDJ	1	66	0.0011696942844483828	0.0013723696248856359	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	5	5	3	2	26	38	48	41	50		TCRBV20-01,TCRBV20-or09_02												CSARRGTAYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYSGANVLTF	In	VDJ	1	66	0.0011696942844483828	0.0013723696248856359	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	6	5	9	0	0	0	24	-1	-1	36	38		TCRBV24-01,TCRBV24-or09_02				01,02								CASSYSGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD02-01	TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCGTTAGCGGGAGGGCTGGATACAATGAGCAGTTCTTCGGGCCA	CASSFVSGRAGYNEQFF	In	VDJ	1	67	0.0011874169251218432	0.0013931631040505698	51	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	5	0	4	5	5	24	36	52	41	57		TCRBV24-01,TCRBV24-or09_02												CASSFVSGRAGYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACCAGGCGGGAGGAACAGATACGCAGTATTTTGGCCCA	CASSDQAGGTDTQYF	In	VDJ	1	68	0.0012051395657953034	0.0014139565832155035	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	7	1	3	6	1	23	35	49	41	50	TCRBV06,TCRBV10													CASSDQAGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCAAATCAGCGGCACTCCTACAATGAGCAGTTCTTCGGGCCA	CATSDSNQRHSYNEQFF	In	VDJ	1	69	0.0012228622064687639	0.0014347500623804374	51	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	6	5	0	6	2	24	40	51	46	53		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDSNQRHSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCACCCCAGATACGCAGTATTTTGGCCCA	CASSFTPDTQYF	In	VDJ	1	69	0.0012228622064687639	0.0014347500623804374	36	TCRBV24						TCRBJ02	TCRBJ02-03	01	6	3	7	4	3	2	24	36	41	39	43		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFTPDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACTGGGCCCTACAAGCCAATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	70	0.0012405848471422243		50	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	8	0	4	2	12	26	40	46	42	58		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTACCTCCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSTSYSNQPQHF	In	VDJ	1	70	0.0012405848471422243	0.0014555435415453714	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	4	9	0	5	0	26	38	-1	43	46	TCRBV06,TCRBV10					01,02								CASSTSYSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAGAATGGGGAAATCCTCCTACAATGAGCAGTTCTTCGGGCCA	CSASRMGKSSYNEQFF	In	VDJ	1	71	0.0012583074878156845	0.0014763370207103053	48	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	0	8	0	7	4	26	37	48	44	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRMGKSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGGGAATTGGACCCGGGGAGCTGTTTTTTGGAGAA	CASSQEGIGPGELFF	In	VDJ	1	71	0.0012583074878156845	0.0014763370207103053	45							TCRBJ02	TCRBJ02-02	01	0	0	8	6	0	7	18	-1	39	35	46	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGIGPGELFF+X+TCRBJ02-02			TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCACTCAGGGACTAGCGGGAGTTAATGAGCAGTTCTTCGGGCCA	CATQGLAGVNEQFF	In	VDJ	1	71	0.0012583074878156845	0.0014763370207103053	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	9	0	2	7	4	2	23	30	48	34	50	TCRBV09,TCRBV12													CATQGLAGVNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTGGGACTAGCGGGAGGGCCTGGGTGAGCAGTTCTTCGGGCCA	CSARDWD*REGLGEQFF	Stop	VDJ	1	77	0.0013646433318564466		51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	0	0	9	2	6	26	40	58	42	64		TCRBV20-01,TCRBV20-or09_02												CSARDWD*REGLGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGAGACAGGGGATCTACGAGCAGTACTTCGGGCCG	CASSLRQGIYEQYF	In	VDJ	1	79	0.0014000886132033673	0.0016426848540297763	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	2	3	2	2	26	40	50	42	52		TCRBV12-03,TCRBV12-04												CASSLRQGIYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAACACGCAGAAAATTAACACTGAAGCTTTCTTTGGACAA	CASNTQKINTEAFF	In	VDJ	1	79	0.0014000886132033673	0.0016426848540297763	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	6	2	0	11	22	-1	35	32	46		TCRBV12-03,TCRBV12-04												CASNTQKINTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCAGGGACTAGCGGCTACGAGCAGTACTTCGGGCCG	CASSPGTSGYEQYF	In	VDJ	1	79	0.0014000886132033673	0.0016426848540297763	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	5	3	4	0	24	35	-1	39	50		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPGTSGYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGCCACTAGCGGGAGGAGGCGTGTACGCAGTATTTTGGCCCA	CSARH*REEACTQYF	Stop	VDJ	1	80	0.0014178112538768277		45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	3	1	8	4	7	26	35	51	39	58		TCRBV20-01,TCRBV20-or09_02												CSARH*REEACTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCTTTATGGCCCATAGCGGGAGAAGCTGTGCTGGGGAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	80	0.0014178112538768277		59	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	8	5	2	6	11	14	22	31	51	42	65	TCRBV07,TCRBV11													X+X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGGGCATCGGGGCGCGGGAGAGTCAGATACGCAGTATTTTGGCCCA	CASSGHRGAGESDTQYF	In	VDJ	1	80	0.0014178112538768277	0.0016634783331947102	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	2	4	11	3	23	36	54	47	57	TCRBV09,TCRBV21													CASSGHRGAGESDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGCGTAGCGGGAGGGTAAGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	81	0.001435533894550288		52	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	5	0	4	5	4	26	39	55	44	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCAGGGGGAGAGACCCAGTACTTCGGGCCA	CSARAGGETQYF	In	VDJ	1	81	0.001435533894550288	0.001684271812359644	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	1	4	0	0	26	-1	-1	39	46		TCRBV20-01,TCRBV20-or09_02												CSARAGGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAGGAGATAAGAGACCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	85	0.0015064244572441294		49	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	10	2	2	2	9	26	43	49	45	58		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTTGTTTGAACAAAAGGGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	86	0.0015241470979175896		50	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	5	2	4	12	0	26	40	-1	52	57		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAATTAGCGGGAGTTATGAGCAGTTCTTCGGGCCA	CASSQEISGSYEQFF	In	VDJ	1	87	0.00154186973859105	0.0018090326873492473	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	5	2	8	3	2	26	43	55	46	57		TCRBV03-01,TCRBV03-02												CASSQEISGSYEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGGGAGGCGGGGACCGGGGAGCTGTTTTTTGGAGAA	CSARREAGTGELFF	In	VDJ	1	88	0.0015595923792645105	0.0018298261665141812	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	8	1	5	0	5	26	-1	45	38	50		TCRBV20-01,TCRBV20-or09_02												CSARREAGTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGAGGTTTACGAGCAGTACTTCGGGCCG	CSARDEVYEQYF	In	VDJ	1	88	0.0015595923792645105	0.0018298261665141812	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	11	1	4	1	2	26	40	45	41	47		TCRBV20-01,TCRBV20-or09_02												CSARDEVYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCGCCAGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CATSDRQGAYNEQFF	In	VDJ	1	89	0.0015773150199379707	0.001850619645679115	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	1	2	3	0	24	39	-1	42	49		TCRBV24-01,TCRBV24-or09_02												CATSDRQGAYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGAGGGGGGATCCAGAGAGACCCAGTACTTCGGGCCA	CASSVEGGSRETQYF	In	VDJ	1	89	0.0015773150199379707	0.001850619645679115	45	unresolved						TCRBJ02	TCRBJ02-05	01	5	5	1	4	4	7	24	36	46	40	53	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVEGGSRETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTGACCAGGGGTTCGGGCTACGAGCAGTACTTCGGGCCG	CSALTRGSGYEQYF	In	VDJ	1	90	0.0015950376606114311	0.0018714131248440489	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	2	3	5	6	26	35	46	40	52		TCRBV20-01,TCRBV20-or09_02												CSALTRGSGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCGGGACTAGTGGCTACGAGCAGTACTTCGGGCCG	CASSPGTSGYEQYF	In	VDJ	1	92	0.0016304829419583518	0.0019130000831739167	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	8	3	3	3	24	36	47	39	50		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPGTSGYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAACTAGCGGGAGCCGAATTAATGGAAGAGACCCAGTACTTCGGGCCA	CSARDQLAGAELMEETQYF	In	VDJ	1	93	0.0016482055826318122	0.0019337935623388505	57	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	3	2	3	3	12	24	38	52	41	64		TCRBV20-01,TCRBV20-or09_02												CSARDQLAGAELMEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTCCCGTCGGACAGGGGCCTATGGCTACACCTTCGGTTCG	CASSSRRTGAYGYTF	In	VDJ	1	94	0.0016659282233052724	0.0019545870415037846	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	2	4	7	1	24	36	52	43	53	TCRBV24,TCRBV27													CASSSRRTGAYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCAGCGGGAGGGCCCTAGGCGGGGAGCTGTTTTTTGGAGAA	CASSQVSGRALGGELFF	In	VDJ	1	95	0.0016836508639787328	0.0019753805206687183	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	6	0	7	2	7	26	42	54	44	61		TCRBV03-01,TCRBV03-02												CASSQVSGRALGGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACAGGGGAGATACGCAGTATTTTGGCCCA	CASSQDRGDTQYF	In	VDJ	1	96	0.0017013735046521932	0.001996173999833652	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	2	5	0	0	26	-1	-1	43	49		TCRBV03-01,TCRBV03-02												CASSQDRGDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACGAGGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSPRGENTEAFF	In	VDJ	1	96	0.0017013735046521932	0.001996173999833652	42	TCRBV03						TCRBJ01	TCRBJ01-01	01	4	5	2	1	4	1	26	39	48	43	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRGENTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCGGGGGGCTGAAAAACTGTTTTTTGGCAGT	CSARRGAEKLFF	In	VDJ	1	96	0.0017013735046521932	0.001996173999833652	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	7	1	7	0	1	26	-1	45	37	46		TCRBV20-01,TCRBV20-or09_02												CSARRGAEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGGGAAGGGATATCAGCCCCAGCATTTTGGTGAT	CASSEGKGYQPQHF	In	VDJ	1	96	0.0017013735046521932	0.001996173999833652	42	unresolved						TCRBJ01	TCRBJ01-05	01	1	0	8	5	4	1	23	39	47	43	48	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGKGYQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAGGGCCGCTACGGATACGAGCAGTACTTCGGGCCG	CSAQGRYGYEQYF	In	VDJ	1	97	0.0017190961453256535	0.002016967478998586	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	3	4	1	10	26	34	40	35	50		TCRBV20-01,TCRBV20-or09_02												CSAQGRYGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCAGCTAGCGGGAGGGATTATGGCAGATACGCAGTATTTTGGCCCA	CSASQLAGGIMADTQYF	In	VDJ	1	98	0.0017368187859991139	0.00203776095816352	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	4	0	4	4	7	26	37	53	41	60		TCRBV20-01,TCRBV20-or09_02												CSASQLAGGIMADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTCGCTGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPRWSSYNEQFF	In	VDJ	1	99	0.0017545414266725743	0.0020585544373284536	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	10	2	0	6	0	26	39	-1	45	49		TCRBV03-01,TCRBV03-02												CASSPRWSSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTACTAGCGGGAGGGCCCAATGAGCAGTTCTTCGGGCCA	CASSLLAGGPNEQFF	In	VDJ	1	99	0.0017545414266725743	0.0020585544373284536	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	3	0	6	1	2	23	36	50	37	52	TCRBV01,TCRBV04													CASSLLAGGPNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGGCAGGGTCCCACTTACAATGAGCAGTTCTTCGGGCCA	CSASRQGPTYNEQFF	In	VDJ	1	100	0.0017722640673460345	0.0020793479164933877	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	3	4	4	7	26	37	46	41	53		TCRBV20-01,TCRBV20-or09_02												CSASRQGPTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTCYTCCGGGACTAGCGGCTACGAGCAGTACTTCGGGCCG	CSSSGTSGYEQYF	In	VDJ	1	100	0.0017722640673460345	0.0020793479164933877	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	0	5	3	6	0	26	32	-1	38	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSSSGTSGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCTAGCGGGAGGCCGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	104	0.001843154630039876		46	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	1	0	1	3	26	35	47	36	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACCCGAGGACTAGCGGGGTACAATGAGCAGTTCTTCGGGCCA	CSATRGLAGYNEQFF	In	VDJ	2	106	0.0018785999113867967	0.002204108791482991	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	1	3	4	7	0	26	34	-1	41	53		TCRBV20-01,TCRBV20-or09_02												CSATRGLAGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAACAGGGTGACAATGAGCAGTTCTTCGGGCCA	CSAREQGDNEQFF	In	VDJ	2	111	0.0019672131147540984	0.0023080761873076603	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	3	5	0	2	26	-1	46	40	48		TCRBV20-01,TCRBV20-or09_02												CSAREQGDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAAGACTAGCGGGAGACTTCTTGAGCAGTTCTTCGGGCCA	CSASKTSGRLLEQFF	In	VDJ	2	111	0.0019672131147540984	0.0023080761873076603	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	2	2	9	3	6	26	37	52	40	58		TCRBV20-01,TCRBV20-or09_02												CSASKTSGRLLEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGAAATAGGGACAGGGTACGAGCAGTTCTTCGGGCCA	CASSLEIGTGYEQFF	In	VDJ	2	111	0.0019672131147540984	0.0023080761873076603	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	3	10	4	3	18	35	48	39	51	TCRBV05,TCRBV11													CASSLEIGTGYEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGAGGGGGACGGGACTCCTCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	112	0.001984935755427559		50	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	5	1	2	2	12	26	37	45	39	57		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCGTCGGGTACTGAAGCTTTCTTTGGACAA	CSARDPSGTEAFF	In	VDJ	2	113	0.002002658396101019	0.002349663145637528	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	4	5	5	1	26	40	49	45	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDPSGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGATGGGGGGTTCGGAAAAACTGTTTTTTGGCAGT	CSARAMGGSEKLFF	In	VDJ	2	114	0.002020381036774479	0.002370456624802462	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	1	9	1	8	4	4	26	39	49	43	53		TCRBV20-01,TCRBV20-or09_02												CSARAMGGSEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGTAAATTCCCATTAGAAAAAACATTCAGTACTTCGGCGCC	CASSP*IPIRKNIQYF	Stop	VDJ	2	116	0.0020558263181214		48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	4	5	8	4	13	1	26	39	55	52	56		TCRBV03-01,TCRBV03-02				01,02								CASSP*IPIRKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01	TCRBJ02-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGGTGGGGTCCCATTTCCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	117	0.0020735489587948605		49	TCRBV03						TCRBJ02	TCRBJ02-01	01	5	6	2	5	4	12	26	38	46	42	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCCAGAGGGAGCTTTAGTAACACCATATATTTTGGAGAG	CASSPRGSFSNTIYF	In	VDJ	2	117	0.0020735489587948605	0.0024328370622972635	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	9	2	7	6	7	18	30	41	36	48	TCRBV07,TCRBV11													CASSPRGSFSNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGCGGGGGGTCGGCACTGAAGCTTTCTTTGGACAA	CSARVRGVGTEAFF	In	VDJ	2	121	0.0021444395214887018	0.002516010978956999	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	7	1	4	1	4	26	39	48	40	52		TCRBV20-01,TCRBV20-or09_02												CSARVRGVGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAACAGGTTGGGGAAAATGAAAAACTGTTTTTTGGCAGT	CSARDQQVGENEKLFF	In	VDJ	2	124	0.002197607443509083	0.0025783914164518008	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	3	4	5	3	8	26	40	48	43	56		TCRBV20-01,TCRBV20-or09_02												CSARDQQVGENEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTTGAAGACTAGCGGGATAACCCAAGAGACCCAGTACTTCGGGCCA	CSALKTSGITQETQYF	In	VDJ	2	125	0.002215330084182543	0.0025991848956167345	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	2	3	1	6	4	26	34	51	40	55		TCRBV20-01,TCRBV20-or09_02												CSALKTSGITQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTCCGACTAGCGGGAGTTGGTCGTATTTTGGCCCA	CSARGPTSGSWSYF	In	VDJ	2	126	0.0022330527248560035	0.0026199783747816686	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	2	2	14	4	6	26	39	55	43	61		TCRBV20-01,TCRBV20-or09_02												CSARGPTSGSWSYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATCCCGAGTTGGCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSANPELASSYNEQFF	In	VDJ	2	127	0.002250775365529464	0.0026407718539466023	48	TCRBV20						TCRBJ02	TCRBJ02-01	01	4	9	0	0	10	3	26	36	49	46	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSANPELASSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGGGCAGAGCTAAATCAGCCCCAGCATTTTGGTGAT	CSASRAELNQPQHF	In	VDJ	2	128	0.0022684980062029243	0.002661565333111536	42	TCRBV20						TCRBJ01	TCRBJ01-05	01	3	8	0	4	2	7	26	37	43	39	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRAELNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGACGGGGGAACCTACGAGCAGTACTTCGGGCCG	CASSDGGTYEQYF	In	VDJ	2	128	0.0022684980062029243	0.002661565333111536	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	2	2	0	2	23	-1	43	37	45	TCRBV02,TCRBV12													CASSDGGTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCACAGGAGCACAGATACGCAGTATTTTGGCCCA	CSARDHRSTDTQYF	In	VDJ	2	136	0.002410279131590607	0.002827913166431007	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	3	4	0	2	0	26	40	-1	42	47		TCRBV20-01,TCRBV20-or09_02												CSARDHRSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCGGGAGGGTACAATGAGCAGTTCTTCGGGCCA	CSARPGGYNEQFF	In	VDJ	2	136	0.002410279131590607	0.002827913166431007	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	8	0	4	2	0	26	37	-1	39	47		TCRBV20-01,TCRBV20-or09_02												CSARPGGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACCCCGGATCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASTPDLAKNIQYF	In	VDJ	2	144	0.00255206025697829	0.002994260999750478	42	TCRBV24						TCRBJ02	TCRBJ02-04	01	11	1	8	0	7	3	24	31	41	38	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTPDLAKNIQYF+TCRBV24-X+TCRBJ02-04	TCRBV24		TCRBJ02-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAGCAGCGGGAGGCCCGACGTAGCACAGATACGCAGTATTTTGGCCCA	CASSEQREARRSTDTQYF	In	VDJ	2	144	0.00255206025697829	0.002994260999750478	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	6	1	0	2	8	23	37	48	39	56	TCRBV02,TCRBV12													CASSEQREARRSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTGACTCCGAGCAGTACTTCGGGCCG	CASSLDSEQYF	In	VDJ	2	145	0.0025697828976517503	0.003015054478915412	33	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	2	10	6	2	1	26	39	45	41	46		TCRBV03-01,TCRBV03-02				01,02								CASSLDSEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGCCGGGACAGATACAAGAGACCCAGTACTTCGGGCCA	CSAPPGQIQETQYF	In	VDJ	2	146	0.0025875055383252103	0.003035847958080346	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	5	2	6	3	26	34	47	40	50		TCRBV20-01,TCRBV20-or09_02												CSAPPGQIQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGAATGTGGAGGGACACCAGACAGATACGCAGTATTTTGGCCCA	CATSDLNVEGHQTDTQYF	In	VDJ	2	146	0.0025875055383252103	0.003035847958080346	54	TCRBV24						TCRBJ02	TCRBJ02-03	01	0	0	6	3	8	4	24	42	56	50	60		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDLNVEGHQTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCCGGGGAGGCCCTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	149	0.0026406734603455916		44	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	9	1	4	5	4	26	37	48	42	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTAGCGTTGGGGGGCACAGATACGCAGTATTTTGGCCCA	CSALALGGTDTQYF	In	VDJ	2	156	0.0027647319450598137	0.0032437827497296848	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	6	1	0	7	26	-1	41	35	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSALALGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGTAGCGACTAGCGGGCACAATGAGCAGTTCTTCGGGCCA	CSASVATSGHNEQFF	In	VDJ	2	159	0.002817899867080195	0.0033061631872244863	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	2	4	5	6	1	26	37	53	43	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSASVATSGHNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACAGGGAGACTACGAGCAGTACTTCGGGCCG	CSARGQGDYEQYF	In	VDJ	2	161	0.002853345148427116	0.003347750145554354	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	3	3	0	3	26	-1	46	39	49		TCRBV20-01,TCRBV20-or09_02												CSARGQGDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAACGGGGGCCCACGAGCAGTACTTCGGGCCG		Out	VDJ	2	161	0.002853345148427116		38	unresolved						TCRBJ02	TCRBJ02-07	01	2	6	0	5	1	2	23	38	45	39	47	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGGGGCTAGCGGGAGTTTTTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	165	0.002924235711120957		49	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	4	2	4	4	4	23	39	53	43	57	TCRBV01,TCRBV04													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGYCACCAGTGATTTAACAGGACACCAAGAGACCCAGTACTTCGGGCCA	CXTSDLTGHQETQYF	In	VDJ	2	168	0.002977403633141338	0.0034933044997088915	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	3	4	0	1	2	24	41	47	42	49		TCRBV24-01,TCRBV24-or09_02												CXTSDLTGHQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCATAGGACAGGGGGAGGAAGAGACCCAGTACTTCGGGCCA	CASSIGQGEEETQYF	In	VDJ	3	176	0.003119184758529021	0.0036596523330283625	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	2	1	3	0	3	18	-1	43	34	46	TCRBV05,TCRBV11													CASSIGQGEEETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTGGGCCGAGTAGATACGCAGTATTTTGGCCCA	CSASLGRVDTQYF	In	VDJ	3	178	0.0031546300398759414	0.00370123929135823	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	8	0	5	3	5	26	37	44	40	49		TCRBV20-01,TCRBV20-or09_02												CSASLGRVDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGTGGGGTTTGGGGAGACCCAGTACTTCGGGCCA	CSARDVGFGETQYF	In	VDJ	3	179	0.003172352680549402	0.003722032770523164	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	0	6	2	5	3	6	26	40	47	43	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDVGFGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGGGGTGGAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQGGGTNEKLFF	In	VDJ	3	180	0.0031900753212228622	0.0037428262496880978	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	9	1	1	0	3	26	-1	46	40	49		TCRBV03-01,TCRBV03-02												CASSQGGGTNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAACCCAAGAGACCCAGTACTTCGGGCCA	CASSETQETQYF	In	VDJ	3	187	0.003314133805937085	0.003888380603842635	36	TCRBV06						TCRBJ02	TCRBJ02-05	01	2	3	7	1	0	0	23	-1	-1	38	40		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSETQETQYF+TCRBV06-X+TCRBJ02-05	TCRBV06		TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCRTGTATSKCTGTGCCAGAAGCTTGGCAGCCTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	3	191	0.003385024368630926		43	unresolved						TCRBJ01	TCRBJ01-05	01	0	4	5	0	0	2	18	-1	37	34	39	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGTTCTGGACCGATGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSSGPMSSYEQYF	In	VDJ	3	224	0.003969871510855118	0.004657739332945188	45	unresolved						TCRBJ02	TCRBJ02-07	01	6	1	7	0	4	7	18	29	37	33	44	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGPMSSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCGCGGGCAGGGGGCGGCTTCCGGGGAGCTGTTTTTTGGAGAA	CASRGQGAASGELFF	In	VDJ	3	234	0.004147097917589721	0.004865674124594527	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	4	0	6	6	5	18	27	41	33	46	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02												CASRGQGAASGELFF+X+TCRBJ02-02		TCRBD01-01*01	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCACGGACTAACTGAAAAACTGTTTTTTGGCAGT	CSASHGLTEKLFF	In	VDJ	4	242	0.0042888790429774035	0.005032021957913998	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	1	9	7	4	2	26	37	47	41	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSASHGLTEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAACACCCCGTCCCAGGGGGGAAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	4	250	0.004430660168365086		46	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	4	1	2	11	3	24	31	49	42	52		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCATGGGGGTCGGGAGATACGCAGTATTTTGGCCCA	CASSPWGSGDTQYF	In	VDJ	4	255	0.004519273371732388	0.005302337187058139	42	unresolved						TCRBJ02	TCRBJ02-03	01	4	6	1	5	4	5	23	35	44	39	49	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPWGSGDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGTAAACAGGGTGAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	4	271	0.004802835622507754		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	3	0	5	3	26	35	46	40	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGTACCGGTAGGCTAGCGGGATTTAACGAGCAGTACTTCGGGCCG		Out	VDJ	4	280	0.004962339388568897		53	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	4	3	5	12	4	26	40	61	52	65		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGAGGGACTAGCGGGCTACGAGCAGTACTTCGGGCCG	CSAEGLAGYEQYF	In	VDJ	5	339	0.006007975188303057	0.0070489894369125845	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	4	3	3	0	26	34	-1	37	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSAEGLAGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTACGGGACAGGGATCAACGAGCAGTACTTCGGGCCG	CSAYGTGINEQYF	In	VDJ	7	475	0.008418254319893664	0.009876902603343592	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	5	3	4	26	35	47	38	51		TCRBV20-01,TCRBV20-or09_02												CSAYGTGINEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGCTTCGACAGAGGCGCAATGAGCAGTTCTTCGGGCCA	CSARGLRQRRNEQFF	In	VDJ	8	555	0.009836065573770493	0.011540380936538301	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	5	6	8	5	26	37	50	45	55		TCRBV20-01,TCRBV20-or09_02												CSARGLRQRRNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAGTCCCCCTACGAGCAGTACTTCGGGCCG	CSAKSPYEQYF	In	VDJ	10	657	0.011643774922463447	0.013661315811361556	33	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	4	6	2	0	6	26	-1	36	34	42		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKSPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGCGGCCCGACAAGAGACCCAGTACTTCGGGCCA	CASSAARQETQYF	In	VDJ	11	740	0.013114754098360656	0.015387174582051069	39	unresolved			unresolved			TCRBJ02	TCRBJ02-05	01	5	7	5	2	1	5	23	34	39	35	44	TCRBV02,TCRBV09			TCRBD01,TCRBD02										CASSAARQETQYF+X+TCRBJ02-05	unresolved	unresolved	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAATCCTACGACAGGGGGCAAACCTACGAGCAGTACTTCGGGCCG	CASSQSYDRGQTYEQYF	In	VDJ	13	867	0.01536552946389012	0.01802794643599767	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	0	2	6	3	23	38	54	44	57	TCRBV01,TCRBV04													CASSQSYDRGQTYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCCAAACCGGGACAGGGCGTCTCGCCGAAGCTTTCTTTGGACAA	CATQTGTGRLAEAFF	In	VDJ	1	21	3.7217545414266725E-4	4.3666306246361144E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	0	3	8	6	9	18	27	42	33	51														CATQTGTGRLAEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCATACAGGGGGCCGACGGGGAGCTGTTTTTTGGAGAA	CATSIQGADGELFF	In	VDJ	1	43	7.620735489587948E-4	8.941196040921567E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	0	7	1	3	18	31	41	32	44														CATSIQGADGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGCAGGGAGCCCTACAATGAGCAGTTCTTCGGGCCA	CATSRGREPYNEQFF	In	VDJ	1	48	8.506867523260966E-4	9.98086999916826E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-01	01	1	4	3	2	1	3	18	34	40	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRGREPYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACAGGGCGGGCACTGAAGCTTTCTTTGGACAA	CATSRDRAGTEAFF	In	VDJ	1	53	9.392999556933983E-4	0.0011020543957414954	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-01	01	0	4	3	4	0	4	18	-1	40	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDRAGTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGACAGGGAGGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CATSRQGGATNEKLFF	In	VDJ	1	58	0.0010279131590607	0.0012060217915661649	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	2	9	0	0	2	1	18	33	42	35	43														CATSRQGGATNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCCGGTGGCAGGGGGCACAGATACGCAGTATTTTGGCCCA	CATSPVAGGTDTQYF	In	VDJ	1	62	0.0010988037217545415	0.0012891957082259004	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	2	1	7	0	18	30	-1	37	43														CATSPVAGGTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCGACGGGAGTAACGGCAGATACGCAGTATTTTGGCCCA	CATSRATGVTADTQYF	In	VDJ	1	65	0.0011519716437749224	0.001351576145720702	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	8	2	4	3	6	18	34	43	37	49														CATSRATGVTADTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCCGAAGGGGGGTGGGCACAGATACGCAGTATTTTGGCCCA	CATRRGVGTDTQYF	In	VDJ	1	65	0.0011519716437749224	0.001351576145720702	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-03	01	8	5	1	1	3	4	18	27	36	30	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATRRGVGTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01		TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTTTACCGGGACTACCCTCCAGGCGGGGAGCTGTTTTTTGGAGAA	CATSRVYRDYPPGGELFF	In	VDJ	1	89	0.0015773150199379707	0.001850619645679115	54	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	0	9	7	6	9	18	34	47	40	56						01,02								CATSRVYRDYPPGGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAAACCGGGCCTTACTCTCCGGGGAGCTGTTTTTTGGAGAA	CATSRNRALLSGELFF	In	VDJ	1	97	0.0017190961453256535	0.002016967478998586	48	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-02	01	2	8	0	6	4	8	18	33	41	37	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRNRALLSGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01		TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCCGGGACTAGCAGATTCTACGAGCAGTACTTCGGGCCG	CATSRAGTSRFYEQYF	In	VDJ	2	119	0.002108994240141781	0.0024744240206271313	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	0	7	3	2	5	18	34	45	36	50						01,02								CATSRAGTSRFYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGGAGTAATCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	131	0.002321665928223305		46	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	10	2	1	2	4	18	35	41	37	45														X+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAACCCGGGAACCCTATGGCTACACCTTCGGTTCG	CATSRTREPYGYTF	In	VDJ	2	133	0.002357111209570226	0.0027655327289362055	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	8	3	4	3	3	18	33	41	36	44														CATSRTREPYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCGAACTAGCGGGAGATAAGAGCGGGGAGCTGTTTTTTGGAGAA	CATELAGDKSGELFF	In	VDJ	2	138	0.0024457244129375277	0.002869500124760875	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	3	2	7	2	7	18	27	40	29	47														CATELAGDKSGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACAGGACATTCTCCTACGAGCAGTACTTCGGGCCG	CATSRDRTFSYEQYF	In	VDJ	3	172	0.0030482941958351792	0.0035764784163686268	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	6	0	2	2	18	35	42	37	44														CATSRDRTFSYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGCCGACTAGCGGGAGGGCCTATACCTACGAGCAGTACTTCGGGCCG	CATSREPTSGRAYTYEQYF	In	VDJ	3	187	0.003314133805937085	0.003888380603842635	57	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	2	0	2	3	6	18	35	52	38	58														CATSREPTSGRAYTYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCAACGCAGGGCAGTCGGGAAACACCATATATTTTGGAGAG	CATNAGQSGNTIYF	In	VDJ	3	199	0.0035268054940186086	0.004137902353821841	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	4	3	4	3	6	18	28	36	31	42														CATNAGQSGNTIYF+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAACTCGGGCTTCGGAAAAACTGTTTTTTGGCAGT	CATSRTRASEKLFF	In	VDJ	3	225	0.003987594151528578	0.004678532812110122	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	2	8	0	8	4	4	18	33	41	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRTRASEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGGACAGGTGAAGAAAAACTGTTTTTTGGCAGT	CATSRDRTGEEKLFF	In	VDJ	3	234	0.004147097917589721	0.004865674124594527	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	1	4	8	2	4	18	35	44	37	48														CATSRDRTGEEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCAGGACTAGCGGACTATACAATGAGCAGTTCTTCGGGCCA	CATRTSGLYNEQFF	In	VDJ	5	304	0.005387682764731945	0.006321217666139899	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	5	4	0	4	18	-1	38	29	42						01,02								CATRTSGLYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTAAAGGGACTAGCGGGCGATGAGCAGTTCTTCGGGCCA	CATSRVKGLAGDEQFF	In	VDJ	10	695	0.01231723526805494	0.014451468019629043	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	0	4	8	4	2	18	34	50	38	52						01,02								CATSRVKGLAGDEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATSTCTGTGCCAGAAGCTTGCCGGCAGAATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	44	7.797961896322552E-4		46	TCRBV05	TCRBV05-03					TCRBJ01	TCRBJ01-05	01	1	4	5	0	4	2	18	33	40	37	42			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV05-03+TCRBJ01-05	TCRBV05-03		TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCCGGGATGGCGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLPGWRAGELFF	In	VDJ	1	19	3.3673017279574655E-4	3.950761041337437E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	7	4	6	9	0	18	32	-1	41	46						01,02								CASSLPGWRAGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCACCTGACAGGGGTAAGCACTGAAGCTTTCTTTGGACAA	CASSHLTGVSTEAFF	In	VDJ	1	20	3.544528134692069E-4	4.1586958329867756E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	2	4	5	4	18	30	43	35	47														CASSHLTGVSTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGAACAGACAAGCTACTACGAGCAGTACTTCGGGCCG	CASSSEQTSYYEQYF	In	VDJ	1	20	3.544528134692069E-4	4.1586958329867756E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	6	3	7	5	18	31	42	38	47														CASSSEQTSYYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGCAGGGGGCGACGAAAAACTGTTTTTTGGCAGT	CASSLEAGGDEKLFF	In	VDJ	1	20	3.544528134692069E-4	4.1586958329867756E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	0	8	2	3	18	35	45	37	48														CASSLEAGGDEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGAGTTAAGACTAGCGTCCACAAATACGCAGTATTTTGGCCCA	CASSLGELRLASTNTQYF	In	VDJ	1	20	3.544528134692069E-4	4.1586958329867756E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	2	6	7	11	7	18	32	51	43	58						01,02								CASSLGELRLASTNTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGAACGGGGGCAATTCATATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSSNGGNSYSNQPQHF	In	VDJ	1	23	4.0762073548958794E-4	4.782500207934792E-4	54	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	4	6	0	0	5	8	18	31	42	36	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSNGGNSYSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCGGGACAGTAGATCAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRDSRSATNEKLFF	In	VDJ	1	24	4.253433761630483E-4	4.99043499958413E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	0	5	0	1	8	18	27	35	28	43														CASRDSRSATNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTACCGGGACCCAGAGCCAAAAACATTCAGTACTTCGGCGCC	CASSVPGPRAKNIQYF	In	VDJ	1	26	4.60788657509969E-4	5.406304582882808E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-04	01	5	0	7	0	5	4	18	30	40	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVPGPRAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01		TCRBJ02-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTGGACAGAGTCCCAAGAGACCCAGTACTTCGGGCCA	CASSSWTESQETQYF	In	VDJ	1	26	4.60788657509969E-4	5.406304582882808E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	5	1	3	4	18	31	40	34	44														CASSSWTESQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACCGGGACAGAAACTACGAGCAGTACTTCGGGCCG	CASSHRDRNYEQYF	In	VDJ	1	27	4.785112981834293E-4	5.614239374532147E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	3	4	3	18	30	41	34	44														CASSHRDRNYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGTGGGACTAGCGTGAGAGAGGACGAGCAGTACTTCGGGCCG	CASSRGTSVREDEQYF	In	VDJ	1	28	4.962339388568897E-4	5.822174166181485E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	6	5	3	9	18	30	43	33	52						01,02								CASSRGTSVREDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCGGGACTAGCGGGGCAAACAATGAGCAGTTCTTCGGGCCA	CASSAGTSGANNEQFF	In	VDJ	1	28	4.962339388568897E-4	5.822174166181485E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	5	3	3	18	30	46	33	49														CASSAGTSGANNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGGGCAGCCGTAACTATGGCTACACCTTCGGTTCG	CASSLVGSRNYGYTF	In	VDJ	1	28	4.962339388568897E-4	5.822174166181485E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	8	0	1	1	5	18	34	39	35	44														CASSLVGSRNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCTGGGGCTAGCGGGAAAGAGACCCAGTACTTCGGGCCA	CASSPGASGKETQYF	In	VDJ	1	29	5.1395657953035E-4	6.030108957830824E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	4	3	3	7	0	18	30	-1	37	46														CASSPGASGKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGCCGCGGACACCTAAACTGTTTTTTGGCAGT	CASSLEPRTPKLFF	In	VDJ	1	29	5.1395657953035E-4	6.030108957830824E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	1	6	11	5	3	18	35	45	40	48														CASSLEPRTPKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGCTAACGACACTCGAGCAGTACTTCGGGCCG	CASSLGLTTLEQYF	In	VDJ	1	29	5.1395657953035E-4	6.030108957830824E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	7	0	6	0	10	18	-1	37	32	47														CASSLGLTTLEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCGGGGTTTTGTGGGGGGAGAGACCCAGTACTTCGGGCCA	CASSFRGFVGGETQYF	In	VDJ	1	31	5.494018608772708E-4	6.445978541129502E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	9	1	4	12	0	18	32	-1	44	50														CASSFRGFVGGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGGCTCGTCAGGGGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	32	5.671245015507311E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	2	6	8	0	18	33	-1	41	47														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGTCCGGGACCGCCGTTAATGAGCAGTTCTTCGGGCCA	CASSLGSGTAVNEQFF	In	VDJ	1	32	5.671245015507311E-4	6.65391333277884E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	1	0	7	7	5	7	18	34	44	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGSGTAVNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGCTAGCATACTACAATGAGCAGTTCTTCGGGCCA	CASSPGLAYYNEQFF	In	VDJ	1	33	5.848471422241914E-4	6.861848124428179E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	7	3	6	3	18	30	41	36	44						01,02								CASSPGLAYYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATGGGCGTCTGGAAACACCATATATTTTGGAGAG	CASSLWASGNTIYF	In	VDJ	1	33	5.848471422241914E-4	6.861848124428179E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	8	0	1	1	1	18	33	38	34	39														CASSLWASGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACCCCGTAGCACAGATACGCAGTATTTTGGCCCA	CASSLGPRSTDTQYF	In	VDJ	1	33	5.848471422241914E-4	6.861848124428179E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	3	0	7	0	0	5	18	-1	37	32	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPRSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTGAGCCGGGTTCCCTTCTAAGATACGCAGTATTTTGGCCCA	CASSLSRVPF*DTQYF	Stop	VDJ	1	33	5.848471422241914E-4		48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	8	4	5	7	10	18	29	40	36	50						01,02								CASSLSRVPF*DTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACGGAAGAGGGGGGATCGGGGAGCTGTTTTTTGGAGAA	CASSHGRGGIGELFF	In	VDJ	1	34	6.025697828976517E-4	7.069782916077518E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	5	5	1	7	8	3	18	30	44	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHGRGGIGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGAGATGGGCCACAAGAGACCCAGTACTTCGGGCCA	CASSRDGPQETQYF	In	VDJ	1	34	6.025697828976517E-4	7.069782916077518E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	8	0	2	6	2	18	30	40	36	42														CASSRDGPQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTTAGCGGGAGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSFLAGGTGELFF	In	VDJ	1	34	6.025697828976517E-4	7.069782916077518E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	5	0	5	2	0	18	32	-1	34	45														CASSFLAGGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGAAAGGAAAGGGGGCGCCCAGATACGCAGTATTTTGGCCCA	CASRKERGRPDTQYF	In	VDJ	1	36	6.380150642445725E-4	7.485652499376195E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	5	0	4	7	3	18	29	43	36	46														CASRKERGRPDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGTCAGACTAGCGGGATAATAACAGATACGCAGTATTTTGGCCCA	CASSRQTSGIITDTQYF	In	VDJ	1	38	6.734603455914931E-4	7.901522082674874E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	2	3	3	5	5	18	30	46	35	51														CASSRQTSGIITDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCCCACGGGGGTTCGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLPRGFAGANVLTF	In	VDJ	1	38	6.734603455914931E-4	7.901522082674874E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	5	8	2	2	6	4	18	30	42	36	46														CASSLPRGFAGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAACTCACAGGGGGTTCTGAAGCTTTCTTTGGACAA	CASSKLTGGSEAFF	In	VDJ	1	39	6.911829862649534E-4	8.109456874324212E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	1	6	6	2	18	30	44	36	46														CASSKLTGGSEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCAAGGGGCCCCCTACGAGCAGTACTTCGGGCCG	CASSLQGAPYEQYF	In	VDJ	1	39	6.911829862649534E-4	8.109456874324212E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	5	2	2	3	3	18	32	40	35	43														CASSLQGAPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACTGGGGGATTGTTGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	41	7.266282676118742E-4		47	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	2	6	1	5	2	8	18	33	40	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCAGACAGGGTTTTCACTGAAGCTTTCTTTGGACAA	CASSPDRVFTEAFF	In	VDJ	1	43	7.620735489587948E-4	8.941196040921567E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	3	4	4	4	18	29	40	33	44														CASSPDRVFTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTCCCCACTAGCGGCCAAGAGACCCAGTACTTCGGGCCA	CASSFPTSGQETQYF	In	VDJ	1	49	8.684093929995569E-4	0.00101888047908176	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	3	5	1	7	0	18	29	-1	36	44						01,02								CASSFPTSGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGTCCTCTCGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	50	8.861320336730173E-4		52	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	11	5	18	30	45	41	50														X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAACAGGGCTATGGAAACACCATATATTTTGGAGAG	CASSLEQGYGNTIYF	In	VDJ	1	52	9.21577315019938E-4	0.0010812609165765615	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	3	3	3	0	3	18	-1	41	35	44														CASSLEQGYGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAAGGGGGACAGAAGCCACAGATACGCAGTATTTTGGCCCA	CASSLRGTEATDTQYF	In	VDJ	1	59	0.0010456357997341605	0.0012268152707310988	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	5	2	6	4	18	30	43	36	47														CASSLRGTEATDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACCGCGAGGGGGCGGCCACTGAAGCTTTCTTTGGACAA	CASNREGAATEAFF	In	VDJ	1	60	0.0010633584404076207	0.0012476087498960325	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	5	0	4	6	3	18	28	41	34	44														CASNREGAATEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAACTAGCGGGAGTAGGCAATGAGCAGTTCTTCGGGCCA	CASSKLAGVGNEQFF	In	VDJ	1	61	0.001081081081081081	0.0012684022290609664	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	3	2	6	2	4	18	30	43	32	47														CASSKLAGVGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAGGGTTCTACACAGATACGCAGTATTTTGGCCCA	CASSLGGFYTDTQYF	In	VDJ	1	62	0.0010988037217545415	0.0012891957082259004	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	11	0	2	0	5	18	-1	39	34	44														CASSLGGFYTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGCCCCGGGACAGGGGAAGAACGAGCAGTACTTCGGGCCG	CASSPAPGQGKNEQYF	In	VDJ	1	63	0.0011165263624280017	0.0013099891873908343	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	5	8	4	18	30	48	38	52														CASSPAPGQGKNEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGGGGACTATTCCTACGAGCAGTACTTCGGGCCG	CASSQGDYSYEQYF	In	VDJ	1	73	0.0012937527691626051	0.001517923979040173	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	9	1	4	1	18	30	41	34	42						01,02								CASSQGDYSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGGGGGACTAGCGACACAGATACGCAGTATTTTGGCCCA	CASSRGTSDTDTQYF	In	VDJ	1	83	0.0014709791758972088	0.0017258587706895118	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	6	2	3	1	18	30	43	33	44						01,02								CASSRGTSDTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATTGACAGGCCCCGGAAACCCTAAGTGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	84	0.001488701816570669		53	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	4	6	3	19	18	30	39	33	58														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGGGGCCGGGGGGCGAGCAGTACTTCGGGCCG	CASSLVGPGGEQYF	In	VDJ	1	99	0.0017545414266725743	0.0020585544373284536	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	8	1	6	6	0	18	34	-1	40	47														CASSLVGPGGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCGACGGCAGGAACACTGAAGCTTTCTTTGGACAA	CASSLVDGRNTEAFF	In	VDJ	2	119	0.002108994240141781	0.0024744240206271313	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	1	2	7	1	2	5	18	34	39	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVDGRNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGGGGCCGGCACCTACGAGCAGTACTTCGGGCCG	CASSLDGAGTYEQYF	In	VDJ	2	127	0.002250775365529464	0.0026407718539466023	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	7	0	2	1	5	18	35	41	36	46														CASSLDGAGTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAATCTGGGGGCGATGGGAGGCACTGAAGCTTTCTTTGGACAA	CASSLNLGAMGGTEAFF	In	VDJ	2	144	0.00255206025697829	0.002994260999750478	51	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	6	0	4	6	9	18	32	44	38	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNLGAMGGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGCGCGGGTAGGCTCCCCGAAGCTTTCTTTGGACAA	CASSPGAGRLPEAFF	In	VDJ	3	178	0.0031546300398759414	0.00370123929135823	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	4	8	6	10	18	30	41	36	51						01,02								CASSPGAGRLPEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGGACAGGGGTAACCACTGAAGCTTTCTTTGGACAA	CASSLRTGVTTEAFF	In	VDJ	3	179	0.003172352680549402	0.003722032770523164	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	2	4	2	4	18	32	43	34	47														CASSLRTGVTTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CAAGCCACGTTTGGTGGAACCCAGGGACTCAGCTGTGTATTTTGTGCTAGTGGTCCAGGAGATAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	19	3.3673017279574655E-4		38	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-02	01	17	4	4	1	12	3	43	43	59	55	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01		TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTTTGGGACTAGCTGAAGACCCAGTACTTCGGGCCA	CASGFWD*LKTQYF	Stop	VDJ	1	54	9.570225963668586E-4		42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	0	7	6	2	3	26	40	51	42	54						01,02								CASGFWD*LKTQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD02-01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGGCCCGGGGACATCCGGGGTGAGCAGTTCTTCGGGCCA	CASGPGDIRGEQFF	In	VDJ	2	122	0.002162162162162162	0.002536804458121933	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	6	9	5	7	26	37	48	42	55														CASGPGDIRGEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGGTCTAGCGGATACAATGAGCAGTTCTTCGGGCCA	CASGLGSSGYNEQFF	In	VDJ	2	156	0.0027647319450598137	0.0032437827497296848	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	4	5	4	3	1	26	42	52	45	53						01,02								CASGLGSSGYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCAGGAGATAACTATGGCTACACCTTCGGTTCG	CASGPGDNYGYTF	In	VDJ	31	2082	0.03689853788214444	0.04329202362139233	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-02	01	5	4	4	1	1	3	26	38	43	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGPGDNYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01		TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAAAAGTTTGGGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	28	4.962339388568897E-4		46	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	2	0	8	1	8	0	20	35	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGGGTGAGACATTTGGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	47	8.329641116526362E-4		47	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	2	6	8	6	5	20	37	47	43	52														X+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACGCAGGGGCAGGGGATCCCCAGTACTTCGGGCCG		Out	VDJ	1	60	0.0010633584404076207		43	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	10	2	11	20	35	43	37	54														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GAGACACGGCACTGTATCTCTGCGCCATCAAATAAGCGGGGGCAATGGCTTAAGAGACCCAGTACTTCGGGCCA	CAIK*AGAMA*ETQYF	Stop	VDJ	1	96	0.0017013735046521932		48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	10	6	2	3	7	9	20	27	42	34	51														CAIK*AGAMA*ETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCGAACCGGGACAGAGAGGTGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	148	0.002622950819672131		56	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	5	0	6	7	20	33	46	39	53														X+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTATTACGACCCTCTGGGCGGGGAGCTGTTTTTTGGAGAA	CASSYYDPLGGELFF	In	VDJ	1	19	3.3673017279574655E-4	3.950761041337437E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	6	0	9	7	15	0	23	34	-1	49	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYYDPLGGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTACTTAGCGGGACGACCAATGAGCAGTTCTTCGGGCCA	CASSLLSGTTNEQFF	In	VDJ	1	20	3.544528134692069E-4	4.1586958329867756E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	5	3	6	6	4	23	34	48	40	52														CASSLLSGTTNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCGGACAGGGACCGTATGGCTACACCTTCGGTTCG	CASSAGQGPYGYTF	In	VDJ	1	22	3.898980948161276E-4	4.574565416285453E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	5	3	4	23	35	46	38	50														CASSAGQGPYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGAGTAGCGGGAATAAATGAGCAGTTCTTCGGGCCA	CASSDGVAGINEQFF	In	VDJ	1	23	4.0762073548958794E-4	4.782500207934792E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	3	7	7	3	23	35	50	42	53														CASSDGVAGINEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGTCATATCAGCCCCAGCATTTTGGTGAT	CASSESYQPQHF	In	VDJ	1	23	4.0762073548958794E-4	4.782500207934792E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	11	2	5	0	4	23	-1	38	35	42														CASSESYQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGCGGGGCAGGGCATGAACACTGAAGCTTTCTTTGGACAA	CAAGQGMNTEAFF	In	VDJ	1	23	4.0762073548958794E-4	4.782500207934792E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	11	7	3	0	0	7	23	-1	35	29	42														CAAGQGMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCAACGAGACAGGGGCGGAAAAACTGTTTTTTGGCAGT	CASSYPNETGAEKLFF	In	VDJ	1	24	4.253433761630483E-4	4.99043499958413E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	2	2	8	8	2	23	38	54	46	56														CASSYPNETGAEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGCCAGCGGGAGGGCTTTGCGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	24	4.253433761630483E-4		56	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	6	0	1	4	7	23	38	52	42	59														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAATCAAAACATTCAGTACTTCGGCGCC	CASSYSNQNIQYF	In	VDJ	1	25	4.4306601683650863E-4	5.198369791233469E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-04	01	0	2	8	5	0	3	23	-1	42	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSNQNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01		TCRBJ02-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGAAATAACGGGCGGCAAGAGACCCAGTACTTCGGGCCA	CASSRNNGRQETQYF	In	VDJ	1	27	4.785112981834293E-4	5.614239374532147E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	5	8	0	2	9	2	23	35	48	44	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRNNGRQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCCAGGCGGTTCCTAATACGCAGTATTTTGGCCCA	CASSFQAVPNTQYF	In	VDJ	1	28	4.962339388568897E-4	5.822174166181485E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	4	4	4	7	2	9	23	36	42	38	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFQAVPNTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGGGTCAATCAGCCCCAGCATTTTGGTGAT	CASSYSGVNQPQHF	In	VDJ	1	29	5.1395657953035E-4	6.030108957830824E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	0	6	1	3	0	1	23	-1	45	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGVNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCCTACAGGGGAATCAGCCCCAGCATTTTGGTGAT	CASSFLQGNQPQHF	In	VDJ	1	29	5.1395657953035E-4	6.030108957830824E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	2	4	4	0	23	36	-1	40	47														CASSFLQGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGACCACCGGGGAGCTGTTTTTTGGAGAA	CASSDSTTGELFF	In	VDJ	1	31	5.494018608772708E-4	6.445978541129502E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	0	2	7	4	0	0	23	-1	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSTTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACATAACCGGAGGGAGGAGTGAGCAGTACTTCGGGCCG	CASSYITGGRSEQYF	In	VDJ	1	31	5.494018608772708E-4	6.445978541129502E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	9	1	7	9	3	23	38	53	47	56														CASSYITGGRSEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCCGGCGGACAGGGGAAGCTTTCTTTGGACAA	CASSYSRRTGEAFF	In	VDJ	1	33	5.848471422241914E-4	6.861848124428179E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	3	8	5	0	23	40	-1	45	53														CASSYSRRTGEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGGCCAGCCCTCTATGGCTACACCTTCGGTTCG	CASSPGPALYGYTF	In	VDJ	1	35	6.202924235711121E-4	7.277717707726857E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	8	0	4	3	7	23	35	42	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPALYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCAACAGGGGGTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASQQGVGANVLTF	In	VDJ	1	35	6.202924235711121E-4	7.277717707726857E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	8	3	1	3	2	1	23	32	42	34	43														CASQQGVGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGTATCCTGGTTGGGCACAGATACGCAGTATTTTGGCCCA	CAISVSWLGTDTQYF	In	VDJ	1	35	6.202924235711121E-4	7.277717707726857E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	5	0	10	1	7	4	23	35	44	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISVSWLGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCCATGGGAGCTAGCACAGATACGCAGTATTTTGGCCCA	CASRPMGASTDTQYF	In	VDJ	1	37	6.557377049180328E-4	7.693587291025534E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	9	2	0	6	2	23	34	45	40	47														CASRPMGASTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCCGGGGCCCATCAGCCCCAGCATTTTGGTGAT	CASRPGAHQPQHF	In	VDJ	1	37	6.557377049180328E-4	7.693587291025534E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	7	0	5	4	2	23	34	43	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPGAHQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGACTAGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSGTSGGTDTQYF	In	VDJ	1	38	6.734603455914931E-4	7.901522082674874E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	1	0	0	23	-1	-1	35	48														CASSGTSGGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGCACTGGGACAAGAGCAGTACTTCGGGCCG	CASSALGQEQYF	In	VDJ	1	42	7.443509082853345E-4	8.733261249272229E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	6	7	6	1	23	34	46	40	47														CASSALGQEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACGGGGGTGAAACTGAAGCTTTCTTTGGACAA	CASSYDGGETEAFF	In	VDJ	1	45	7.975188303057156E-4	9.357065624220244E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	2	5	2	4	23	38	46	40	50														CASSYDGGETEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACTTGACAGGGTTCGGGAGCAGTACTTCGGGCCG	CASRLDRVREQYF	In	VDJ	1	47	8.329641116526362E-4	9.772935207518923E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	7	4	5	23	34	45	38	50														CASRLDRVREQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGCGAGGGATCGAGGGCTACACCTTCGGTTCG	CASSYGRGIEGYTF	In	VDJ	1	47	8.329641116526362E-4	9.772935207518923E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	11	0	8	4	6	23	38	47	42	53														CASSYGRGIEGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCAAGGGCGGGACCTCCTACGAGCAGTACTTCGGGCCG	CASTKGGTSYEQYF	In	VDJ	1	48	8.506867523260966E-4	9.98086999916826E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	7	3	0	6	1	23	33	45	39	46														CASTKGGTSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCAGGGGATGGGGCCAACGTCCTGACTTTCGGGGCC	CASAGDGANVLTF	In	VDJ	1	48	8.506867523260966E-4	9.98086999916826E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	8	4	2	3	1	1	23	32	39	33	40														CASAGDGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAAGTAGCGGGAGGCTCCTACGAGCAGTACTTCGGGCCG	CASKVAGGSYEQYF	In	VDJ	1	49	8.684093929995569E-4	0.00101888047908176	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	5	1	0	3	0	23	33	-1	36	46														CASKVAGGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGAGCGAGGGATTTGAACTATGGCTACACCTTCGGTTCG	CASSRARDLNYGYTF	In	VDJ	1	52	9.21577315019938E-4	0.0010812609165765615	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	11	0	2	6	5	23	34	45	40	50														CASSRARDLNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCAAGTAAGCGTGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRPSKRDSGANVLTF	In	VDJ	1	53	9.392999556933983E-4	0.0011020543957414954	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	6	6	6	0	8	3	23	34	46	42	49						01,02								CASRPSKRDSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01	TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCGCCCTCAGGGGGCTTAACGGCTACACCTTCGGTTCG	CASIALRGLNGYTF	In	VDJ	1	54	9.570225963668586E-4	0.0011228478749064294	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	0	8	7	5	23	33	48	40	53														CASIALRGLNGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGTGGGGAATGAGCAGTTCTTCGGGCCA	CASSYVGNEQFF	In	VDJ	1	55	9.74745237040319E-4	0.0011436413540713633	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	2	6	2	7	2	0	23	38	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYVGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGTGAAAAACTGTTTTTTGGCAGT	CASSYSGEKLFF	In	VDJ	1	55	9.74745237040319E-4	0.0011436413540713633	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	0	0	9	7	0	0	23	-1	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCGACGCAGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSADAASTDTQYF	In	VDJ	1	60	0.0010633584404076207	0.0012476087498960325	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	5	2	7	0	3	6	23	35	41	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSADAASTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGCCAGGGGGTTGGTTTCTTTGGACAA	CASSYSGQGVGFF	In	VDJ	1	66	0.0011696942844483828	0.0013723696248856359	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	1	13	4	4	23	40	51	44	55														CASSYSGQGVGFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATACCAGGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASIPGGSTDTQYF	In	VDJ	1	66	0.0011696942844483828	0.0013723696248856359	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	4	1	0	3	1	23	33	43	36	44														CASIPGGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCGGGCGCGGGGAGAATCAATGAGCAGTTCTTCGGGCCA	CASSPGAGRINEQFF	In	VDJ	1	67	0.0011874169251218432	0.0013931631040505698	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	3	6	7	5	23	34	47	41	52														CASSPGAGRINEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCCGTACAACTAGTAACACAGATACGCAGTATTTTGGCCCA	CATRTTSNTDTQYF	In	VDJ	1	68	0.0012051395657953034	0.0014139565832155035	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	10	3	8	2	8	3	23	30	43	38	46						01,02								CATRTTSNTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGTTGGCCTTAAAAACGCGGGGCATTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	70	0.0012405848471422243		53	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	7	3	2	15	4	23	32	53	47	57														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTATACTAGCGGGAGATCAACTTACAATGAGCAGTTCTTCGGGCCA	CASSYTSGRSTYNEQFF	In	VDJ	1	71	0.0012583074878156845	0.0014763370207103053	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	3	2	4	4	7	23	34	49	38	56														CASSYTSGRSTYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGGTGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPGVSGANVLTF	In	VDJ	1	71	0.0012583074878156845	0.0014763370207103053	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	8	4	0	1	3	23	35	40	36	43						01,02								CASSPGVSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01	TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATGGTGATCCTGGTGAGCAGTTCTTCGGGCCA	CASSDGDPGEQFF	In	VDJ	1	72	0.001276030128489145	0.001497130499875239	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	0	10	9	3	9	23	35	40	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDGDPGEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATGGGGACTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSMGTSSYNEQFF	In	VDJ	1	75	0.001329198050509526	0.0015595109373700408	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	8	0	3	0	23	35	-1	38	46						01,02								CASSMGTSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGCTAACAGATTTCTGGAAACACCATATATTTTGGAGAG	CASSC*QISGNTIYF	Stop	VDJ	1	76	0.0013469206911829862		45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	5	1	4	3	23	36	44	40	47														CASSC*QISGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSDGSGSTDTQYF	In	VDJ	1	80	0.0014178112538768277	0.0016634783331947102	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	4	0	5	0	23	35	-1	40	47						01,02								CASSDGSGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATTGTGCCGGGCCCCAAAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	82	0.0014532565352237483		44	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	7	8	0	5	7	6	23	33	44	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTGACTAGCGGGACGAATGAGCAGTTCTTCGGGCCA	CASSYLTSGTNEQFF	In	VDJ	1	83	0.0014709791758972088	0.0017258587706895118	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	2	3	7	1	2	23	39	51	40	53														CASSYLTSGTNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCGCCCGTCACTAATGAACACTGAAGCTTTCTTTGGACAA	CASSSRPSLMNTEAFF	In	VDJ	1	86	0.0015241470979175896	0.0017882392081843134	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	3	9	0	10	1	23	36	50	46	51						01,02								CASSSRPSLMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTCTAAGACTTATGCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	90	0.0015950376606114311		55	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	2	10	5	6	13	23	35	45	41	58						01,02								X+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01	TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGAGATAAGCAAATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASREISKSGANVLTF	In	VDJ	1	95	0.0016836508639787328	0.0019753805206687183	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	6	6	7	1	7	3	23	34	44	41	47						01,02								CASREISKSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01	TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACCCAAGGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASNPRGSSYNEQFF	In	VDJ	2	101	0.001789986708019495	0.0021001413956583215	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	5	1	0	5	2	23	33	44	38	46														CASNPRGSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCATCGATCCCGGGACCTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASHRSRDLGANVLTF	In	VDJ	2	103	0.0018254319893664156	0.0021417283539881893	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	8	0	7	3	10	2	23	32	47	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASHRSRDLGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGACAGGGGACTATGGCTACACCTTCGGTTCG		Out	VDJ	2	105	0.0018608772707133362		37	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	2	3	1	0	23	34	-1	35	43														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGAGTAGCGGGAGACGTCAACAATGAGCAGTTCTTCGGGCCA	CASGVAGDVNNEQFF	In	VDJ	2	105	0.0018608772707133362	0.002183315312318057	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	5	2	5	4	6	23	32	45	36	51														CASGVAGDVNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCGGGGAATCAGCCCCAGCATTTTGGTGAT	CASRPGNQPQHF	In	VDJ	2	107	0.001896322552060257	0.0022249022706479246	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	8	3	4	2	0	23	34	-1	36	41														CASRPGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGCCCGGGACAGGTACACTGAAGCTTTCTTTGGACAA	CAIARDRYTEAFF	In	VDJ	2	113	0.002002658396101019	0.002349663145637528	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	0	4	3	6	1	23	30	44	36	45														CAIARDRYTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGTCGGGTCGATGAACACTGAAGCTTTCTTTGGACAA	CASSVGSMNTEAFF	In	VDJ	2	119	0.002108994240141781	0.0024744240206271313	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	8	4	0	3	4	23	34	41	37	45						01,02								CASSVGSMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCGGGACAGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRPGQSNTGELFF	In	VDJ	2	133	0.002357111209570226	0.0027655327289362055	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	5	0	3	1	23	34	44	37	45														CASRPGQSNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTTCAGGATCAACTAATGAAAAACTGTTTTTTGGCAGT	CASTSGSTNEKLFF	In	VDJ	2	155	0.0027470093043863537	0.003222989270564751	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	4	4	0	3	2	23	33	40	36	42														CASTSGSTNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGCCCTACAGGGGACGGGCGAAAAACTGTTTTTTGGCAGT	CASSALQGTGEKLFF	In	VDJ	3	200	0.003544528134692069	0.0041586958329867755	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	2	8	6	6	23	34	47	40	53														CASSALQGTGEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCGGGAGCCGCCTTACTGAAGCTTTCTTTGGACAA	CASSPGSRLTEAFF	In	VDJ	3	211	0.003739477182100133	0.004387424103801048	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	8	2	5	3	7	23	34	43	37	50														CASSPGSRLTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCACGGCCCAATTGGGGGCAGATACGCAGTATTTTGGCCCA	CASTAQLGADTQYF	In	VDJ	1	28	4.962339388568897E-4	5.822174166181485E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	8	6	1	4	11	0	24	33	-1	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASTAQLGADTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTTGCGGGACCTCCGCTCTGAGCAGTTCTTCGGGCCA	CASLRDLRSEQFF	In	VDJ	1	29	5.1395657953035E-4	6.030108957830824E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	7	3	9	1	9	24	34	41	35	50													Vb 18	CASLRDLRSEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGTCACGGGTCAATGAGCAGTTCTTCGGGCCA	CASSPPSRVNEQFF	In	VDJ	1	39	6.911829862649534E-4	8.109456874324212E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	8	4	6	4	1	24	41	49	45	50						01,02							Vb 18	CASSPPSRVNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGGCCGGGTATGGCTACACCTTCGGTTCG	CASSPGAGYGYTF	In	VDJ	1	39	6.911829862649534E-4	8.109456874324212E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	7	0	5	0	4	24	-1	44	39	48													Vb 18	CASSPGAGYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTACAGTCGCCAAAAACATTCAGTACTTCGGCGCC	CASSPTVAKNIQYF	In	VDJ	1	39	6.911829862649534E-4	8.109456874324212E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	3	5	1	1	2	24	38	43	39	45													Vb 18	CASSPTVAKNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAAATTTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	41	7.266282676118742E-4		41	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	5	2	7	4	10	0	24	36	-1	46	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCGGGAGGGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSSGGGSYEQYF	In	VDJ	1	41	7.266282676118742E-4	8.525326457622889E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	0	0	1	2	24	36	45	37	47													Vb 18	CASSSGGGSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTAGGACTAGCGGGGTTAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPRTSGVSSGANVLTF	In	VDJ	1	67	0.0011874169251218432	0.0013931631040505698	57	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	3	1	3	0	2	4	24	38	52	40	56													Vb 18	CASSPRTSGVSSGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-06*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAAGAGGGGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSKRGENTEAFF	In	VDJ	1	77	0.0013646433318564466	0.0016010978956999085	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	5	5	1	1	3	2	24	36	45	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSKRGENTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTTCCAGGACAGGAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	81	0.001435533894550288		43	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	1	4	1	4	0	24	34	-1	38	45													Vb 18	X+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCTCCCTGGACAGACCCCGAACACTGAAGCTTTCTTTGGACAA	CASSPLPGQTPNTEAFF	In	VDJ	1	90	0.0015950376606114311	0.0018714131248440489	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	5	1	7	5	24	38	51	45	56													Vb 18	CASSPLPGQTPNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTTCCGGGACTACCTTGTCGGATGAGCAGTTCTTCGGGCCA	CASSPSGTTLSDEQFF	In	VDJ	2	101	0.001789986708019495	0.0021001413956583215	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	9	8	4	9	24	38	49	42	58						01,02							Vb 18	CASSPSGTTLSDEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCACGCAGGGACACAAAAACATTCAGTACTTCGGCGCC	CASSPTQGHKNIQYF	In	VDJ	2	107	0.001896322552060257	0.0022249022706479246	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	0	6	3	6	0	24	38	-1	44	50													Vb 18	CASSPTQGHKNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACGGCGACTAACTCCTACGAGCAGTACTTCGGGCCG	CASSPTATNSYEQYF	In	VDJ	2	109	0.0019317678334071777	0.0022664892289777925	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	2	9	0	5	1	24	39	49	44	50						01,02							Vb 18	CASSPTATNSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGTGACAGGTCCCAATCAGCCCCAGCATTTTGGTGAT	CASSPVTGPNQPQHF	In	VDJ	2	121	0.0021444395214887018	0.002516010978956999	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	2	4	3	2	3	24	39	47	41	50													Vb 18	CASSPVTGPNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCGAACCGGGACTAGCGGGTACAATGAGCAGTTCTTCGGGCCA	CASSRTGTSGYNEQFF	In	VDJ	2	122	0.002162162162162162	0.002536804458121933	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	4	4	7	0	24	35	-1	42	54						01,02							Vb 18	CASSRTGTSGYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATTTGCCGGGACAGGGGACACTGAAGCTTTCTTTGGACAA	CASSFAGTGDTEAFF	In	VDJ	2	131	0.002321665928223305	0.002723945770606338	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	2	3	6	0	24	36	-1	42	52													Vb 18	CASSFAGTGDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCGGCGAACGGGGGATAGCCAAAAACATTCAGTACTTCGGCGCC	CASSGERGIAKNIQYF	In	VDJ	2	152	0.0026938413823659724	0.0031606088330699495	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	6	8	2	0	7	2	24	35	48	42	50													Vb 18	CASSGERGIAKNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGGCCAAAAACATTCAGTACTTCGGCGCC	CASSPGAKNIQYF	In	VDJ	4	239	0.004235711120957023	0.004969641520419197	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-04	01	2	0	9	1	0	0	24	-1	-1	39	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGAKNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01		TCRBJ02-04*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGGGGTGTTTGGCGAGCAGTTCTTCGGGCCA	CASSGVFGEQFF	In	VDJ	4	299	0.005299069561364643	0.006217250270315229	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	5	6	2	10	0	8	24	-1	40	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSGVFGEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCCAGGGGGTCCAAACTGAAGCTTTCTTTGGACAA	CASSPPQGVQTEAFF	In	VDJ	5	354	0.006273814798404963	0.007360891624386592	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	1	5	1	5	24	41	49	42	54													Vb 18	CASSPPQGVQTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	0481A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1046	891	137	17	0	752	622	113	17	0	56425	48092	7408	925	0	0.0724479258	8.60839844	0.0659559965	8.92440605				10558	0.0758721307	0.0432920232	0.0368985385	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:03	Age (Range):45-65 Years (Late Adulthood),Age:47 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2121,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 1261,type of chemo:carbo/taxol	0.8518164203771781	MSKCC- Snyder- P01-02		801.0	
